EXHIBIT 99.01
Item 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
HARTFORD LIFE INSURANCE COMPANY
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SCHEDULES
| | | | |
| | Page(s) | |
| |
Report of Independent Registered Public Accounting Firm | | | F-2 | |
| |
Consolidated Statements of Operations — For the Years Ended December 31, 2011, 2010 and 2009 | | | F-3 | |
| |
Consolidated Statements of Comprehensive Income (Loss) — For the Years Ended December 31, 2011, 2010 and 2009 | | | F-4 | |
| |
Consolidated Balance Sheets — As of December 31, 2011 and 2010 | | | F-5 | |
| |
Consolidated Statements of Changes in Equity — For the Years Ended December 31, 2011, 2010 and 2009 | | | F-6 | |
| |
Consolidated Statements of Cash Flows — For the Years Ended December 31, 2011, 2010 and 2009 | | | F-7 | |
| |
Notes to Consolidated Financial Statements | | | F-8-63 | |
| |
Schedule I — Summary of Investments — Other Than Investments in Affiliates | | | S-1 | |
| |
Schedule III — Supplementary Insurance Information | | | S-2-3 | |
| |
Schedule IV — Reinsurance | | | S-4 | |
| |
Schedule V — Valuation and Qualifying Accounts | | | S-5 | |
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholder of
Hartford Life Insurance Company
Hartford, Connecticut
We have audited the accompanying consolidated balance sheets of Hartford Life Insurance Company and subsidiaries (the “Company”) as of December 31, 2011 and 2010, and the related consolidated statements of operations, changes in equity, comprehensive income (loss), and cash flows for each of the three years in the period ended December 31, 2011. Our audits also included the consolidated financial statement schedules listed in the Index at Item 8. These consolidated financial statements and financial statement schedules are the responsibility of the Company’s management. Our responsibility is to express an opinion on the consolidated financial statements and financial statement schedules based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Hartford Life Insurance Company and subsidiaries as of December 31, 2011 and 2010, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2011, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such consolidated financial statement schedules, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly, in all material respects, the information set forth therein.
As discussed in Note 4 of the consolidated financial statements, the Company changed its method of accounting and reporting for variable interest entities and embedded credit derivatives as required by accounting guidance adopted in 2010 and for other-than-temporary impairments as required by accounting guidance adopted in 2009.
DELOITTE & TOUCHE LLP
Hartford, Connecticut
February 24, 2012, except for Note 21, as to which the date is April 23, 2012
F-2
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
Consolidated Statements of Operations
| | | | | | | | | | | | |
| | For the years ended December 31, | |
(In millions) | | 2011 | | | 2010 | | | 2009 | |
Revenues | | | | | | | | | | | | |
Fee income and other | | $ | 3,802 | | | $ | 3,806 | | | $ | 3,723 | |
Earned premiums | | | 234 | | | | 260 | | | | 377 | |
Net investment income (loss) | | | | | | | | | | | | |
Securities available-for-sale and other | | | 2,580 | | | | 2,621 | | | | 2,505 | |
Equity securities, trading | | | (14 | ) | | | 238 | | | | 343 | |
| | | | | | | | | | | | |
Total net investment income | | | 2,566 | | | | 2,859 | | | | 2,848 | |
Net realized capital gains (losses): | | | | | | | | | | | | |
Total other-than-temporary impairment (“OTTI”) losses | | | (196 | ) | | | (712 | ) | | | (1,722 | ) |
OTTI losses recognized in other comprehensive income | | | 71 | | | | 376 | | | | 530 | |
| | | | | | | | | | | | |
Net OTTI losses recognized in earnings | | | (125 | ) | | | (336 | ) | | | (1,192 | ) |
Net realized capital gains (losses), excluding net OTTI losses recognized in earnings | | | 126 | | | | (608 | ) | | | 316 | |
| | | | | | | | | | | | |
Total net realized capital gains (losses) | | | 1 | | | | (944 | ) | | | (876 | ) |
| | | | | | | | | | | | |
Total revenues | | | 6,603 | | | | 5,981 | | | | 6,072 | |
| | | | | | | | | | | | |
Benefits, losses and expenses | | | | | | | | | | | | |
Benefits, loss and loss adjustment expenses | | | 3,107 | | | | 2,948 | | | | 3,716 | |
Benefits, loss and loss adjustment expenses – returns credited on international unit-linked bonds and pension products | | | (14 | ) | | | 238 | | | | 343 | |
Amortization of deferred policy acquisition costs and present value of future profits | | | 616 | | | | 215 | | | | 3,716 | |
Insurance operating costs and other expenses | | | 2,896 | | | | 1,610 | | | | 1,826 | |
Dividends to policyholders | | | 17 | | | | 21 | | | | 12 | |
| | | | | | | | | | | | |
Total benefits, losses and expenses | | | 6,622 | | | | 5,032 | | | | 9,613 | |
| | | | | | | | | | | | |
Income (loss) from continuing operations before income taxes | | | (19 | ) | | | 949 | | | | (3,541 | ) |
Income tax expense (benefit) | | | (263 | ) | | | 228 | | | | (1,399 | ) |
| | | | | | | | | | | | |
Income (loss) from continuing operations, net of tax | | | 244 | | | | 721 | | | | (2,142 | ) |
Income (loss) from discontinued operations, net of tax | | | — | | | | 31 | | | | (5 | ) |
| | | | | | | | | | | | |
Net income (loss) | | | 244 | | | | 752 | | | | (2,147 | ) |
Net income attributable to the noncontrolling interest | | | — | | | | 8 | | | | 10 | |
| | | | | | | | | | | | |
Net income (loss) attributable to Hartford Life Insurance Company | | $ | 244 | | | $ | 744 | | | $ | (2,157 | ) |
| | | | | | | | | | | | |
See Notes to Consolidated Financial Statements.
F-3
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
Consolidated Statements of Comprehensive Income (Loss)
| | | | | | | | | | | | |
| | For the years ended December 31, | |
(In millions) | | 2011 | | | 2010 | | | 2009 | |
Comprehensive Income (Loss) | | | | | | | | | | | | |
Net income (loss) | | $ | 244 | | | $ | 744 | | | $ | (2,157 | ) |
| | | | | | | | | | | | |
Other comprehensive income (loss)[1] | | | | | | | | | | | | |
Change in net unrealized gain/loss on securities[2] | | | 1,100 | | | | 1,298 | | | | 3,229 | |
Change in net gain/loss on cash-flow hedging instruments | | | 103 | | | | 117 | | | | (292 | ) |
Change in foreign currency translation adjustments | | | (2 | ) | | | (18 | ) | | | 115 | |
| | | | | | | | | | | | |
Total other comprehensive income | | | 1,201 | | | | 1,397 | | | | 3,052 | |
| | | | | | | | | | | | |
Total comprehensive income | | $ | 1,445 | | | $ | 2,141 | | | $ | 895 | |
| | | | | | | | | | | | |
[1] | Net change in unrealized capital gain on securities is reflected net of tax benefit and other items of $713, $(699) and $(1,739) for the years ended December 31, 2011, 2010 and 2009, respectively. Net gain (loss) on cash flow hedging instruments is net of tax provision (benefit) of $(55), $(63) and $157 for the years ended December 31, 2011, 2010 and 2009, respectively. There is no tax effect on cumulative translation adjustments. |
[2] | There were reclassification adjustments for after-tax gains (losses) realized in net income of $52, $(121) and $(1,076) for the years ended December 31, 2011, 2010 and 2009, respectively. |
See Notes to Consolidated Financial Statements.
F-4
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
Consolidated Balance Sheets
| | | | | | | | |
| | As of December 31, | |
(In millions, except for share data) | | 2011 | | | 2010 | |
Assets | | | | | | | | |
Investments: | | | | | | | | |
Fixed maturities, available-for-sale, at fair value (amortized cost of $46,236 and $45,323) (includes variable interest entity assets, at fair value, of $153 and $406) | | $ | 47,778 | | | $ | 44,834 | |
Fixed maturities, at fair value using the fair value option (includes variable interest entity assets, at fair value, of $338 and $323) | | | 1,317 | | | | 639 | |
Equity securities, trading, at fair value (cost of $1,860 and $2,061) | | | 1,967 | | | | 2,279 | |
Equity securities, available for sale, at fair value (cost of $443 and $320) | | | 398 | | | | 340 | |
Mortgage loans (net of allowances for loan losses of $23 and $62) | | | 4,182 | | | | 3,244 | |
Policy loans, at outstanding balance | | | 1,952 | | | | 2,128 | |
Limited partnership and other alternative investments (includes variable interest entity assets of $7 and $14) | | | 1,376 | | | | 838 | |
Other investments | | | 1,974 | | | | 1,461 | |
Short-term investments | | | 3,882 | | | | 3,489 | |
| | | | | | | | |
Total investments | | | 64,826 | | | | 59,252 | |
Cash | | | 1,183 | | | | 531 | |
Premiums receivable and agents’ balances | | | 64 | | | | 67 | |
Reinsurance recoverables | | | 5,006 | | | | 3,924 | |
Deferred policy acquisition costs and present value of future profits | | | 4,598 | | | | 4,949 | |
Deferred income taxes, net | | | 1,606 | | | | 2,138 | |
Goodwill | | | 470 | | | | 470 | |
Other assets | | | 925 | | | | 692 | |
Separate account assets | | | 143,859 | | | | 159,729 | |
| | | | | | | | |
Total assets | | $ | 222,537 | | | $ | 231,752 | |
| | | | | | | | |
Liabilities | | | | | | | | |
Reserve for future policy benefits and unpaid losses and loss adjustment expenses | | | 11,831 | | | $ | 11, 385 | |
Other policyholder funds and benefits payable | | | 45,016 | | | | 43,395 | |
Other policyholder funds and benefits payable – international unit-linked bonds and pension products | | | 1,929 | | | | 2,252 | |
Consumer notes | | | 314 | | | | 382 | |
Other liabilities (includes variable interest entity liabilities of $477 and $422) | | | 9,927 | | | | 6,398 | |
Separate account liabilities | | | 143,859 | | | | 159,729 | |
| | | | | | | | |
Total liabilities | | $ | 212,876 | | | $ | 223,541 | |
| | |
Commitments and Contingencies (Note 10) | | | | | | | | |
| | |
Stockholder’s Equity | | | | | | | | |
Common stock — 1,000 shares authorized, issued and outstanding, par value $5,690 | | | 6 | | | | 6 | |
Additional paid-in capital | | | 8,271 | | | | 8,265 | |
Accumulated other comprehensive income (loss), net of tax | | | 829 | | | | (372 | ) |
Retained earnings | | | 555 | | | | 312 | |
| | | | | | | | |
Total stockholder’s equity | | | 9,661 | | | | 8,211 | |
| | | | | | | | |
Total liabilities and stockholder’s equity | | $ | 222,537 | | | $ | 231,752 | |
| | | | | | | | |
See Notes to Consolidated Financial Statements.
F-5
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
Consolidated Statements of Changes in Equity
| | | | | | | | | | | | | | | | | | | | | | | | |
(In millions) | | Common Stock | | | Additional Paid-In Capital | | | Accumulated Other Comprehensive Income (Loss) | | | Retained Earnings (Deficit) | | | Non- Controlling Interest | | | Total Stockholder’s Equity | |
Balance, December 31, 2010 | | $ | 6 | | | $ | 8,265 | | | $ | (372 | ) | | $ | 312 | | | $ | — | | | $ | 8,211 | |
| | | | | | |
Capital contributions from parent | | | — | | | | 6 | | | | — | | | | — | | | | — | | | | 6 | |
Dividends declared | | | — | | | | — | | | | — | | | | (1 | ) | | | — | | | | (1 | ) |
Net income | | | — | | | | — | | | | — | | | | 244 | | | | — | | | | 244 | |
Total other comprehensive income | | | — | | | | — | | | | 1,201 | | | | — | | | | — | | | | 1,201 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Balance December 31, 2011 | | $ | 6 | | | $ | 8,271 | | | $ | 829 | | | $ | 555 | | | $ | — | | | $ | 9,661 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Balance, December 31, 2009 | | $ | 6 | | | $ | 8,457 | | | $ | (1,941 | ) | | $ | (287 | ) | | $ | 61 | | | $ | 6,296 | |
| | | | | | |
Cumulative effect of accounting changes, net of DAC and tax | | | — | | | | — | | | | 172 | | | | (146 | ) | | | — | | | | 26 | |
Capital contributions from parent | | | — | | | | (192 | ) | | | — | | | | — | | | | — | | | | (192 | ) |
Dividends declared | | | — | | | | — | | | | — | | | | 1 | | | | — | | | | 1 | |
Change in noncontrolling interest ownership | | | — | | | | — | | | | — | | | | — | | | | (69 | ) | | | (69 | ) |
Net income | | | — | | | | — | | | | — | | | | 744 | | | | 8 | | | | 752 | |
Total other comprehensive income | | | — | | | | — | | | | 1,397 | | | | — | | | | — | | | | 1,397 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Balance December 31, 2010 | | $ | 6 | | | $ | 8,265 | | | $ | (372 | ) | | $ | 312 | | | $ | — | | | $ | 8,211 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Balance, December 31, 2008 | | $ | 6 | | | $ | 6,157 | | | $ | (4,531 | ) | | $ | 1,446 | | | $ | 165 | | | $ | 3,243 | |
| | | | | | |
Cumulative effect of accounting changes, net of DAC and tax | | | — | | | | — | | | | (462 | ) | | | 462 | | | | — | | | | — | |
Capital contributions from parent (1) | | | — | | | | 2,300 | | | | — | | | | — | | | | — | | | | 2,300 | |
Dividends declared | | | — | | | | — | | | | — | | | | (38 | ) | | | — | | | | (38 | ) |
Change in noncontrolling interest ownership | | | — | | | | — | | | | — | | | | — | | | | (114 | ) | | | (114 | ) |
Net loss | | | — | | | | — | | | | — | | | | (2,157 | ) | | | 10 | | | | (2,147 | ) |
Total other comprehensive income | | | — | | | | — | | | | 3,052 | | | | — | | | | — | | | | 3,052 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Balance December 31, 2009 | | $ | 6 | | | $ | 8,457 | | | $ | (1,941 | ) | | $ | (287 | ) | | $ | 61 | | | $ | 6,296 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
(1) | For the year ended December 31, 2009, the Company received $2.1 billion in capital contributions from its parent and returned capital of $700 to its parent. The Company received noncash capital contributions of $887 as a result of valuations associated with the October 1, 2009 reinsurance transaction with an affiliated captive reinsurer. Refer to Note 16 of the Notes to Consolidated Financial Statements. |
See Notes to Consolidated Financial Statements
F-6
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
Consolidated Statements of Cash Flows
| | | | | | | | | | | | |
| | For the years ended December 31, | |
(In millions) | | 2011 | | | 2010 | | | 2009 | |
Operating Activities | | | | | | | | | | | | |
Net income (loss) | | $ | 244 | | | $ | 752 | | | $ | (2,147 | ) |
Adjustments to reconcile net income(loss) to net cash provided by operating activities | | | | | | | | | | | | |
Amortization of deferred policy acquisition costs and present value of future profits | | | 616 | | | | 232 | | | | 3,727 | |
Additions to deferred policy acquisition costs and present value of future profits | | | (533 | ) | | | (521 | ) | | | (674 | ) |
Change in: | | | | | | | | | | | | |
Reserve for future policy benefits and unpaid losses and loss adjustment expenses | | | 252 | | | | 13 | | | | 574 | |
Reinsurance recoverables | | | 57 | | | | 26 | | | | 66 | |
Receivables and other assets | | | 9 | | | | (112 | ) | | | (20 | ) |
Payables and accruals | | | 2,402 | | | | 295 | | | | 420 | |
Accrued and deferred income taxes | | | (115 | ) | | | (90 | ) | | | (797 | ) |
Net realized capital losses | | | 1 | | | | 882 | | | | 877 | |
Net receipts (disbursements) from investment contracts related to policyholder funds – international unit-linked bonds and pension products | | | (323 | ) | | | (167 | ) | | | 804 | |
Net (increase) decrease in equity securities, trading | | | 312 | | | | 164 | | | | (809 | ) |
Depreciation and amortization | | | 194 | | | | 207 | | | | 173 | |
Other, net | | | (108 | ) | | | 201 | | | | 328 | |
| | | | | | | | | | | | |
Net cash provided by operating activities | | $ | 3,008 | | | $ | 1,882 | | | $ | 2,522 | |
Investing Activities | | | | | | | | | | | | |
Proceeds from the sale/maturity/prepayment of: | | | | | | | | | | | | |
Fixed maturities and short-term investments, available-for-sale | | $ | 19,203 | | | $ | 28,581 | | | $ | 37,224 | |
Fixed maturities, fair value option | | | 37 | | | | 20 | | | | — | |
Equity securities, available-for-sale | | | 147 | | | | 171 | | | | 162 | |
Mortgage loans | | | 332 | | | | 1,288 | | | | 413 | |
Partnerships | | | 128 | | | | 151 | | | | 173 | |
Payments for the purchase of: | | | | | | | | | | | | |
Fixed maturities and short-term investments, available-for-sale | | | (20,517 | ) | | | (28,871 | ) | | | (35,519 | ) |
Fixed maturities, fair value option | | | (661 | ) | | | (74 | ) | | | — | |
Equity securities, available-for-sale | | | (230 | ) | | | (122 | ) | | | (61 | ) |
Mortgage loans | | | (1,246 | ) | | | (189 | ) | | | (197 | ) |
Partnerships | | | (436 | ) | | | (172 | ) | | | (121 | ) |
Proceeds from business sold | | | — | | | | 241 | | | | — | |
Derivatives payments (sales), net | | | 938 | | | | (644 | ) | | | (520 | ) |
Change in policy loans, net | | | 176 | | | | (8 | ) | | | 34 | |
Change in payables for collateral under securities lending, net | | | — | | | | (46 | ) | | | (1,805 | ) |
Change in all other, net | | | 1 | | | | (117 | ) | | | 25 | |
| | | | | | | | | | | | |
Net cash provided by (used for) investing activities | | $ | (2,128 | ) | | $ | 209 | | | $ | (192 | ) |
Financing Activities | | | | | | | | | | | | |
Deposits and other additions to investment and universal life-type contracts | | $ | 12,124 | | | $ | 15,405 | | | $ | 13,398 | |
Withdrawals and other deductions from investment and universal life-type contracts | | | (22,720 | ) | | | (25,030 | ) | | | (23,487 | ) |
| | | |
Net transfers from (to) separate accounts related to investment and universal life-type contracts | | | 10,439 | | | | 8,211 | | | | 6,805 | |
Net repayments at maturity or settlement of consumer notes | | | (68 | ) | | | (754 | ) | | | (74 | ) |
Issuance of structured financing | | | — | | | | — | | | | (189 | ) |
Capital contributions (1) (2) | | | — | | | | (195 | ) | | | 1,397 | |
Dividends paid (1) | | | — | | | | — | | | | (33 | ) |
| | | | | | | | | | | | |
Net cash used for financing activities | | $ | (225 | ) | | $ | (2,363 | ) | | $ | (2,183 | ) |
Foreign exchange rate effect on cash | | | (3 | ) | | | 10 | | | | (15 | ) |
Net increase (decrease) in cash | | | 652 | | | | (262 | ) | | | 132 | |
Cash — beginning of year | | | 531 | | | | 793 | | | | 661 | |
| | | | | | | | | | | | |
Cash — end of year | | $ | 1,183 | | | $ | 531 | | | $ | 793 | |
| | | | | | | | | | | | |
Supplemental Disclosure of Cash Flow Information: | | | | | | | | | | | | |
Net cash paid (received) during the year for income taxes | | $ | (105 | ) | | $ | 354 | | | $ | (282 | ) |
Supplemental schedule of noncash operating and financing activities:
(1) | The Company made noncash dividends of $5 in 2009 related to the assumed reinsurance agreements with Hartford Life Insurance K.K. |
(2) | The Company received noncash capital contributions of $887 as a result of valuations associated with an October 1, 2009 reinsurance transaction with an affiliated captive reinsurer. Refer to Note 16 of the Notes to Consolidated Financial Statements for further discussion of this transaction. |
See Notes to Consolidated Financial Statements.
F-7
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in millions, unless otherwise stated)
1. Basis of Presentation and Accounting Policies
Basis of Presentation
Hartford Life Insurance Company (together with its subsidiaries, “HLIC”, “Company”, “we” or “our”) is a provider of insurance and investment products in the United States (“U.S.”) and is a wholly-owned subsidiary of Hartford Life and Accident Insurance Company (“HLA”). The Hartford Financial Services Group, Inc. (“The Hartford”) is the ultimate parent of the Company.
The Consolidated Financial Statements have been prepared on the basis of accounting principles generally accepted in the United States of America (“U.S. GAAP”), which differ materially from the accounting practices prescribed by various insurance regulatory authorities.
Consolidation
The Consolidated Financial Statements include the accounts of HLIC, companies in which the Company directly or indirectly has a controlling financial interest and those variable interest entities (“VIEs”) in which the Company is required to consolidate. Entities in which HLIC has significant influence over the operating and financing decisions but are not required to consolidate are reported using the equity method. For further discussions on VIEs, see Note 4 of the Notes to Consolidated Financial Statements. Material intercompany transactions and balances between HLIC and its subsidiaries have been eliminated.
Discontinued Operations
The results of operations of a component of the Company that either has been disposed of or is classified as held-for-sale are reported in discontinued operations if the operations and cash flows of the component have been or will be eliminated from the ongoing operations of the Company as a result of the disposal transaction and the Company will not have any significant continuing involvement in the operations of the component after the disposal transaction.
The Company is presenting the operations of certain businesses that meet the criteria for reporting as discontinued operations. Amounts for prior periods have been retrospectively reclassified. See Note 19 of the Notes to Consolidated Financial Statements for information on the specific subsidiaries and related impacts.
Use of Estimates
The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
The most significant estimates include those used in determining estimated gross profits used in the valuation and amortization of assets and liabilities associated with variable annuity and other universal life-type contracts; evaluation of other-than-temporary impairments on available-for-sale securities and valuation allowances on investments; living benefits required to be fair valued; goodwill impairment; valuation of investments and derivative instruments; valuation allowance on deferred tax assets; and contingencies relating to corporate litigation and regulatory matters. Certain of these estimates are particularly sensitive to market conditions, and deterioration and/or volatility in the worldwide debt or equity markets could have a material impact on the Consolidated Financial Statements.
Mutual Funds
The Company maintains a retail mutual fund operation whereby the Company, through wholly-owned subsidiaries, provides investment management and administrative services to The Hartford Mutual Funds, Inc. and The Hartford Mutual Funds II, Inc. (collectively, “mutual funds”), consisting of 57 non-proprietary mutual funds, as of December 31, 2011. The Company charges fees to these mutual funds, which are recorded as revenue by the Company. These mutual funds are registered with the Securities and Exchange Commission (“SEC”) under the Investment Company Act of 1940. The mutual funds are owned by the shareholders of those funds and not by the Company. In the fourth quarter of 2011, the Company entered into a preferred partnership agreement with Wellington Management Company, LLP (“Wellington Management”) and announced that Wellington Management will serve as the sole sub-advisor for The Hartford’s non-proprietary mutual funds, including equity and fixed income funds, pending a fund-by-fund review by The Hartford’s mutual funds board of directors. As of December 31, 2011, Wellington Management served as the sub-advisor for 29 of The Hartford’s non-proprietary mutual funds and has been the primary manager for the Company’s equity funds.
The mutual funds are owned by the shareholders of those funds and not by the Company. As such, the mutual fund assets and liabilities and related investment returns are not reflected in the Company’s Consolidated Financial Statements since they are not assets, liabilities and operations of the Company.
Reclassifications
Certain reclassifications have been made to prior year financial information to conform to the current year presentation.
F-8
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
1. Basis of Presentation and Accounting Policies (continued)
Future Adoption of New Accounting Standards
Accounting for Costs Associated with Acquiring or Renewing Insurance Contracts
In October 2010, the FASB issued a standard clarifying the definition of acquisition costs that are eligible for deferral. Acquisition costs are to include only those costs that are directly related to the successful acquisition or renewal of insurance contracts; incremental direct costs of contract acquisition that are incurred in transactions with either independent third parties or employees; and advertising costs meeting the capitalization criteria for direct-response advertising.
This standard will be effective for fiscal years beginning after December 15, 2011, and interim periods within those years. This standard may be applied prospectively upon the date of adoption, with retrospective application permitted, but not required. Early adoption as of the beginning of a fiscal year is permitted.
The Company elected to adopt this standard retrospectively on January 1, 2012, resulting in a write down of the Company’s deferred acquisition costs relating to those costs which no longer meet the revised standard as summarized above. The Company estimates the cumulative effect of the retrospective adoption of this standard, when reflected in future financial statements, will reduce stockholders’ equity as of December 31, 2011 by approximately $750, after-tax and decrease 2011 net income by approximately $15. Excluding the effects of DAC Unlock and amortization related to realized gains and losses, the estimated effect would be a decrease to 2011 net income of approximately $50. Future income statement impacts will reflect higher non-deferrable expenses and lower amortization due to the lower DAC balance, before the effect of any DAC Unlock and amortization related to realized gains and losses.
Significant Accounting Policies
The Company’s significant accounting policies are described below or are referenced below to the applicable Note where the description is included.
| | | | |
Accounting Policy | | Note | |
Fair Value Measurements | | | 3 | |
Investments and Derivative Instruments | | | 4 | |
Reinsurance | | | 5 | |
Deferred Policy Acquisition Costs and Present Value of Future Profits | | | 6 | |
Goodwill and Other Intangible Assets | | | 7 | |
Separate Accounts, Death Benefits and Other Insurance Benefit Features | | | 8 | |
Sales Inducements | | | 9 | |
Commitments and Contingencies | | | 10 | |
Income Taxes | | | 11 | |
Revenue Recognition
For investment and universal life-type contracts, the amounts collected from policyholders are considered deposits and are not included in revenue. Fee income for universal life-type contracts consists of policy charges for policy administration, cost of insurance charges and surrender charges assessed against policyholders’ account balances and are recognized in the period in which services are provided. For the Company’s traditional life and group disability products premiums are recognized as revenue when due from policyholders.
Dividends to Policyholders
Policyholder dividends are paid to certain life insurance policyholders. Policies that receive dividends are referred to as participating policies. Such dividends are accrued using an estimate of the amount to be paid based on underlying contractual obligations under policies and applicable state laws.
Participating policies were 2%, 3% and 3% of the total life insurance policies as of December 31, 2011, 2010, and 2009, respectively. Dividends to policyholders were $17, $21 and $12 for the years ended December 31, 2011, 2010, and 2009, respectively. There were no additional amounts of income allocated to participating policyholders. If limitations exist on the amount of net income from participating life insurance contracts that may be distributed to stockholder’s, the policyholder’s share of net income on those contracts that cannot be distributed is excluded from stockholder’s equity by a charge to operations and a credit to a liability.
F-9
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
1. Basis of Presentation and Accounting Policies (continued)
Cash
Cash represents cash on hand and demand deposits with banks or other financial institutions.
Other Policyholder Funds and Benefits Payable
The Company has classified its fixed and variable annuities, 401(k), certain governmental annuities, private placement life insurance (“PPLI”), variable universal life insurance, universal life insurance and interest sensitive whole life insurance as universal life-type contracts. The liability for universal life-type contracts is equal to the balance that accrues to the benefit of the policyholders as of the financial statement date (commonly referred to as the account value), including credited interest, amounts that have been assessed to compensate the Company for services to be performed over future periods, and any amounts previously assessed against policyholders that are refundable on termination of the contract.
The Company has classified its institutional and governmental products, without life contingencies, including funding agreements, certain structured settlements and guaranteed investment contracts, as investment contracts. The liability for investment contracts is equal to the balance that accrues to the benefit of the contract holder as of the financial statement date, which includes the accumulation of deposits plus credited interest, less withdrawals and amounts assessed through the financial statement date. Contract holder funds include funding agreements held by Variable Interest Entities issuing medium-term notes.
Reserve for Future Policy Benefits and Unpaid Losses and Loss Adjustment
Liabilities for the Company’s group life and disability contracts as well its individual term life insurance policies include amounts for unpaid losses and future policy benefits. Liabilities for unpaid losses include estimates of amounts to fully settle known reported claims as well as claims related to insured events that the Company estimates have been incurred but have not yet been reported. Liabilities for future policy benefits are calculated by the net level premium method using interest, withdrawal and mortality assumptions appropriate at the time the policies were issued. The methods used in determining the liability for unpaid losses and future policy benefits are standard actuarial methods recognized by the American Academy of Actuaries. For the tabular reserves, discount rates are based on the Company’s earned investment yield and the morbidity/mortality tables used are standard industry tables modified to reflect the Company’s actual experience when appropriate. In particular, for the Company’s group disability known claim reserves, the morbidity table for the early durations of claim is based exclusively on the Company’s experience, incorporating factors such as gender, elimination period and diagnosis. These reserves are computed such that they are expected to meet the Company’s future policy obligations. Future policy benefits are computed at amounts that, with additions from estimated premiums to be received and with interest on such reserves compounded annually at certain assumed rates, are expected to be sufficient to meet the Company’s policy obligations at their maturities or in the event of an insured’s death. Changes in or deviations from the assumptions used for mortality, morbidity, expected future premiums and interest can significantly affect the Company’s reserve levels and related future operations and, as such, provisions for adverse deviation are built into the long-tailed liability assumptions.
Certain contracts classified as universal life-type may also include additional death or other insurance benefit features, such as guaranteed minimum death benefits offered with variable annuity contracts and no lapse guarantees offered with universal life insurance contracts. An additional liability is established for these benefits by estimating the expected present value of the benefits in excess of the projected account value in proportion to the present value of total expected assessments. Excess benefits are accrued as a liability as actual assessments are recorded. Determination of the expected value of excess benefits and assessments are based on a range of scenarios and assumptions including those related to market rates of return and volatility, contract surrender rates and mortality experience. Revisions to assumptions are made consistent with the Company’s process for a DAC unlock. For further information, see MD&A, Critical Accounting Estimates, Life Deferred Policy Acquisition Costs and Present Value of Future Benefits.
Foreign Currency Translation
Foreign currency translation gains and losses are reflected in stockholders’ equity as a component of accumulated other comprehensive income. The Company’s foreign subsidiaries’ balance sheet accounts are translated at the exchange rates in effect at each year end and income statement accounts are translated at the average rates of exchange prevailing during the year. The national currencies of the international operations are generally their functional currencies.
F-10
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
2. Segment Information
The Company has five reporting segments: Individual Annuity, Individual Life, Retirement Plans, Mutual Funds and Runoff Operations, as well as an Other category, as follows:
Individual Annuity
Individual Annuity offers variable, fixed market value adjusted (“MVA”), fixed index and single premium immediate annuities and longevity assurance to individuals.
Individual Life
Individual Life sells a variety of life insurance products, including variable universal life, universal life, and term life.
Retirement Plans
Retirement Plans provides products and services to corporations pursuant to Section 401(k) of the Internal Revenue Service Code of 1986 as amended (“the Code”) and products and services to municipalities and not-for-profit organizations under Sections 457 and 403(b) of the Code, collectively referred to as government plans.
Mutual Funds
Mutual Funds offers retail mutual funds, investment-only mutual funds and college savings plans under Section 529 of the Code (collectively referred to as non-proprietary) and proprietary mutual funds supporting the insurance products issued by The Hartford.
Runoff Operations
Runoff Operations consists of the international annuity business of the former Global Annuity reporting segment as well as certain product offerings previously included in the former Global Annuity and Life Insurance reporting segments. Runoff Operations encompasses the administration of investment retirement savings and other insurance and savings products to individuals and groups outside of the U.S., primarily in Japan and Europe, as well institutional investment products and private placement life insurance. In addition, Runoff Operations includes direct and assumed guaranteed minimum income benefit (“GMIB”), guaranteed minimum death benefit (“GMDB”), guaranteed minimum accumulation benefit (“GMAB”) and guaranteed minimum withdrawal benefit (“GMWB”) which is subsequently ceded to an affiliated captive reinsurer.
Other
The Company includes in an Other category corporate items not directly allocated to any of its reporting segments, intersegment eliminations, and certain group benefit products, including group life and group disability insurance that is directly written by the Company and for which nearly half is ceded to its parent, Hartford Life and Accident Insurance Company (“HLA”).
The accounting policies of the reporting segments are the same as those described in the summary of significant accounting policies in Note 1. The Company evaluates performance of its segments based on revenues, net income and the segment’s return on allocated capital. Each operating segment is allocated corporate surplus as needed to support its business.
The Company charges direct operating expenses to the appropriate segment and allocates the majority of indirect expenses to the segments based on an intercompany expense arrangement. Inter-segment revenues primarily occur between the Company’s Other category and the reporting segments. These amounts primarily include interest income on allocated surplus and interest charges on excess separate account surplus. Consolidated net investment income is unaffected by such transactions.
The following tables represent summarized financial information concerning the Company’s reporting segments.
| | | | | | | | |
| | As of December 31, | |
Assets | | 2011 | | | 2010 | |
Individual Annuity | | $ | 87,245 | | | $ | 99,482 | |
Individual Life | | | 17,456 | | | | 15,911 | |
Retirement Plans | | | 35,410 | | | | 34,153 | |
Mutual Funds | | | 182 | | | | 153 | |
Runoff Operations | | | 79,658 | | | | 78,905 | |
Other | | | 2,586 | | | | 3,148 | |
| | | | | | | | |
Total assets | | $ | 222,537 | | | $ | 231,752 | |
| | | | | | | | |
F-11
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
2. Segment Information (continued)
| | | | | | | | | | | | |
| | For the years ended December 31, | |
Revenues by Product Line | | 2011 | | | 2010 | | | 2009 | |
Earned premiums, fees, and other considerations | | | | | | | | | | | | |
Individual Annuity | | | | | | | | | | | | |
Individual variable annuity | | $ | 1,595 | | | $ | 1,707 | | | $ | 1,551 | |
Fixed / MVA and other annuity | | | 56 | | | | 14 | | | | (2 | ) |
| | | | | | | | | | | | |
Total Individual Annuity | | | 1,651 | | | | 1,721 | | | | 1,549 | |
Individual Life | | | | | | | | | | | | |
Variable life | | | 396 | | | | 416 | | | | 503 | |
Universal life | | | 429 | | | | 367 | | | | 362 | |
Term life | | | 33 | | | | 36 | | | | 37 | |
| | | | | | | | | | | | |
Total Individual Life | | | 858 | | | | 819 | | | | 902 | |
Retirement Plans | | | | | | | | | | | | |
401(k) | | | 332 | | | | 318 | | | | 286 | |
Government plans | | | 48 | | | | 41 | | | | 38 | |
| | | | | | | | | | | | |
Total Retirement Plans | | | 380 | | | | 359 | | | | 324 | |
Mutual Funds | | | | | | | | | | | | |
Non-Proprietary | | | 511 | | | | 519 | | | | 437 | |
Proprietary | | | 58 | | | | 61 | | | | — | |
| | | | | | | | | | | | |
Total Mutual Funds | | | 569 | | | | 580 | | | | 437 | |
| | | | | | | | | | | | |
Runoff Operations | | | 221 | | | | 254 | | | | 549 | |
| | | | | | | | | | | | |
Other | | | 357 | | | | 333 | | | | 339 | |
| | | | | | | | | | | | |
Total premiums, fees, and other considerations | | | 4,036 | | | | 4,066 | | | | 4,100 | |
| | | | | | | | | | | | |
Net investment income | | | 2,566 | | | | 2,859 | | | | 2,848 | |
Net realized capital losses | | | 1 | | | | (944 | ) | | | (876 | ) |
| | | | | | | | | | | | |
Total Revenues | | $ | 6,603 | | | $ | 5,981 | | | $ | 6,072 | |
| | | | | | | | | | | | |
Net income (loss) attributable to Hartford Life Insurance Company | | | | | | | | | | | | |
Individual Annuity | | $ | 87 | | | $ | 371 | | | $ | (1,962 | ) |
Individual Life | | | 104 | | | | 195 | | | | 8 | |
Retirement Plans | | | 15 | | | | 47 | | | | (222 | ) |
Mutual Funds | | | 98 | | | | 129 | | | | 32 | |
Runoff Operations | | | (20 | ) | | | (78 | ) | | | 77 | |
Other | | | (40 | ) | | | 80 | | | | (90 | ) |
| | | | | | | | | | | | |
Total net income (loss) | | $ | 244 | | | $ | 744 | | | $ | (2,157 | ) |
| | | | | | | | | | | | |
Net investment income (loss) | | | | | | | | | | | | |
Individual Annuity | | $ | 769 | | | $ | 813 | | | $ | 770 | |
Individual Life | | | 420 | | | | 362 | | | | 304 | |
Retirement Plans | | | 396 | | | | 364 | | | | 315 | |
Mutual Funds | | | 1 | | | | (1 | ) | | | (16 | ) |
Runoff Operations | | | 941 | | | | 1,221 | | | | 1,279 | |
Other | | | 39 | | | | 100 | | | | 196 | |
| | | | | | | | | | | | |
Total net investment income | | $ | 2,566 | | | $ | 2,859 | | | $ | 2,848 | |
| | | | | | | | | | | | |
Amortization of deferred policy acquisition and present value of future profits | | | | | | | | | | | | |
Individual Annuity | | $ | 186 | | | $ | (39 | ) | | $ | 3,189 | |
Individual Life | | | 219 | | | | 120 | | | | 312 | |
Retirement Plans | | | 134 | | | | 27 | | | | 56 | |
Mutual Funds | | | 47 | | | | 51 | | | | 50 | |
Runoff Operations | | | 30 | | | | 56 | | | | 111 | |
Other | | | — | | | | — | | | | (2 | ) |
| | | | | | | | | | | | |
Total amortization of DAC | | $ | 616 | | | $ | 215 | | | $ | 3,716 | |
| | | | | | | | | | | | |
F-12
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
2. Segment Information (continued)
| | | | | | | | | | | | |
| | For the years ended December 31, | |
Income tax expense (benefit) | | 2011 | | | 2010 | | | 2009 | |
Individual Annuity | | $ | (220 | ) | | $ | 41 | | | $ | (1,299 | ) |
Individual Life | | | 22 | | | | 93 | | | | (27 | ) |
Retirement Plans | | | (45 | ) | | | 13 | | | | (143 | ) |
Mutual Funds | | | 52 | | | | 51 | | | | 20 | |
Runoff Operations | | | (48 | ) | | | 10 | | | | 80 | |
Other | | | (24 | ) | | | 20 | | | | (30 | ) |
| | | | | | | | | | | | |
Total income tax expense (benefit) | | $ | (263 | ) | | $ | 228 | | | $ | (1,399 | ) |
| | | | | | | | | | | | |
3. Fair Value Measurements
The following financial instruments are carried at fair value in the Company’s Consolidated Financial Statements: fixed maturity and equity securities, available-for-sale (“AFS”), fixed maturities at fair value using fair value option (“FVO”); equity securities, trading; short-term investments; freestanding and embedded derivatives; separate account assets; and certain other liabilities.
The following section applies the fair value hierarchy and disclosure requirements for the Company’s financial instruments that are carried at fair value. The fair value hierarchy prioritizes the inputs in the valuation techniques used to measure fair value into three broad Levels (Level 1, 2 and 3).
| | |
Level 1 | | Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. Level 1 securities include highly liquid U.S. Treasuries, money market funds, and exchange traded equity and derivative securities. |
| |
Level 2 | | Observable inputs, other than quoted prices included in Level 1, for the asset or liability or prices for similar assets and liabilities. Most fixed maturities and preferred stocks are model priced by vendors using observable inputs and are classified within Level 2. |
| |
Level 3 | | Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Level 3 securities include less liquid securities, guaranteed product embedded and reinsurance derivatives and other complex derivatives securities. Because Level 3 fair values, by their nature, contain unobservable inputs as there is little or no observable market for these assets and liabilities, considerable judgment is used to determine the Level 3 fair values. Level 3 fair values represent the Company’s best estimate of an amount that could be realized in a current market exchange absent actual market exchanges. |
In many situations, inputs used to measure the fair value of an asset or liability position may fall into different levels of the fair value hierarchy. In these situations, the Company will determine the level in which the fair value falls based upon the lowest level input that is significant to the determination of the fair value. Transfers of securities among the levels occur at the beginning of the reporting period. Transfers between Level 1 and Level 2 were not material for the year ended December 31, 2011. In most cases, both observable (e.g., changes in interest rates) and unobservable (e.g., changes in risk assumptions) inputs are used in the determination of fair values that the Company has classified within Level 3. Consequently, these values and the related gains and losses are based upon both observable and unobservable inputs. The Company’s fixed maturities included in Level 3 are classified as such because these securities are primarily priced by independent brokers and/or within illiquid markets.
F-13
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
| | | | | | | | | | | | | | | | |
| | December 31, 2011 | |
| | Total | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | | Significant Observable Inputs (Level 2) | | | Significant Unobservable Inputs (Level 3) | |
Assets accounted for at fair value on a recurring basis | | | | | | | | | | | | | | | | |
Fixed maturities, AFS | | | | | | | | | | | | | | | | |
ABS | | $ | 2,093 | | | $ | — | | | $ | 1,776 | | | $ | 317 | |
CDOs | | | 1,798 | | | | — | | | | 1,470 | | | | 328 | |
CMBS | | | 4,269 | | | | — | | | | 3,921 | | | | 348 | |
Corporate | | | 30,229 | | | | — | | | | 28,732 | | | | 1,497 | |
Foreign government/government agencies | | | 1,224 | | | | — | | | | 1,187 | | | | 37 | |
States, municipalities and political subdivisions (“Municipal”) | | | 1,557 | | | | — | | | | 1,175 | | | | 382 | |
RMBS | | | 3,823 | | | | — | | | | 2,890 | | | | 933 | |
U.S. Treasuries | | | 2,785 | | | | 487 | | | | 2,298 | | | | — | |
| | | | | | | | | | | | | | | | |
Total fixed maturities | | | 47,778 | | | | 487 | | | | 43,449 | | | | 3,842 | |
Fixed maturities, FVO | | | 1,317 | | | | — | | | | 833 | | | | 484 | |
Equity securities, trading | | | 1,967 | | | | 1,967 | | | | — | | | | — | |
Equity securities, AFS | | | 398 | | | | 227 | | | | 115 | | | | 56 | |
Derivative assets | | | | | | | | | | | | | | | | |
Credit derivatives | | | (27 | ) | | | — | | | | (6 | ) | | | (21 | ) |
Equity derivatives | | | 31 | | | | — | | | | — | | | | 31 | |
Foreign exchange derivatives | | | 505 | | | | — | | | | 505 | | | | — | |
Interest rate derivatives | | | 78 | | | | — | | | | 38 | | | | 40 | |
U.S. GMWB hedging instruments | | | 494 | | | | — | | | | 11 | | | | 483 | |
U.S. macro hedge program | | | 357 | | | | — | | | | — | | | | 357 | |
International program hedging instruments | | | 533 | | | | — | | | | 567 | | | | (34 | ) |
| | | | | | | | | | | | | | | | |
Total derivative assets [1] | | | 1,971 | | | | — | | | | 1,115 | | | | 856 | |
Short-term investments | | | 3,882 | | | | 520 | | | | 3,362 | | | | — | |
Reinsurance recoverable for U.S. GMWB and Japan GMWB, GMIB, and GMAB | | | 3,073 | | | | — | | | | — | | | | 3,073 | |
Separate account assets [2] | | | 139,421 | | | | 101,633 | | | | 36,757 | | | | 1,031 | |
| | | | | | | | | | | | | | | | |
Total assets accounted for at fair value on a recurring basis | | $ | 199,807 | | | | 104,834 | | | | 85,631 | | | | 9,342 | |
| | | | | | | | | | | | | | | | |
Liabilities accounted for at fair value on a recurring basis | | | | | | | | | | | | | | | | |
Other policyholder funds and benefits payable | | | | | | | | | | | | | | | | |
Guaranteed living benefits | | $ | (5,776 | ) | | $ | — | | | $ | — | | | $ | (5,776 | ) |
Equity linked notes | | | (9 | ) | | | — | | | | — | | | | (9 | ) |
| | | | | | | | | | | | | | | | |
Total other policyholder funds and benefits payable | | | (5,785 | ) | | | — | | | | — | | | | (5,785 | ) |
Derivative liabilities | | | | | | | | | | | | | | | | |
Credit derivatives | | | (493 | ) | | | — | | | | (25 | ) | | | (468 | ) |
Equity derivatives | | | 5 | | | | — | | | | — | | | | 5 | |
Foreign exchange derivatives | | | 140 | | | | — | | | | 140 | | | | — | |
Interest rate derivatives | | | (315 | ) | | | — | | | | (184 | ) | | | (131 | ) |
U.S. GMWB hedging instruments | | | 400 | | | | — | | | | — | | | | 400 | |
International program hedging instruments | | | 9 | | | | — | | | | 10 | | | | (1 | ) |
| | | | | | | | | | | | | | | | |
Total derivative liabilities [3] | | | (254 | ) | | | — | | | | (59 | ) | | | (195 | ) |
Other liabilities | | | (9 | ) | | | — | | | | — | | | | (9 | ) |
Consumer notes [4] | | | (4 | ) | | | — | | | | — | | | | (4 | ) |
| | | | | | | | | | | | | | | | |
Total liabilities accounted for at fair value on a recurring basis | | $ | (6,052 | ) | | $ | — | | | $ | (59 | ) | | $ | (5,993 | ) |
| | | | | | | | | | | | | | | | |
F-14
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
| | | | | | | | | | | | | | | | |
| | December 31, 2010 | |
| | Total | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | | Significant Observable Inputs (Level 2) | | | Significant Unobservable Inputs (Level 3) | |
Assets accounted for at fair value on a recurring basis | | | | | | | | | | | | | | | | |
Fixed maturities, AFS | | | | | | | | | | | | | | | | |
ABS | | $ | 2,068 | | | $ | — | | | $ | 1,660 | | | $ | 408 | |
CDOs | | | 1,899 | | | | — | | | | 30 | | | | 1,869 | |
CMBS | | | 5,028 | | | | — | | | | 4,536 | | | | 492 | |
Corporate | | | 26,915 | | | | — | | | | 25,429 | | | | 1,486 | |
Foreign government/government agencies | | | 1,002 | | | | — | | | | 962 | | | | 40 | |
Municipal | | | 1,032 | | | | — | | | | 774 | | | | 258 | |
RMBS | | | 4,118 | | | | — | | | | 3,013 | | | | 1,105 | |
U.S. Treasuries | | | 2,772 | | | | 248 | | | | 2,524 | | | | — | |
| | | | | | | | | | | | | | | | |
Total fixed maturities | | | 44,834 | | | | 248 | | | | 38,928 | | | | 5,658 | |
Fixed maturities, FVO | | | 639 | | | | — | | | | 128 | | | | 511 | |
Equity securities, trading | | | 2,279 | | | | 2,279 | | | | — | | | | — | |
Equity securities, AFS | | | 340 | | | | 174 | | | | 119 | | | | 47 | |
Derivative assets | | | | | | | | | | | | | | | | |
Credit derivatives | | | (11 | ) | | | — | | | | (19 | ) | | | 8 | |
Equity derivatives | | | 2 | | | | — | | | | — | | | | 2 | |
Foreign exchange derivatives | | | 784 | | | | — | | | | 784 | | | | — | |
Interest rate derivatives | | | (99 | ) | | | — | | | | (63 | ) | | | (36 | ) |
U.S. GMWB hedging instruments | | | 339 | | | | — | | | | (122 | ) | | | 461 | |
U.S. macro hedge program | | | 203 | | | | — | | | | — | | | | 203 | |
International program hedging instruments | | | 235 | | | | 2 | | | | 228 | | | | 5 | |
| | | | | | | | | | | | | | | | |
Total derivative assets [1] | | | 1,453 | | | | 2 | | | | 808 | | | | 643 | |
Short-term investments | | | 3,489 | | | | 204 | | | | 3,285 | | | | — | |
Reinsurance recoverable for U.S. GMWB and Japan GMWB, GMIB, and GMAB | | | 2,002 | | | | — | | | | — | | | | 2,002 | |
Separate account assets [2] | | | 153,713 | | | | 116,703 | | | | 35,763 | | | | 1,247 | |
| | | | | | | | | | | | | | | | |
Total assets accounted for at fair value on a recurring basis | | $ | 208,749 | | | | 119,610 | | | | 79,031 | | | | 10,108 | |
| | | | | | | | | | | | | | | | |
Liabilities accounted for at fair value on a recurring basis | | | | | | | | | | | | | | | | |
Other policyholder funds and benefits payable | | | | | | | | | | | | | | | | |
Guaranteed living benefits | | $ | (4,258 | ) | | $ | — | | | $ | — | | | $ | (4,258 | ) |
Equity linked notes | | | (9 | ) | | | — | | | | — | | | | (9 | ) |
| | | | | | | | | | | | | | | | |
Total other policyholder funds and benefits payable | | | (4,267 | ) | | | — | | | | — | | | | (4,267 | ) |
Derivative liabilities | | | | | | | | | | | | | | | | |
Credit derivatives | | | (401 | ) | | | — | | | | (49 | ) | | | (352 | ) |
Equity derivatives | | | 2 | | | | — | | | | — | | | | 2 | |
Foreign exchange derivatives | | | (25 | ) | | | — | | | | (25 | ) | | | — | |
Interest rate derivatives | | | (59 | ) | | | — | | | | (42 | ) | | | (17 | ) |
U.S. GMWB hedging instruments | | | 128 | | | | — | | | | (11 | ) | | | 139 | |
International program hedging instruments | | | (2 | ) | | | (2 | ) | | | — | | | | — | |
| | | | | | | | | | | | | | | | |
Total derivative liabilities [3] | | | (357 | ) | | | (2 | ) | | | (127 | ) | | | (228 | ) |
Other liabilities | | | (37 | ) | | | — | | | | — | | | | (37 | ) |
Consumer notes [4] | | | (5 | ) | | | — | | | | — | | | | (5 | ) |
| | | | | | | | | | | | | | | | |
Total liabilities accounted for at fair value on a recurring basis | | $ | (4,666 | ) | | $ | (2 | ) | | $ | (127 | ) | | $ | (4,537 | ) |
| | | | | | | | | | | | | | | | |
| [1] | Includes over-the-counter derivative instruments in a net asset value position which may require the counterparty to pledge collateral to the Company. At December 31, 2011 and 2010, $1.4 billion and $962, respectively was the amount of cash collateral liability that was netted against the derivative asset value on the Consolidated Balance Sheet, and is excluded from the table above. For further information on derivative liabilities, see below in this Note 3. |
| [2] | As of December 31, 2011 and 2010 excludes approximately $4 and $6 billion of investment sales receivable that are not subject to fair value accounting, respectively. |
| [3] | Includes over-the-counter derivative instruments in a net negative market value position (derivative liability). In the Level 3 roll forward table included below in this Note, the derivative asset and liability are referred to as “freestanding derivatives” and are presented on a net basis. |
| [4] | Represents embedded derivatives associated with non-funding agreement-backed consumer equity-linked notes. |
F-15
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
Determination of Fair Values
The valuation methodologies used to determine the fair values of assets and liabilities under the “exit price” notion, reflect market-participant objectives and are based on the application of the fair value hierarchy that prioritizes relevant observable market inputs over unobservable inputs. The Company determines the fair values of certain financial assets and financial liabilities based on quoted market prices where available and where prices represent a reasonable estimate of fair value. The Company also determines fair value based on future cash flows discounted at the appropriate current market rate. Fair values reflect adjustments for counterparty credit quality, the Company’s default spreads, liquidity and, where appropriate, risk margins on unobservable parameters. The following is a discussion of the methodologies used to determine fair values for the financial instruments listed in the above tables.
The fair valuation process is monitored by the Valuation Committee, which is a cross-functional group of senior management within HIMCO that meets at least quarterly. The Valuation Committee is co-chaired by the Heads of Investment Operations and Accounting, and has representation from various investment sector professionals, accounting, operations, legal, compliance and risk management. The purpose of the committee is to oversee the pricing policy and procedures by ensuring objective and reliable valuation practices and pricing of financial instruments, as well as addressing fair valuation issues and approving changes to valuation methodologies and pricing sources. There is also a Fair Value Working Group (“Working Group”) which includes the Heads of Investment Operations and Accounting, as well as other investment, operations, accounting and risk management professionals that meet monthly to review market data trends, pricing and trading statistics and results, and any proposed pricing methodology changes described in more detail in the following paragraphs.
Available-for-Sale Securities, Fixed Maturities, FVO, Equity Securities, Trading, and Short-term Investments
The fair value of AFS securities, fixed maturities, FVO, equity securities, trading, and short-term investments in an active and orderly market (e.g. not distressed or forced liquidation) are determined by management after considering one of three primary sources of information: third-party pricing services, independent broker quotations or pricing matrices. Security pricing is applied using a “waterfall” approach whereby publicly available prices are first sought from third-party pricing services, the remaining unpriced securities are submitted to independent brokers for prices, or lastly, securities are priced using a pricing matrix. Based on the typical trading volumes and the lack of quoted market prices for fixed maturities, third-party pricing services will normally derive the security prices from recent reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information as outlined above. If there are no recently reported trades, the third-party pricing services and independent brokers may use matrix or model processes to develop a security price where future cash flow expectations are developed based upon collateral performance and discounted at an estimated market rate. Included in the pricing of ABS and RMBS are estimates of the rate of future prepayments of principal over the remaining life of the securities. Such estimates are derived based on the characteristics of the underlying structure and prepayment speeds previously experienced at the interest rate levels projected for the underlying collateral. Actual prepayment experience may vary from these estimates.
Prices from third-party pricing services are often unavailable for securities that are rarely traded or are traded only in privately negotiated transactions. As a result, certain securities are priced via independent broker quotations which utilize inputs that may be difficult to corroborate with observable market based data. Additionally, the majority of these independent broker quotations are non-binding.
A pricing matrix is used to price private placement securities for which the Company is unable to obtain a price from a third-party pricing service by discounting the expected future cash flows from the security by a developed market discount rate utilizing current credit spreads. Credit spreads are developed each month using market based data for public securities adjusted for credit spread differentials between public and private securities which are obtained from a survey of multiple private placement brokers. The appropriate credit spreads determined through this survey approach are based upon the issuer’s financial strength and term to maturity, utilizing an independent public security index and trade information and adjusting for the non-public nature of the securities.
The Working Group performs a ongoing analysis of the prices and credit spreads received from third parties to ensure that the prices represent a reasonable estimate of the fair value. This process involves quantitative and qualitative analysis and is overseen by investment and accounting professionals. As a part of this analysis, the Company considers trading volume, new issuance activity and other factors to determine whether the market activity is significantly different than normal activity in an active market, and if so, whether transactions may not be orderly considering the weight of available evidence. If the available evidence indicates that pricing is based upon transactions that are stale or not orderly, the Company places little, if any, weight on the transaction price and will estimate fair value utilizing an internal pricing model. In addition, the Company ensures that prices received from independent brokers represent a reasonable estimate of fair value through the use of internal and external cash flow models developed based on spreads, and when available, market indices. As a result of this analysis, if the Company determines that there is a more appropriate fair value based upon the available market data, the price received from the third party is adjusted accordingly and approved by the Valuation Committee. The Company’s internal pricing model utilizes the Company’s best estimate of expected future cash flows discounted at a rate of return that a market participant would require. The significant inputs to the model include, but are not limited to, current market inputs, such as credit loss assumptions, estimated prepayment speeds and market risk premiums.
F-16
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
The Company conducts other specific activities to monitor controls around pricing. Daily analyses identify price changes over 3-5%, sale trade prices that differ over 3% from the prior day’s price and purchase trade prices that differ more than 3% from the current day’s price. Weekly analyses identify prices that differ more than 5% from published bond prices of a corporate bond index. Monthly analyses identify price changes over 3%, prices that haven’t changed, missing prices and second source validation on most sectors. Analyses are conducted by a dedicated pricing unit who follows up with trading and investment sector professionals and challenges prices with vendors when the estimated assumptions used differ from what the Company feels a market participant would use. Any changes from the identified pricing source are verified by further confirmation of assumptions used. Examples of other procedures performed include, but are not limited to, initial and on-going review of third-party pricing services’ methodologies, review of pricing statistics and trends and back testing recent trades. For a sample of structured securities, a comparison of the vendor’s assumptions to our internal econometric models is also performed; any differences are challenged in accordance with the process described above.
The Company has analyzed the third-party pricing services’ valuation methodologies and related inputs, and has also evaluated the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy level based upon trading activity and the observability of market inputs. Most prices provided by third-party pricing services are classified into Level 2 because the inputs used in pricing the securities are market observable. Due to a general lack of transparency in the process that brokers use to develop prices, most valuations that are based on brokers’ prices are classified as Level 3. Some valuations may be classified as Level 2 if the price can be corroborated with observable market data.
Derivative Instruments, including embedded derivatives within investments
Derivative instruments are fair valued using pricing valuation models; that utilize independent market data inputs, quoted market prices for exchange-traded derivatives, or independent broker quotations. Excluding embedded and reinsurance related derivatives, as of December 31, 2011 and 2010, 98% and 97%, respectively, of derivatives, based upon notional values, were priced by valuation models or quoted market prices. The remaining derivatives were priced by broker quotations. The Company performs a monthly analysis on derivative valuations which includes both quantitative and qualitative analysis. Examples of procedures performed include, but are not limited to, review of pricing statistics and trends, back testing recent trades, analyzing the impacts of changes in the market environment, and review of changes in market value for each derivative including those derivatives priced by brokers.
The Company performs various controls on derivative valuations which includes both quantitative and qualitative analysis. Analyses are conducted by a dedicated derivative pricing team that works directly with investment sector professionals to analyze impacts of changes in the market environment and investigate variances. There is a monthly analysis to identify market value changes greater than pre-defined thresholds, stale prices, missing prices and zero prices. Also on a monthly basis, a second source validation, typically to broker quotations, is performed for certain of the more complex derivatives, as well as for all new deals during the month. A model validation review is performed on any new models, which typically includes detailed documentation and validation to a second source. The model validation documentation and results of validation are presented to the Valuation Committee for approval. There is a monthly control to review changes in pricing sources to ensure that new models are not moved to production until formally approved.
The Company utilizes derivative instruments to manage the risk associated with certain assets and liabilities. However, the derivative instrument may not be classified with the same fair value hierarchy level as the associated assets and liabilities. Therefore the realized and unrealized gains and losses on derivatives reported in Level 3 may not reflect the offsetting impact of the realized and unrealized gains and losses of the associated assets and liabilities.
Valuation Techniques and Inputs for Investments
Generally, the Company determines the estimated fair value of its AFS securities, fixed maturities, FVO, equity securities, trading, and short-term investments using the market approach. The income approach is used for securities priced using a pricing matrix, as well as for derivative instruments. For Level 1 investments, which are comprised of on-the-run U.S. Treasuries, exchange-traded equity securities, short-term investments, and exchange traded futures and option contracts, valuations are based on observable inputs that reflect quoted prices for identical assets in active markets that the Company has the ability to access at the measurement date.
For most of the Company’s debt securities, the following inputs are typically used in the Company’s pricing methods: reported trades, benchmark yields, bids and/or estimated cash flows. For securities except U.S. Treasuries, inputs also include issuer spreads, which may consider credit default swaps. Derivative instruments are valued using mid-market inputs that are predominantly observable in the market.
F-17
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
A description of additional inputs used in the Company’s Level 2 and Level 3 measurements is listed below:
Level 2 | The fair values of most of the Company’s Level 2 investments are determined by management after considering prices received from third party pricing services. These investments include most fixed maturities and preferred stocks, including those reported in separate account assets. |
| • | | ABS, CDOs, CMBS and RMBS– Primary inputs also include monthly payment information, collateral performance, which varies by vintage year and includes delinquency rates, collateral valuation loss severity rates, collateral refinancing assumptions, credit default swap indices and, for ABS and RMBS, estimated prepayment rates. |
| • | | Corporates, including investment grade private placements– Primary inputs also include observations of credit default swap curves related to the issuer. |
| • | | Foreign government/government agencies—Primary inputs also include observations of credit default swap curves related to the issuer and political events in emerging markets. |
| • | | Municipals– Primary inputs also include Municipal Securities Rulemaking Board reported trades and material event notices, and issuer financial statements. |
| • | | Short-term investments– Primary inputs also include material event notices and new issue money market rates. |
| • | | Equity securities, trading– Consist of investments in mutual funds. Primary inputs include net asset values obtained from third party pricing services. |
| • | | Credit derivatives – Significant inputs primarily include the swap yield curve and credit curves. |
| • | | Foreign exchange derivatives –Significant inputs primarily include the swap yield curve, currency spot and forward rates, and cross currency basis curves. |
| • | | Interest rate derivatives –Significant input is primarily the swap yield curve. |
Level 3 | Most of the Company’s securities classified as Level 3 are valued based on brokers’ prices. This includes less liquid securities such as lower quality asset-backed securities (“ABS”), commercial mortgage-backed securities (“CMBS”), commercial real estate (“CRE”) CDOs and residential mortgage-backed securities (“RMBS”) primarily backed by below-prime loans. Primary inputs for these structured securities are consistent with the typical inputs used in Level 2 measurements noted above, but are Level 3 due to their illiquid markets. Additionally, certain long-dated securities are priced based on third party pricing services, including municipal securities, foreign government/government agencies, bank loans and below investment grade private placement securities. Primary inputs for these long-dated securities are consistent with the typical inputs used in Level 1 and Level 2 measurements noted above, but include benchmark interest rate or credit spread assumptions that are not observable in the marketplace. Also included in Level 3 are certain derivative instruments that either have significant unobservable inputs or are valued based on broker quotations. Significant inputs for these derivative contracts primarily include the typical inputs used in the Level 1 and Level 2 measurements noted above, but also may include the following: |
| • | | Credit derivatives-Significant unobservable inputs may include credit correlation and swap yield curve and credit curve extrapolation beyond observable limits. |
| • | | Equity derivatives –Significant unobservable inputs may include equity volatility. |
| • | | Interest rate contracts –Significant unobservable inputs may include swap yield curve extrapolation beyond observable limits and interest rate volatility. |
Product Derivatives
The Company currently offers certain variable annuity products with GMWB rider in the U.S., and formerly offered GMWBs in the U.K. The Company has also assumed, through reinsurance from Hartford Life Insurance KK (“HLIKK”), a Japanese affiliate of the Company, GMIB, GMWB and GMAB. The Company has subsequently ceded certain GMWB rider liabilities and the assumed reinsurance from HLIKK to an affiliated captive reinsurer. The GMWB represents an embedded derivative in the variable annuity contract. When it is determined that (1) the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and (2) a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host for measurement purposes. The embedded derivative, which is reported with the host instrument in the Consolidated Balance Sheets, is carried at fair value with changes in fair value reported in net realized capital gains and losses. The Company’s GMWB liability is carried at fair value and reported in other policyholder funds.
F-18
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
In valuing the embedded derivative, the Company attributes to the derivative a portion of the fees collected from the contract holder equal to the present value of future GMWB claims (the “Attributed Fees”). All changes in the fair value of the embedded derivative are recorded in net realized capital gains and losses. The excess of fees collected from the contract holder over the Attributed Fees are associated with the host variable annuity contract reported in fee income.
The reinsurance assumed on the HLIKK GMIB, GMWB, and GMAB and ceded to an affiliated captive reinsurer meets the characteristics of a free-standing derivative instrument. As a result, the derivative asset or liability is recorded at fair value with changes in the fair value reported in net realized capital gains and losses.
U.S. GMWB Ceded Reinsurance Derivative
The fair value of the U.S.��GMWB reinsurance derivative is calculated as an aggregation of the components described in the Living Benefits Required to be Fair Valued discussion below and is modeled using significant unobservable policyholder behavior inputs, identical to those used in calculating the underlying liability, such as lapses, fund selection, resets and withdrawal utilization and risk margins.
During 2009, the Company entered into a reinsurance arrangement with an affiliated captive reinsurer to transfer a portion of its risk of loss associated with direct US GMWB and assumed HLIKK GMIB, GMWB, and GMAB. In addition, in 2010 the Company entered into reinsurance arrangements with the affiliated captive reinsurer to transfer its risk of loss associated with direct UK GMWB. These arrangements are recognized as a derivative and carried at fair value in reinsurance recoverables. Changes in the fair value of the reinsurance agreements are reported in net realized capital gains and losses. Please see Note 16 for more information on this transaction.
Separate Account Assets
Separate account assets are primarily invested in mutual funds but also have investments in fixed maturity and equity securities. The separate account investments are valued in the same manner, and using the same pricing sources and inputs, as the fixed maturity, equity security, and short-term investments of the Company.
Living Benefits Required to be Fair Valued (in Other Policyholder Funds and Benefits Payable)
Fair values for GMWB and guaranteed minimum accumulation benefit (“GMAB”) contracts are calculated using the income approach based upon internally developed models because active, observable markets do not exist for those items. The fair value of the Company’s guaranteed benefit liabilities, classified as embedded derivatives, and the related reinsurance and customized freestanding derivatives is calculated as an aggregation of the following components: Best Estimate Claims Costs calculated based on actuarial and capital market assumptions related to projected cash flows over the lives of the contracts; Credit Standing Adjustment; and Margins representing an amount that market participants would require for the risk that the Company’s assumptions about policyholder behavior could differ from actual experience. The resulting aggregation is reconciled or calibrated, if necessary, to market information that is, or may be, available to the Company, but may not be observable by other market participants, including reinsurance discussions and transactions. The Company believes the aggregation of these components, as necessary and as reconciled or calibrated to the market information available to the Company, results in an amount that the Company would be required to transfer or receive, for an asset, to or from market participants in an active liquid market, if one existed, for those market participants to assume the risks associated with the guaranteed minimum benefits and the related reinsurance and customized derivatives. The fair value is likely to materially diverge from the ultimate settlement of the liability as the Company believes settlement will be based on our best estimate assumptions rather than those best estimate assumptions plus risk margins. In the absence of any transfer of the guaranteed benefit liability to a third party, the release of risk margins is likely to be reflected as realized gains in future periods’ net income. Each component described below is unobservable in the marketplace and requires subjectivity by the Company in determining their value.
Best Estimate Claims Costs
The Best Estimate Claims Costs is calculated based on actuarial and capital market assumptions related to projected cash flows, including the present value of benefits and related contract charges, over the lives of the contracts, incorporating expectations concerning policyholder behavior such as lapses, fund selection, resets and withdrawal utilization (for the customized derivatives, policyholder behavior is prescribed in the derivative contract). Because of the dynamic and complex nature of these cash flows, best estimate assumptions and a Monte Carlo stochastic process involving the generation of thousands of scenarios that assume risk neutral returns consistent with swap rates and a blend of observable implied index volatility levels were used. Estimating these cash flows involves numerous estimates and subjective judgments including those regarding expected markets rates of return, market volatility, correlations of market index returns to funds, fund performance, discount rates and various actuarial assumptions for policyholder behavior which emerge over time.
F-19
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
At each valuation date, the Company assumes expected returns based on:
| • | | risk-free rates as represented by the Eurodollar futures, LIBOR deposits and swap rates to derive forward curve rates; |
| • | | market implied volatility assumptions for each underlying index based primarily on a blend of observed market “implied volatility” data; |
| • | | correlations of historical returns across underlying well known market indices based on actual observed returns over the ten years preceding the valuation date; and |
| • | | three years of history for fund regression. |
As many guaranteed benefit obligations are relatively new in the marketplace, actual policyholder behavior experience is limited. As a result, estimates of future policyholder behavior are subjective and based on analogous internal and external data. As markets change, mature and evolve and actual policyholder behavior emerges, management continually evaluates the appropriateness of its assumptions for this component of the fair value model.
On a daily basis, the Company updates capital market assumptions used in the GMWB liability model such as interest rates, equity indices and the blend of implied equity index volatilities. The Company monitors various aspects of policyholder behavior and may modify certain of its assumptions, including living benefit lapses and withdrawal rates, if credible emerging data indicates that changes are warranted. At a minimum, all policyholder behavior assumptions are reviewed and updated, as appropriate, in conjunction with the completion of the Company’s comprehensive study to refine its estimate of future gross profits during the third quarter of each year.
Credit Standing Adjustment
This assumption makes an adjustment that market participants would make, in determining fair value, to reflect the risk that guaranteed benefit obligations or the GMWB reinsurance recoverables will not be fulfilled (“nonperformance risk”). As a result of sustained volatility in the Company’s credit default spreads, during 2009 the Company changed its estimate of the Credit Standing Adjustment to incorporate a blend of observable Company and reinsurer credit default spreads from capital markets, adjusted for market recoverability. Prior to the first quarter of 2009, the Company calculated the Credit Standing Adjustment by using default rates published by rating agencies, adjusted for market recoverability. For the year ended December 30, 2011, 2010 and 2009, the credit standing adjustment assumption, net of reinsurance and exclusive of the impact of the credit standing adjustment on other market sensitivities, resulted in pre-tax realized losses of $(156), $(8) and $(263), respectively.
Margins
The behavior risk margin adds a margin that market participants would require for the risk that the Company’s assumptions about policyholder behavior could differ from actual experience. The behavior risk margin is calculated by taking the difference between adverse policyholder behavior assumptions and best estimate assumptions.
Assumption updates, including policyholder behavior assumptions, affected best estimates and margins for a total pre-tax realized gains of approximately $13, $45 and $231 for the year ended December, 31, 2011, 2010 and 2009, respectively.
In addition to the non-market-based updates described above, the Company recognized non-market-based updates driven by the relative outperformance (underperformance) of the underlying actively managed funds as compared to their respective indices resulting in before-tax realized gains/(losses) of approximately $(18), $31 and $481 for the year ended December 31, 2011, 2010 and 2009, respectively.
F-20
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)
The tables below provide a fair value roll forward for the years ending December 31, 2011 and 2010, for the financial instruments classified as Level 3.
Roll-forward of Financial Instruments Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) for twelve months from January 1, 2011 to December 31, 2011
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fixed Maturities, AFS | | | | |
Assets | | ABS | | | CDOs | | | CMBS | | | Corporate | | | Foreign govt./govt. agencies | | | Municipal | | | RMBS | | | Total Fixed Maturities, AFS | | | Fixed Maturities, FVO | |
Fair value as of January 1, 2011 | | $ | 408 | | | $ | 1,869 | | | $ | 492 | | | $ | 1,486 | | | $ | 40 | | | $ | 258 | | | $ | 1,105 | | | $ | 5,658 | | | $ | 511 | |
Total realized/unrealized gains (losses) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Included in net income [2] | | | (26 | ) | | | (30 | ) | | | 13 | | | | (27 | ) | | | — | | | | — | | | | (21 | ) | | | (91 | ) | | | 23 | |
Included in OCI [3] | | | 18 | | | | 112 | | | | 41 | | | | (14 | ) | | | — | | | | 46 | | | | (3 | ) | | | 200 | | | | — | |
Purchases | | | 35 | | | | — | | | | 18 | | | | 83 | | | | — | | | | 87 | | | | 25 | | | | 248 | | | | — | |
Settlements | | | (32 | ) | | | (129 | ) | | | (72 | ) | | | (92 | ) | | | (3 | ) | | | — | | | | (111 | ) | | | (439 | ) | | | (2 | ) |
Sales | | | (9 | ) | | | (54 | ) | | | (225 | ) | | | (122 | ) | | | — | | | | — | | | | (16 | ) | | | (426 | ) | | | (43 | ) |
Transfers into Level 3 [4] | | | 79 | | | | 30 | | | | 131 | | | | 498 | | | | 29 | | | | — | | | | 69 | | | | 836 | | | | — | |
Transfers out of Level 3 [4] | | | (156 | ) | | | (1,470 | ) | | | (50 | ) | | | (315 | ) | | | (29 | ) | | | (9 | ) | | | (115 | ) | | | (2,144 | ) | | | (5 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Fair Value as of December 31, 2011 | | $ | 317 | | | $ | 328 | | | $ | 348 | | | $ | 1,497 | | | $ | 37 | | | $ | 382 | | | $ | 933 | | | $ | 3,842 | | | $ | 484 | |
Changes in unrealized gains (losses) included in net income related to financial instruments still held at December 31, 2011 [2] | | $ | (14 | ) | | $ | (29 | ) | | $ | (5 | ) | | $ | (11 | ) | | $ | — | | | $ | — | | | $ | (15 | ) | | $ | (74 | ) | | $ | 19 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Freestanding Derivatives [5] | |
Assets (Liabilities) | | Equity Securities, AFS | | | Credit | | | Equity | | | Interest Rate | | | U.S. GMWB Hedging | | | U.S. Macro Hedge Program | | | Intl. Program Hedging Instr. | | | Total Free- Standing Derivatives [5] | |
Fair value as of January 1, 2011 | | $ | 47 | | | $ | (344 | ) | | $ | 4 | | | $ | (53 | ) | | $ | 600 | | | $ | 203 | | | $ | 5 | | | $ | 415 | |
Total realized/unrealized gains (losses) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Included in net income [2] | | | (11 | ) | | | (144 | ) | | | (8 | ) | | | 9 | | | | 279 | | | | (128 | ) | | | 3 | | | | 11 | |
Included in OCI [3] | | | (3 | ) | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
Purchases | | | 31 | | | | 20 | | | | 40 | | | | — | | | | 23 | | | | 347 | | | | (43 | ) | | | 387 | |
Settlements | | | — | | | | (21 | ) | | | — | | | | (47 | ) | | | (19 | ) | | | (65 | ) | | | — | | | | (152 | ) |
Sales | | | (4 | ) | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
Transfers out of Level 3 [4] | | | (4 | ) | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Fair value as of December 31, 2011 | | $ | 56 | | | $ | (489 | ) | | $ | 36 | | | $ | (91 | ) | | $ | 883 | | | $ | 357 | | | $ | (35 | ) | | $ | 661 | |
Changes in unrealized gains (losses) included in net income related to financial instruments still held at December 31, 2011 [2] | | $ | (9 | ) | | $ | (137 | ) | | $ | (8 | ) | | $ | 10 | | | $ | 278 | | | $ | (107 | ) | | $ | (4 | ) | | $ | 32 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | |
Assets | | Reinsurance Recoverable for U.S. GMWB and Japan GMWB, GMIB, and GMAB [6] | | | Separate Accounts | |
Fair value as of January 1, 2011 | | $ | 2,002 | | | $ | 1,247 | |
Total realized/unrealized gains (losses) | | | | | | | | |
Included in net income [1], [2] | | | 504 | | | | 25 | |
Included in OCI [3] | | | 111 | | | | — | |
Purchases | | | — | | | | 292 | |
Settlements | | | 456 | | | | — | |
Sales | | | — | | | | (171 | ) |
Transfers into Level 3 [4] | | | — | | | | 14 | |
Transfers out of Level 3 [4] | | | — | | | | (376 | ) |
| | | | | | | | |
Fair value as of December 31, 2011 | | $ | 3,073 | | | $ | 1,031 | |
| | | | | | | | |
Changes in unrealized gains (losses) included in net income related to financial instruments still held at December 31, 2011 [2] | | $ | 504 | | | $ | (1 | ) |
| | | | | | | | |
F-21
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
| | | | | | | | | | | | | | | | | | | | |
| | Other Policyholder Funds and Benefits Payable | | | | |
Liabilities | | Guaranteed Living Benefits [7] | | | Equity Linked Notes | | | Total Other Policyholder Funds and Benefits Payable | | | Other Liabilities | | | Consumer Notes | |
Fair value as of January 1, 2011 | | $ | (4,258 | ) | | $ | (9 | ) | | $ | (4,267 | ) | | $ | (37 | ) | | $ | (5 | ) |
Total realized/unrealized gains (losses) | | | | | | | | | | | | | | | | | | | | |
Included in net income [1], [2] | | | (1,118 | ) | | | — | | | | (1,118 | ) | | | 28 | | | | 1 | |
Included in OCI [3] | | | (126 | ) | | | — | | | | (126 | ) | | | — | | | | — | |
Settlements | | | (274 | ) | | | — | | | | (274 | ) | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | |
Fair value as of December 31, 2011 | | $ | (5,776 | ) | | $ | (9 | ) | | $ | (5,785 | ) | | $ | (9 | ) | | $ | (4 | ) |
| | | | | | | | | | | | | | | | | | | | |
Changes in unrealized gains (losses) included in net income related to financial instruments still held at December 31, 2011 [2] | | $ | (1,118 | ) | | $ | — | | | $ | (1,118 | ) | | $ | 28 | | | $ | 1 | |
| | | | | | | | | | | | | | | | | | | | |
Roll-forward of Financial Instruments Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) for the twelve months from January 1, 2010 to December 31, 2010
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fixed Maturities, AFS | | | | |
Assets | | ABS | | | CDOs | | | CMBS | | | Corporate | | | Foreign govt./govt. agencies | | | Municipal | | | RMBS | | | Total Fixed Maturities, AFS | | | Fixed Maturities, FVO | |
Fair value as of January 1, 2010 | | $ | 497 | | | $ | 2,109 | | | $ | 269 | | | $ | 5,239 | | | $ | 80 | | | $ | 218 | | | $ | 995 | | | $ | 9,407 | | | $ | — | |
Total realized/unrealized gains (losses) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Included in net income [2] | | | (16 | ) | | | (124 | ) | | | (98 | ) | | | (10 | ) | | | — | | | | 1 | | | | (38 | ) | | | (285 | ) | | | 74 | |
Included in OCI [3] | | | 71 | | | | 467 | | | | 327 | | | | 193 | | | | 1 | | | | 24 | | | | 228 | | | | 1,311 | | | | — | |
Purchases, issuances, and settlements | | | (59 | ) | | | (187 | ) | | | (157 | ) | | | (66 | ) | | | (8 | ) | | | 19 | | | | (129 | ) | | | (587 | ) | | | (10 | ) |
Transfers into Level 3 [4] | | | 40 | | | | 42 | | | | 267 | | | | 800 | | | | — | | | | — | | | | 102 | | | | 1,251 | | | | 447 | |
Transfers out of Level 3 [4] | | | (125 | ) | | | (438 | ) | | | (116 | ) | | | (4,670 | ) | | | (33 | ) | | | (4 | ) | | | (53 | ) | | | (5,439 | ) | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Fair Value as of December 31, 2010 | | $ | 408 | | | $ | 1,869 | | | $ | 492 | | | $ | 1,486 | | | $ | 40 | | | $ | 258 | | | $ | 1,105 | | | $ | 5,658 | | | $ | 511 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in unrealized gains (losses) included in net income related to financial instruments still held at December 31, 2010 [2] | | $ | (6 | ) | | $ | (130 | ) | | $ | (58 | ) | | $ | (20 | ) | | $ | — | | | $ | — | | | $ | (35 | ) | | $ | (249 | ) | | $ | 71 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Freestanding Derivatives [5] | |
Assets (Liabilities) | | Equity Securities, AFS | | | Credit | | | Equity | | | Interest Rate | | | U.S. GMWB Hedging | | | U.S. Macro Hedge Program | | | Intl. Program Hedging Instr. | | | Total Free- Standing Derivatives [5] | |
Fair value as of January 1, 2010 | | $ | 32 | | | $ | (161 | ) | | $ | (2 | ) | | $ | 5 | | | $ | 236 | | | $ | 278 | | | $ | 12 | | | $ | 368 | |
Total realized/unrealized gains (losses) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Included in net income [2] | | | (3 | ) | | | 104 | | | | 6 | | | | (3 | ) | | | (74 | ) | | | (312 | ) | | | (29 | ) | | | (308 | ) |
Included in OCI [3] | | | 7 | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
Purchases, issuances, and settlements | | | 11 | | | | 3 | | | | — | | | | (44 | ) | | | 442 | | | | 237 | | | | 22 | | | | 660 | |
Transfers into Level 3 [4] | | | — | | | | (290 | ) | | | — | | | | — | | | | — | | | | — | | | | — | | | | (290 | ) |
Transfers out of Level 3 [4] | | | — | | | | — | | | | — | | | | (11 | ) | | | (4 | ) | | | — | | | | — | | | | (15 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Fair value as of December 31, 2010 | | $ | 47 | | | $ | (344 | ) | | $ | 4 | | | $ | (53 | ) | | $ | 600 | | | $ | 203 | | | $ | 5 | | | $ | 415 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Changes in unrealized gains (losses) included in net income related to financial instruments still held at December 31, 2010 [2] | | $ | (3 | ) | | $ | 103 | | | $ | 6 | | | $ | (23 | ) | | $ | (61 | ) | | $ | (292 | ) | | $ | (29 | ) | | $ | (296 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | |
Assets | | Reinsurance Recoverable for U.S. GMWB [6] | | | Separate Accounts | |
Fair value as of January 1, 2010 | | $ | 1,108 | | | $ | 962 | |
Total realized/unrealized gains (losses) | | | | | | | | |
Included in net income [1], [2] | | | 182 | | | | 142 | |
Included in OCI [3] | | | 260 | | | | — | |
Purchases, issuances, and settlements | | | 452 | | | | 314 | |
Transfers into Level 3 [4] | | | — | | | | 14 | |
Transfers out of Level 3 [4] | | | — | | | | (185 | ) |
| | | | | | | | |
Fair value as of December 31, 2010 | | $ | 2,002 | | | $ | 1,247 | |
| | | | | | | | |
Changes in unrealized gains (losses) included in net income related to financial instruments still held at December 31, 2010 [2] | | $ | 182 | | | $ | 20 | |
| | | | | | | | |
F-22
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Other Policyholder Funds and Benefits Payable [1] | | | | | | | |
Liabilities | | Guaranteed Living Benefits [7] | | | Institutional Notes | | | Equity Linked Notes | | | Total Other Policyholder Funds and Benefits Payable | | | Other Liabilities | | | Consumer Notes | |
Fair value as of January 1, 2010 | | $ | (3,439 | ) | | $ | (2 | ) | | $ | (10 | ) | | $ | (3,451 | ) | | $ | — | | | $ | (5 | ) |
Total realized/unrealized gains (losses) | | | | | | | | | | | | | | | | | | | | | | | | |
Included in net income [1], [2] | | | (259 | ) | | | 2 | | | | — | | | | (257 | ) | | | (26 | ) | | | — | |
Included in OCI [3] | | | (307 | ) | | | — | | | | — | | | | (307 | ) | | | — | | | | — | |
Purchases, issuances and settlements | | | (253 | ) | | | — | | | | 1 | | | | (252 | ) | | | — | | | | — | |
Transfers into Level 3 [4] | | | — | | | | — | | | | — | | | | — | | | | (11 | ) | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Fair value as of December 31, 2010 | | $ | (4,258 | ) | | $ | — | | | $ | (9 | ) | | $ | (4,267 | ) | | $ | (37 | ) | | $ | (5 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | |
Changes in unrealized gains (losses) included in net income related to financial instruments still held at December 31, 2010 [2] | | $ | (259 | ) | | $ | 2 | | | $ | — | | | $ | (257 | ) | | $ | — | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | |
[1] | The Company classifies gains and losses on GMWB reinsurance derivatives and Guaranteed Living Benefit embedded derivatives as unrealized gains (losses) for purposes of disclosure in this table because it is impracticable to track on a contract-by-contract basis the realized gains (losses) for these derivatives and embedded derivatives. |
[2] | All amounts in these rows are reported in net realized capital gains (losses). The realized/unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on net income for the Company. All amounts are before income taxes and amortization of DAC. |
[3] | All amounts are before income taxes and amortization of DAC. |
[4] | Transfers in and/or (out) of Level 3 are primarily attributable to the availability of market observable information and the re-evaluation of the observability of pricing inputs. |
[5] | Derivative instruments are reported in this table on a net basis for asset/(liability) positions and reported in the Consolidated Balance Sheet in other investments and other liabilities. |
[6] | Includes fair value of reinsurance recoverables of approximately $2.6 billion and $1.7 billion as of December 31, 2011 and December 31, 2010, respectively, related to a transaction entered into with an affiliated captive reinsurer. See Note 16 of the Notes to Consolidated Financial Statements for more information. |
[7] | Includes both market and non-market impacts in deriving realized and unrealized gains (losses). |
Fair Value Option
The Company elected the fair value option for its investments containing an embedded credit derivative which were not bifurcated as a result of adoption of new accounting guidance effective July 1, 2010. The underlying credit risk of these securities is primarily corporate bonds and commercial real estate. The Company elected the fair value option given the complexity of bifurcating the economic components associated with the embedded credit derivative. Additionally, the Company elected the fair value option for purchases of foreign government securities to align with the accounting for yen-based fixed annuity liabilities, which are adjusted for changes in spot rates through realized gains and losses. Similar to other fixed maturities, income earned from these securities is recorded in net investment income. Changes in the fair value of these securities are recorded in net realized capital gains and losses.
The Company previously elected the fair value option for one of its consolidated VIEs in order to apply a consistent accounting model for the VIE’s assets and liabilities. The VIE is an investment vehicle that holds high quality investments, derivative instruments that references third-party corporate credit and issues notes to investors that reflect the credit characteristics of the high quality investments and derivative instruments. The risks and rewards associated with the assets of the VIE inure to the investors. The investors have no recourse against the Company. As a result, there has been no adjustment to the market value of the notes for the Company’s own credit risk.
The following table presents the changes in fair value of those assets and liabilities accounted for using the fair value option reported in net realized capital gains and losses in the Company’s Consolidated Statements of Operations.
| | | | | | | | |
| | For the years ended December 31, | |
| | 2011 | | | 2010 | |
Assets | | | | | | | | |
Fixed maturities, FVO | | | | | | | | |
ABS | | $ | — | | | $ | (5 | ) |
Corporate | | | 10 | | | | (7 | ) |
CRE CDOs | | | (33 | ) | | | 79 | |
Foreign government | | | 45 | | | | — | |
Other liabilities | | | | | | | | |
Credit-linked notes | | | 28 | | | | (26 | ) |
| | | | | | | | |
Total realized capital gains | | $ | 50 | | | $ | 41 | |
| | | | | | | | |
F-23
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
The following table presents the fair value of assets and liabilities accounted for using the fair value option included in the Company’s Consolidated Balance Sheets.
| | | | | | | | |
| | As of December 31, | |
| | 2011 | | | 2010 | |
Assets | | | | | | | | |
Fixed maturities, FVO | | | | | | | | |
ABS | | $ | 65 | | | $ | 64 | |
CRE CDOs | | | 214 | | | | 260 | |
Corporate | | | 272 | | | | 251 | |
Foreign government | | | 766 | | | | 64 | |
| | | | | | | | |
Total fixed maturities, FVO | | $ | 1,317 | | | $ | 639 | |
Other liabilities | | | | | | | | |
Credit-linked notes [1] | | $ | 9 | | | $ | 37 | |
| | | | | | | | |
[1] | As of December 31, 2011 and 2010, the outstanding principal balance of the notes was $243. |
Financial Instruments Not Carried at Fair Value
The following presents carrying amounts and fair values of the Company’s financial instruments not carried at fair value, and not included in the above fair value discussion as of December 31, 2011 and 2010 were as follows:
| | | | | | | | | | | | | | | | |
| | December 31, 2011 | | | December 31, 2010 | |
| | Carrying Amount | | | Fair Value | | | Carrying Amount | | | Fair Value | |
Assets | | | | | | | | | | | | | | | | |
Policy loans | | $ | 1,952 | | | $ | 2,099 | | | $ | 2,128 | | | $ | 2,164 | |
Mortgage loans | | | 4,182 | | | | 4,382 | | | | 3,244 | | | | 3,272 | |
| | | | | | | | | | | | | | | | |
Liabilities | | | | | | | | | | | | | | | | |
Other policyholder funds and benefits payable [1] | | $ | 10,065 | | | $ | 10,959 | | | $ | 10,824 | | | $ | 11,050 | |
Consumer notes [2] | | | 310 | | | | 305 | | | | 377 | | | | 392 | |
| | | | | | | | | | | | | | | | |
[1] | Excludes group accident and health and universal life insurance contracts, including corporate owned life insurance. |
[2] | Excludes amounts carried at fair value and included in disclosures above. |
The Company has not made any changes in its valuation methodologies for the following assets and liabilities since December 31, 2010.
| • | | Fair value for policy loans and consumer notes were estimated using discounted cash flow calculations using current interest rates. |
| • | | Fair values for mortgage loans were estimated using discounted cash flow calculations based on current lending rates for similar type loans. Current lending rates reflect changes in credit spreads and the remaining terms of the loans. |
| • | | Other policyholder funds and benefits payable, not carried at fair value, is determined by estimating future cash flows, discounted at the current market rate. |
F-24
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments
Significant Investment Accounting Policies
Overview
The Company’s investments in fixed maturities include bonds, redeemable preferred stock and commercial paper. These investments, along with certain equity securities, which include common and non-redeemable preferred stocks, are classified as AFS and are carried at fair value. The after-tax difference from cost or amortized cost is reflected in stockholders’ equity as a component of Other Comprehensive Income (Loss) (“OCI”), after adjustments for the effect of deducting the life and pension policyholders’ share of the immediate participation guaranteed contracts and certain life and annuity deferred policy acquisition costs and reserve adjustments. Fixed maturities for which the Company elected the fair value option are classified as FVO and are carried at fair value. The equity investments associated with the variable annuity products offered in Japan are recorded at fair value and are classified as trading with changes in fair value recorded in net investment income. Policy loans are carried at outstanding balance. Mortgage loans are recorded at the outstanding principal balance adjusted for amortization of premiums or discounts and net of valuation allowances. Short-term investments are carried at amortized cost, which approximates fair value. Limited partnerships and other alternative investments are reported at their carrying value with the change in carrying value accounted for under the equity method and accordingly the Company’s share of earnings are included in net investment income. Recognition of limited partnerships and other alternative investment income is delayed due to the availability of the related financial information, as private equity and other funds are generally on a three-month delay and hedge funds are on a one-month delay. Accordingly, income for the years ended December 31, 2011, 2010 and 2009 may not include the full impact of current year changes in valuation of the underlying assets and liabilities, which are generally obtained from the limited partnerships and other alternative investments’ general partners. Other investments primarily consist of derivatives instruments which are carried at fair value.
Recognition and Presentation of Other-Than-Temporary Impairments
The Company deems debt securities and certain equity securities with debt-like characteristics (collectively “debt securities”) to be other-than-temporarily impaired (“impaired”) if a security meets the following conditions: a) the Company intends to sell or it is more likely than not the Company will be required to sell the security before a recovery in value, or b) the Company does not expect to recover the entire amortized cost basis of the security. If the Company intends to sell or it is more likely than not the Company will be required to sell the security before a recovery in value, a charge is recorded in net realized capital losses equal to the difference between the fair value and amortized cost basis of the security. For those impaired debt securities which do not meet the first condition and for which the Company does not expect to recover the entire amortized cost basis, the difference between the security’s amortized cost basis and the fair value is separated into the portion representing a credit other-than-temporary impairment (“impairment”), which is recorded in net realized capital losses, and the remaining impairment, which is recorded in OCI. Generally, the Company determines a security’s credit impairment as the difference between its amortized cost basis and its best estimate of expected future cash flows discounted at the security’s effective yield prior to impairment. The remaining non-credit impairment, which is recorded in OCI, is the difference between the security’s fair value and the Company’s best estimate of expected future cash flows discounted at the security’s effective yield prior to the impairment, which typically represents current market liquidity and risk premiums. The previous amortized cost basis less the impairment recognized in net realized capital losses becomes the security’s new cost basis. The Company accretes the new cost basis to the estimated future cash flows over the expected remaining life of the security by prospectively adjusting the security’s yield, if necessary.
The Company’s evaluation of whether a credit impairment exists for debt securities includes but is not limited to, the following factors: (a) changes in the financial condition of the security’s underlying collateral, (b) whether the issuer is current on contractually obligated interest and principal payments, (c) changes in the financial condition, credit rating and near-term prospects of the issuer, (d) the extent to which the fair value has been less than the amortized cost of the security and (e) the payment structure of the security. The Company’s best estimate of expected future cash flows used to determine the credit loss amount is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the security. The Company’s best estimate of future cash flows involves assumptions including, but not limited to, various performance indicators, such as historical and projected default and recovery rates, credit ratings, current and projected delinquency rates, and loan-to-value (“LTV”) ratios. In addition, for structured securities, the Company considers factors including, but not limited to, average cumulative collateral loss rates that vary by vintage year, commercial and residential property value declines that vary by property type and location and commercial real estate delinquency levels. These assumptions require the use of significant management judgment and include the probability of issuer default and estimates regarding timing and amount of expected recoveries which may include estimating the underlying collateral value. In addition, projections of expected future debt security cash flows may change based upon new information regarding the performance of the issuer and/or underlying collateral such as changes in the projections of the underlying property value estimates.
F-25
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
For equity securities where the decline in the fair value is deemed to be other-than-temporary, a charge is recorded in net realized capital losses equal to the difference between the fair value and cost basis of the security. The previous cost basis less the impairment becomes the security’s new cost basis. The Company asserts its intent and ability to retain those equity securities deemed to be temporarily impaired until the price recovers. Once identified, these securities are systematically restricted from trading unless approved by a committee of investment and accounting professionals (“Committee”). The Committee will only authorize the sale of these securities based on predefined criteria that relate to events that could not have been reasonably foreseen. Examples of the criteria include, but are not limited to, the deterioration in the issuer’s financial condition, security price declines, a change in regulatory requirements or a major business combination or major disposition.
The primary factors considered in evaluating whether an impairment exists for an equity security include, but are not limited to: (a) the length of time and extent to which the fair value has been less than the cost of the security, (b) changes in the financial condition, credit rating and near-term prospects of the issuer, (c) whether the issuer is current on preferred stock dividends and (d) the intent and ability of the Company to retain the investment for a period of time sufficient to allow for recovery.
Mortgage Loan Valuation Allowances
The Company’s security monitoring process reviews mortgage loans on a quarterly basis to identify potential credit losses. Commercial mortgage loans are considered to be impaired when management estimates that, based upon current information and events, it is probable that the Company will be unable to collect amounts due according to the contractual terms of the loan agreement. Criteria used to determine if an impairment exists include, but are not limited to: current and projected macroeconomic factors, such as unemployment rates, and property-specific factors such as rental rates, occupancy levels, LTV ratios and debt service coverage ratios (“DSCR”). In addition, the Company considers historic, current and projected delinquency rates and property values. These assumptions require the use of significant management judgment and include the probability and timing of borrower default and loss severity estimates. In addition, projections of expected future cash flows may change based upon new information regarding the performance of the borrower and/or underlying collateral such as changes in the projections of the underlying property value estimates.
For mortgage loans that are deemed impaired, a valuation allowance is established for the difference between the carrying amount and the Company’s share of either (a) the present value of the expected future cash flows discounted at the loan’s effective interest rate, (b) the loan’s observable market price or, most frequently, (c) the fair value of the collateral. A valuation allowance has been established for either individual loans or as a projected loss contingency for loans with an LTV ratio of 90% or greater and consideration of other credit quality factors, including DSCR. Changes in valuation allowances are recorded in net realized capital gains and losses. Interest income on impaired loans is accrued to the extent it is deemed collectible and the loans continue to perform under the original or restructured terms. Interest income ceases to accrue for loans when it is probable that the Company will not receive interest and principal payments according to the contractual terms of the loan agreement, or if a loan is more than 60 days past due. Loans may resume accrual status when it is determined that sufficient collateral exists to satisfy the full amount of the loan and interest payments, as well as when it is probable cash will be received in the foreseeable future. Interest income on defaulted loans is recognized when received.
Net Realized Capital Gains and Losses
Net realized capital gains and losses from investment sales, after deducting the life and pension policyholders’ share for certain products, are reported as a component of revenues and are determined on a specific identification basis, as well as changes in value associated with fixed maturities for which the fair value option was elected. Net realized capital gains and losses also result from fair value changes in derivatives contracts (both free-standing and embedded) that do not qualify, or are not designated, as a hedge for accounting purposes, and the change in value of derivatives in certain fair-value hedge relationships. Impairments and mortgage loan valuation allowances are recognized as net realized capital losses in accordance with the Company’s policies previously discussed. Foreign currency transaction remeasurements are also included in net realized capital gains and losses.
Net Investment Income
Interest income from fixed maturities and mortgage loans is recognized when earned on the constant effective yield method based on estimated timing of cash flows. The amortization of premium and accretion of discount for fixed maturities also takes into consideration call and maturity dates that produce the lowest yield. For securitized financial assets subject to prepayment risk, yields are recalculated and adjusted periodically to reflect historical and/or estimated future repayments using the retrospective method; however, if these investments are impaired, any yield adjustments are made using the prospective method. Prepayment fees on fixed maturities and mortgage loans are recorded in net investment income when earned. For limited partnerships and other alternative investments, the equity method of accounting is used to recognize the Company’s share of earnings. For impaired debt securities, the Company accretes the new cost basis to the estimated future cash flows over the expected remaining life of the security by prospectively adjusting the security’s yield, if necessary. The Company’s non-income producing investments were not material for the years ended December 31, 2011, 2010 and 2009.
F-26
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Net investment income on equity securities, trading, includes dividend income and the changes in market value of the securities associated with the variable annuity products sold in Japan and the United Kingdom. The returns on these policyholder-directed investments inure to the benefit of the variable annuity policyholders but the underlying funds do not meet the criteria for separate account reporting. Accordingly, these assets are reflected in the Company’s general account and the returns credited to the policyholders are reflected in interest credited, a component of benefits, losses and loss adjustment expenses.
Significant Derivative Instruments Accounting Policies
Overview
The Company utilizes a variety of derivative instruments, including swaps, caps, floors, forwards, futures and options through one of four Company-approved objectives: to hedge risk arising from interest rate, equity market, credit spread and issuer default, price or currency exchange rate risk or volatility; to manage liquidity; to control transaction costs; or to enter into replication transactions.
Interest rate, volatility, dividend, credit default and index swaps involve the periodic exchange of cash flows with other parties, at specified intervals, calculated using agreed upon rates or other financial variables and notional principal amounts. Generally, no cash or principal payments are exchanged at the inception of the contract. Typically, at the time a swap is entered into, the cash flow streams exchanged by the counterparties are equal in value.
Interest rate cap and floor contracts entitle the purchaser to receive from the issuer at specified dates, the amount, if any, by which a specified market rate exceeds the cap strike interest rate or falls below the floor strike interest rate, applied to a notional principal amount. A premium payment is made by the purchaser of the contract at its inception and no principal payments are exchanged.
Forward contracts are customized commitments that specify a rate of interest or currency exchange rate to be paid or received on an obligation beginning on a future start date and are typically settled in cash.
Financial futures are standardized commitments to either purchase or sell designated financial instruments, at a future date, for a specified price and may be settled in cash or through delivery of the underlying instrument. Futures contracts trade on organized exchanges. Margin requirements for futures are met by pledging securities or cash, and changes in the futures’ contract values are settled daily in cash.
Option contracts grant the purchaser, for a premium payment, the right to either purchase from or sell to the issuer a financial instrument at a specified price, within a specified period or on a stated date.
Foreign currency swaps exchange an initial principal amount in two currencies, agreeing to re-exchange the currencies at a future date, at an agreed upon exchange rate. There may also be a periodic exchange of payments at specified intervals calculated using the agreed upon rates and exchanged principal amounts.
The Company’s derivative transactions are used in strategies permitted under the derivative use plans required by the State of Connecticut, the State of Illinois and the State of New York insurance departments.
Accounting and Financial Statement Presentation of Derivative Instruments and Hedging Activities
Derivative instruments are recognized on the Consolidated Balance Sheets at fair value. For balance sheet presentation purposes, the Company offsets the fair value amounts, income accruals, and cash collateral held, related to derivative instruments executed in a legal entity and with the same counterparty under a master netting agreement, which provides the Company with the legal right of offset.
On the date the derivative contract is entered into, the Company designates the derivative as (1) a hedge of the fair value of a recognized asset or liability (“fair value” hedge), (2) a hedge of the variability in cash flows of a forecasted transaction or of amounts to be received or paid related to a recognized asset or liability (“cash flow” hedge), (3) a hedge of a net investment in a foreign operation (“net investment” hedge) or (4) held for other investment and/or risk management purposes, which primarily involve managing asset or liability related risks which do not qualify for hedge accounting.
Fair Value Hedges
Changes in the fair value of a derivative that is designated and qualifies as a fair value hedge, including foreign-currency fair value hedges, along with the changes in the fair value of the hedged asset or liability that is attributable to the hedged risk, are recorded in current period earnings with any differences between the net change in fair value of the derivative and the hedged item representing the hedge ineffectiveness. Periodic cash flows and accruals of income/expense (“periodic derivative net coupon settlements”) are recorded in the line item of the consolidated statements of operations in which the cash flows of the hedged item are recorded.
F-27
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Cash Flow Hedges
Changes in the fair value of a derivative that is designated and qualifies as a cash flow hedge, including foreign-currency cash flow hedges, are recorded in AOCI and are reclassified into earnings when the variability of the cash flow of the hedged item impacts earnings. Gains and losses on derivative contracts that are reclassified from AOCI to current period earnings are included in the line item in the consolidated statements of operations in which the cash flows of the hedged item are recorded. Any hedge ineffectiveness is recorded immediately in current period earnings as net realized capital gains and losses. Periodic derivative net coupon settlements are recorded in the line item of the consolidated statements of operations in which the cash flows of the hedged item are recorded.
Net Investment in a Foreign Operation Hedges
Changes in fair value of a derivative used as a hedge of a net investment in a foreign operation, to the extent effective as a hedge, are recorded in the foreign currency translation adjustments account within AOCI. Cumulative changes in fair value recorded in AOCI are reclassified into earnings upon the sale or complete, or substantially complete, liquidation of the foreign entity. Any hedge ineffectiveness is recorded immediately in current period earnings as net realized capital gains and losses. Periodic derivative net coupon settlements are recorded in the line item of the consolidated statements of operations in which the cash flows of the hedged item are recorded.
Other Investment and/or Risk Management Activities
The Company’s other investment and/or risk management activities primarily relate to strategies used to reduce economic risk or replicate permitted investments and do not receive hedge accounting treatment. Changes in the fair value, including periodic derivative net coupon settlements, of derivative instruments held for other investment and/or risk management purposes are reported in current period earnings as net realized capital gains and losses.
Hedge Documentation and Effectiveness Testing
To qualify for hedge accounting treatment, a derivative must be highly effective in mitigating the designated changes in fair value or cash flow of the hedged item. At hedge inception, the Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking each hedge transaction. The documentation process includes linking derivatives that are designated as fair value, cash flow, or net investment hedges to specific assets or liabilities on the balance sheet or to specific forecasted transactions and defining the effectiveness and ineffectiveness testing methods to be used. The Company also formally assesses both at the hedge’s inception and ongoing on a quarterly basis, whether the derivatives that are used in hedging transactions have been and are expected to continue to be highly effective in offsetting changes in fair values or cash flows of hedged items. Hedge effectiveness is assessed using qualitative and quantitative methods. Qualitative methods may include comparison of critical terms of the derivative to the hedged item. Quantitative methods include regression or other statistical analysis of changes in fair value or cash flows associated with the hedge relationship. Hedge ineffectiveness of the hedge relationships are measured each reporting period using the “Change in Variable Cash Flows Method”, the “Change in Fair Value Method”, the “Hypothetical Derivative Method”, or the “Dollar Offset Method”.
Discontinuance of Hedge Accounting
The Company discontinues hedge accounting prospectively when (1) it is determined that the derivative is no longer highly effective in offsetting changes in the fair value or cash flows of a hedged item; (2) the derivative is de-designated as a hedging instrument; or (3) the derivative expires or is sold, terminated or exercised.
When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the derivative continues to be carried at fair value on the balance sheet with changes in its fair value recognized in current period earnings.
When hedge accounting is discontinued because the Company becomes aware that it is not probable that the forecasted transaction will occur, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses that were accumulated in AOCI are recognized immediately in earnings.
In other situations in which hedge accounting is discontinued on a cash-flow hedge, including those where the derivative is sold, terminated or exercised, amounts previously deferred in AOCI are reclassified into earnings when earnings are impacted by the variability of the cash flow of the hedged item.
F-28
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Embedded Derivatives
The Company purchases and issues financial instruments and products that contain embedded derivative instruments. When it is determined that (1) the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and (2) a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host for measurement purposes. The embedded derivative, which is reported with the host instrument in the consolidated balance sheets, is carried at fair value with changes in fair value reported in net realized capital gains and losses.
Credit Risk
Credit risk is measured as the amount owed to the Company based on current market conditions and potential payment obligations between the Company and its counterparties. For each legal entity of the Company, credit exposures are generally quantified daily based on the prior business day’s market value and collateral is pledged to and held by, or on behalf of, the Company to the extent the current value of derivatives exceeds the contractual thresholds for every counterparty. The maximum uncollateralized threshold for a derivative counterparty for a single level entity is $10. The Company also minimizes the credit risk of derivative instruments by entering into transactions with high quality counterparties primarily rated A or better, which are monitored and evaluated by the Company’s risk management team and reviewed by senior management. In addition, the Company monitors counterparty credit exposure on a monthly basis to ensure compliance with Company policies and statutory limitations. The Company generally requires that derivative contracts, other than exchange traded contracts, certain forward contracts, and certain embedded and reinsurance derivatives, be governed by an International Swaps and Derivatives Association Master Agreement which is structured by legal entity and by counterparty and permits right of offset.
Net Investment Income (Loss)
| | | | | | | | | | | | |
| | For the years ended December 31, | |
(Before-tax) | | 2011 | | | 2010 | | | 2009 | |
Fixed maturities | | $ | 1,941 | | | $ | 1,977 | | | $ | 2,094 | |
Equity securities, AFS | | | 10 | | | | 14 | | | | 43 | |
Mortgage loans | | | 206 | | | | 199 | | | | 232 | |
Policy loans | | | 128 | | | | 129 | | | | 136 | |
Limited partnerships and other alternative investments | | | 143 | | | | 121 | | | | (171 | ) |
Other investments | | | 226 | | | | 253 | | | | 242 | |
Investment expenses | | | (74 | ) | | | (72 | ) | | | (71 | ) |
| | | | | | | | | | | | |
Total securities AFS and other | | | 2,580 | | | | 2,621 | | | | 2,505 | |
Equity securities, trading | | | (14 | ) | | | 238 | | | | 343 | |
| | | | | | | | | | | | |
Total net investment income (loss) | | $ | 2,566 | | | $ | 2,859 | | | $ | 2,848 | |
| | | | | | | | | | | | |
The net unrealized gain (loss) on equity securities, trading, included in net investment income during the years ended December 31, 2011, 2010 and 2009, was ($111), $160 and $276, respectively, substantially all of which have corresponding amounts credited to policyholders. These amounts were not included in gross unrealized gains (losses).
F-29
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Net Realized Capital Gains (Losses)
| | | | | | | | | | | | |
| | For the years ended December 31, | |
(Before-tax) | | 2011 | | | 2010 | | | 2009 | |
Gross gains on sales | | $ | 405 | | | $ | 486 | | | $ | 364 | |
Gross losses on sales | | | (200 | ) | | | (336 | ) | | | (828 | ) |
Net OTTI losses recognized in earnings | | | (125 | ) | | | (336 | ) | | | (1,192 | ) |
Valuation allowances on mortgage loans | | | 25 | | | | (108 | ) | | | (292 | ) |
Japanese fixed annuity contract hedges, net [1] | | | 3 | | | | 27 | | | | 47 | |
Periodic net coupon settlements on credit derivatives/Japan | | | — | | | | (3 | ) | | | (33 | ) |
Results of variable annuity hedge program | | | | | | | | | | | | |
U. S. GMWB derivatives, net | | | (397 | ) | | | 89 | | | | 1,464 | |
U. S. Macro hedge program | | | (216 | ) | | | (445 | ) | | | (733 | ) |
| | | | | | | | | | | | |
Total U.S. program | | | (613 | ) | | | (356 | ) | | | 731 | |
International program | | | 723 | | | | (13 | ) | | | (138 | ) |
| | | | | | | | | | | | |
Total results of variable annuity hedge program | | | 110 | | | | (369 | ) | | | 593 | |
GMIB/GMAB/GMWB reinsurance assumed | | | (326 | ) | | | (769 | ) | | | 1,106 | |
Coinsurance and modified coinsurance ceded reinsurance contracts | | | 373 | | | | 284 | | | | (577 | ) |
Other, net [2] | | | (264 | ) | | | 180 | | | | (64 | ) |
| | | | | | | | | | | | |
Net realized capital gains (losses) | | $ | 1 | | | $ | (944 | ) | | $ | (876 | ) |
| | | | | | | | | | | | |
[1] | Relates to the Japanese fixed annuity product (adjustment of product liability for changes in spot currency exchange rates, related derivative hedging instruments, excluding net period coupon settlements, and Japan FVO securities). |
[2] | Primarily consists of losses on non-qualifying derivatives and fixed maturities, FVO, Japan 3Win related foreign currency swaps and other investment gains and losses. |
F-30
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Sales of Available-for-Sale Securities
| | | | | | | | | | | | |
| | For the years ended December 31, | |
| | 2011 | | | 2010 | | | 2009 | |
Fixed maturities, AFS | | | | | | | | | | | | |
Sale proceeds | | $ | 19,861 | | | $ | 27,739 | | | $ | 27,809 | |
Gross gains | | | 354 | | | | 413 | | | | 495 | |
Gross losses | | | (205 | ) | | | (299 | ) | | | (830 | ) |
Equity securities, AFS | | | | | | | | | | | | |
Sale proceeds | | $ | 147 | | | $ | 171 | | | $ | 162 | |
Gross gains | | | 50 | | | | 12 | | | | 2 | |
Gross losses | | | — | | | | (4 | ) | | | (27 | ) |
| | | | | | | | | | | | |
Sales of AFS securities in 2011 were the result of the reinvestment into spread product well-positioned for modest economic growth, as well as the purposeful reduction of certain exposures.
Other-Than-Temporary Impairment Losses
The following table presents a roll-forward of the Company’s cumulative credit impairments on debt securities held as of December 31, 2011 and 2010.
| | | | | | | | | | | | |
| | For the years ended December 31, | |
| | 2011 | | | 2010 | | | 2009 | |
Balance as of beginning of period | | $ | (1,598 | ) | | $ | (1,632 | ) | | $ | — | |
Credit impairments remaining in retained earnings related to adoption of new accounting guidance in April 2009 | | | — | | | | — | | | | (941 | ) |
Additions for credit impairments recognized on [1]: | | | | | | | | | | | | |
Securities not previously impaired | | | (41 | ) | | | (181 | ) | | | (690 | ) |
Securities previously impaired | | | (47 | ) | | | (122 | ) | | | (201 | ) |
Reductions for credit impairments previously recognized on: | | | | | | | | | | | | |
Securities that matured or were sold during the period | | | 358 | | | | 314 | | | | 196 | |
Securities that the Company intends to sell or more likely than not will be required to sell before recovery | | | — | | | | — | | | | 1 | |
Securities due to an increase in expected cash flows | | | 9 | | | | 23 | | | | 3 | |
| | | | | | | | | | | | |
Balance as of end of period | | $ | (1,319 | ) | | $ | (1,598 | ) | | $ | (1,632 | ) |
| | | | | | | | | | | | |
[1] | These additions are included in the net OTTI losses recognized in earnings in the Consolidated Statements of Operations. |
Available-for-Sale Securities
The following table presents the Company’s AFS securities by type.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2011 | | | December 31, 2010 | |
| | Cost or Amortized Cost | | | Gross Unrealized Gains | | | Gross Unrealized Losses | | | Fair Value | | | Non- Credit OTTI [1] | | | Cost or Amortized Cost | | | Gross Unrealized Gains | | | Gross Unrealized Losses | | | Fair Value | | | Non- Credit OTTI [1] | |
ABS | | $ | 2,361 | | | $ | 38 | | | $ | (306 | ) | | $ | 2,093 | | | $ | (3 | ) | | $ | 2,395 | | | $ | 29 | | | $ | (356 | ) | | $ | 2,068 | | | $ | (1 | ) |
CDOs | | | 2,055 | | | | 15 | | | | (272 | ) | | | 1,798 | | | | (29 | ) | | | 2,278 | | | | — | | | | (379 | ) | | | 1,899 | | | | (59 | ) |
CMBS | | | 4,418 | | | | 169 | | | | (318 | ) | | | 4,269 | | | | (19 | ) | | | 5,283 | | | | 146 | | | | (401 | ) | | | 5,028 | | | | (15 | ) |
Corporate [2] | | | 28,084 | | | | 2,729 | | | | (539 | ) | | | 30,229 | | | | — | | | | 25,934 | | | | 1,545 | | | | (538 | ) | | | 26,915 | | | | 6 | |
Foreign govt./govt. agencies | | | 1,121 | | | | 106 | | | | (3 | ) | | | 1,224 | | | | — | | | | 963 | | | | 48 | | | | (9 | ) | | | 1,002 | | | | — | |
Municipal | | | 1,504 | | | | 104 | | | | (51 | ) | | | 1,557 | | | | — | | | | 1,149 | | | | 7 | | | | (124 | ) | | | 1,032 | | | | — | |
RMBS | | | 4,069 | | | | 170 | | | | (416 | ) | | | 3,823 | | | | (97 | ) | | | 4,450 | | | | 79 | | | | (411 | ) | | | 4,118 | | | | (113 | ) |
U.S. Treasuries | | | 2,624 | | | | 162 | | | | (1 | ) | | | 2,785 | | | | — | | | | 2,871 | | | | 11 | | | | (110 | ) | | | 2,772 | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total fixed maturities, AFS | | | 46,236 | | | | 3,493 | | | | (1,906 | ) | | | 47,778 | | | | (148 | ) | | | 45,323 | | | | 1,865 | | | | (2,328 | ) | | | 44,834 | | | | (182 | ) |
Equity securities, AFS | | | 443 | | | | 21 | | | | (66 | ) | | | 398 | | | | — | | | | 320 | | | | 61 | | | | (41 | ) | | | 340 | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total AFS securities | | $ | 46,679 | | | $ | 3,514 | | | $ | (1,972 | ) | | $ | 48,176 | | | $ | (148 | ) | | $ | 45,643 | | | $ | 1,926 | | | $ | (2,369 | ) | | $ | 45,174 | | | $ | (182 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Represents the amount of cumulative non-credit OTTI losses recognized in OCI on securities that also had credit impairments. These losses are included in gross unrealized losses as of December 31, 2011 and 2010. |
[2] | Gross unrealized gains (losses) exclude the fair value of bifurcated embedded derivative features of certain securities. Subsequent changes in value will be recorded in net realized capital gains (losses). |
F-31
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
The following table presents the Company’s fixed maturities, AFS, by contractual maturity year.
| | | | | | | | |
| | December 31, 2011 | |
Maturity | | Amortized Cost | | | Fair Value | |
One year or less | | $ | 2,340 | | | $ | 2,359 | |
Over one year through five years | | | 10,006 | | | | 10,378 | |
Over five years through ten years | | | 8,133 | | | | 8,728 | |
Over ten years | | | 12,854 | | | | 14,330 | |
| | | | | | | | |
Subtotal | | | 33,333 | | | | 35,795 | |
Mortgage-backed and asset-backed securities | | | 12,903 | | | | 11,983 | |
| | | | | | | | |
Total | | $ | 46,236 | | | $ | 47,778 | |
| | | | | | | | |
Estimated maturities may differ from contractual maturities due to security call or prepayment provisions. Due to the potential for variability in payment spreads (i.e. prepayments or extensions), mortgage-backed and asset-backed securities are not categorized by contractual maturity.
Concentration of Credit Risk
The Company aims to maintain a diversified investment portfolio including issuer, sector and geographic stratification, where applicable, and has established certain exposure limits, diversification standards and review procedures to mitigate credit risk.
As of December 31, 2011 and 2010, the Company was not exposed to any concentration of credit risk of a single issuer greater than 10% of the Company’s stockholders’ equity other than U.S. government and certain U.S. government agencies. As of December 31, 2011, other than U.S. government and certain U.S. government agencies, the Company’s three largest exposures by issuer were the Government of Japan, the Government of the United Kingdom and AT&T Inc. which each comprised less than 1.2% of total invested assets. As of December 31, 2010, other than U.S. government and certain U.S. government agencies, the Company’s three largest exposures by issuer were JP Morgan Chase & Co., Berkshire Hathaway Inc. and Wells Fargo & Co. which each comprised less than 0.6% of total invested assets.
The Company’s three largest exposures by sector as of December 31, 2011 were commercial real estate, U.S. Treasuries and utilities which comprised approximately 14%, 9% and 9%, respectively, of total invested assets. The Company’s three largest exposures by sector as of December 31, 2010 were commercial real estate, U.S. Treasuries and financial services which comprised approximately 15%, 10% and 9%, respectively, of total invested assets.
Security Unrealized Loss Aging
The following tables present the Company’s unrealized loss aging for AFS securities by type and length of time the security was in a continuous unrealized loss position.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2011 | |
| | Less Than 12 Months | | | 12 Months or More | | | Total | |
| | Amortized Cost | | | Fair Value | | | Unrealized Losses | | | Amortized Cost | | | Fair Value | | | Unrealized Losses | | | Amortized Cost | | | Fair Value | | | Unrealized Losses | |
ABS | | $ | 420 | | | $ | 385 | | | $ | (35 | ) | | $ | 1,002 | | | $ | 731 | | | $ | (271 | ) | | $ | 1,422 | | | $ | 1,116 | | | $ | (306 | ) |
CDOs | | | 80 | | | | 58 | | | | (22 | ) | | | 1,956 | | | | 1,706 | | | | (250 | ) | | | 2,036 | | | | 1,764 | | | | (272 | ) |
CMBS | | | 911 | | | | 830 | | | | (81 | ) | | | 1,303 | | | | 1,066 | | | | (237 | ) | | | 2,214 | | | | 1,896 | | | | (318 | ) |
Corporate [1] | | | 2,942 | | | | 2,823 | | | | (119 | ) | | | 2,353 | | | | 1,889 | | | | (420 | ) | | | 5,295 | | | | 4,712 | | | | (539 | ) |
Foreign govt./govt. agencies | | | 24 | | | | 23 | | | | (1 | ) | | | 40 | | | | 38 | | | | (2 | ) | | | 64 | | | | 61 | | | | (3 | ) |
Municipal | | | 202 | | | | 199 | | | | (3 | ) | | | 348 | | | | 300 | | | | (48 | ) | | | 550 | | | | 499 | | | | (51 | ) |
RMBS | | | 355 | | | | 271 | | | | (84 | ) | | | 1,060 | | | | 728 | | | | (332 | ) | | | 1,415 | | | | 999 | | | | (416 | ) |
U.S. Treasuries | | | 185 | | | | 184 | | | | (1 | ) | | | — | | | | — | | | | — | | | | 185 | | | | 184 | | | | (1 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total fixed maturities | | | 5,119 | | | | 4,773 | | | | (346 | ) | | | 8,062 | | | | 6,458 | | | | (1,560 | ) | | | 13,181 | | | | 11,231 | | | | (1,906 | ) |
Equity securities | | | 115 | | | | 90 | | | | (25 | ) | | | 104 | | | | 63 | | | | (41 | ) | | | 219 | | | | 153 | | | | (66 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total securities in an unrealized loss | | $ | 5,234 | | | $ | 4,863 | | | $ | (371 | ) | | $ | 8,166 | | | $ | 6,521 | | | $ | (1,601 | ) | | $ | 13,400 | | | $ | 11,384 | | | $ | (1,972 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Unrealized losses exclude the fair value of bifurcated embedded derivative features of certain securities. Subsequent changes in value will be recorded in net realized capital gains (losses). |
F-32
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2010 | |
| | Less Than 12 Months | | | 12 Months or More | | | Total | |
| | Cost or Amortized Cost | | | Fair Value | | | Unrealized Losses | | | Cost or Amortized Cost | | | Fair Value | | | Unrealized Losses | | | Cost or Amortized Cost | | | Fair Value | | | Unrealized Losses | |
ABS | | $ | 237 | | | $ | 226 | | | $ | (11 | ) | | $ | 1,226 | | | $ | 881 | | | $ | (345 | ) | | $ | 1,463 | | | $ | 1,107 | | | $ | (356 | ) |
CDOs | | | 316 | | | | 288 | | | | (28 | ) | | | 1,934 | | | | 1,583 | | | | (351 | ) | | | 2,250 | | | | 1,871 | | | | (379 | ) |
CMBS | | | 374 | | | | 355 | | | | (19 | ) | | | 2,532 | | | | 2,150 | | | | (382 | ) | | | 2,906 | | | | 2,505 | | | | (401 | ) |
Corporate | | | 3,726 | | | | 3,591 | | | | (130 | ) | | | 2,777 | | | | 2,348 | | | | (408 | ) | | | 6,503 | | | | 5,939 | | | | (538 | ) |
Foreign govt./govt. agencies | | | 250 | | | | 246 | | | | (4 | ) | | | 40 | | | | 35 | | | | (5 | ) | | | 290 | | | | 281 | | | | (9 | ) |
Municipal | | | 415 | | | | 399 | | | | (16 | ) | | | 575 | | | | 467 | | | | (108 | ) | | | 990 | | | | 866 | | | | (124 | ) |
RMBS | | | 1,187 | | | | 1,155 | | | | (32 | ) | | | 1,379 | | | | 1,000 | | | | (379 | ) | | | 2,566 | | | | 2,155 | | | | (411 | ) |
U.S. Treasuries | | | 1,142 | | | | 1,073 | | | | (69 | ) | | | 158 | | | | 117 | | | | (41 | ) | | | 1,300 | | | | 1,190 | | | | (110 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total fixed maturities, AFS | | | 7,647 | | | | 7,333 | | | | (309 | ) | | | 10,621 | | | | 8,581 | | | | (2,019 | ) | | | 18,268 | | | | 15,914 | | | | (2,328 | ) |
Equity securities. AFS | | | 18 | | | | 17 | | | | (1 | ) | | | 148 | | | | 108 | | | | (40 | ) | | | 166 | | | | 125 | | | | (41 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total AFS securities in an unrealized loss | | $ | 7,665 | | | $ | 7,350 | | | $ | (310 | ) | | $ | 10,769 | | | $ | 8,689 | | | $ | (2,059 | ) | | $ | 18,434 | | | $ | 16,039 | | | $ | (2,369 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
As of December 31, 2011, AFS securities in an unrealized loss position, comprised of 1,922 securities, primarily related to corporate securities primarily within the financial services sector, CMBS and RMBS which have experienced significant price deterioration. As of December 31, 2011, 73% of these securities were depressed less than 20% of cost or amortized cost. The decline in unrealized losses during 2011 was primarily attributable to a decline in interest rates, partially offset by credit spread widening.
Most of the securities depressed for twelve months or more relate to structured securities with exposure to commercial and residential real estate, as well as certain floating rate corporate securities or those securities with greater than 10 years to maturity, concentrated in the financial services sector. Current market spreads continue to be significantly wider for structured securities with exposure to commercial and residential real estate, as compared to spreads at the security’s respective purchase date, largely due to the economic and market uncertainties regarding future performance of commercial and residential real estate. In addition, the majority of securities have a floating-rate coupon referenced to a market index where rates have declined substantially. The Company neither has an intention to sell nor does it expect to be required to sell the securities outlined above.
Mortgage Loans
| | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2011 | | | December 31, 2010 | |
| | Amortized Cost [1] | | | Valuation Allowance | | | Carrying Value | | | Amortized Cost [1] | | | Valuation Allowance | | | Carrying Value | |
Commercial | | $ | 4,205 | | | $ | (23 | ) | | $ | 4,182 | | | $ | 3,306 | | | | (62 | ) | | | 3,244 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total mortgage loans | | $ | 4,205 | | | $ | (23 | ) | | $ | 4,182 | | | $ | 3,306 | | | $ | (62 | ) | | $ | 3,244 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Amortized cost represents carrying value prior to valuation allowances, if any. |
As of December 31, 2011, the carrying value of mortgage loans associated with the valuation allowance was $347. Included in the table above are mortgage loans held-for-sale with a carrying value and valuation allowance of $57 and $4, respectively, as of December 31, 2011, and $64 and $4, respectively, as of December 31, 2010. The carrying value of these loans is included in mortgage loans in the Company’s Consolidated Balance Sheets. As of December 31, 2011, loans within the Company’s mortgage loan portfolio that have had extensions or restructurings other than what is allowable under the original terms of the contract are immaterial.
The following table presents the activity within the Company’s valuation allowance for mortgage loans. These loans have been evaluated both individually and collectively for impairment. Loans evaluated collectively for impairment are immaterial.
| | | | | | | | | | | | |
| | For the years ended December 31, | |
| | 2011 | | | 2010 | | | 2009 | |
Balance as of January 1 | | $ | (62 | ) | | $ | (260 | ) | | $ | (13 | ) |
Additions | | | 25 | | | | (108 | ) | | | (292 | ) |
Deductions | | | 14 | | | | 306 | | | | 45 | |
| | | | | | | | | | | | |
Balance as of December 31 | | $ | (23 | ) | | $ | (62 | ) | | $ | (260 | ) |
| | | | | | | | | | | | |
F-33
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
The current weighted-average LTV ratio of the Company’s commercial mortgage loan portfolio was 66% as of December 31, 2011, while the weighted-average LTV ratio at origination of these loans was 63%. LTV ratios compare the loan amount to the value of the underlying property collateralizing the loan. The loan values are updated no less than annually through property level reviews of the portfolio. Factors considered in the property valuation include, but are not limited to, actual and expected property cash flows, geographic market data and capitalization rates. DSCRs compare a property’s net operating income to the borrower’s principal and interest payments. The current weighted average DSCR of the Company’s commercial mortgage loan portfolio was approximately 1.99x as of December 31, 2011. The Company did not hold any commercial mortgage loans greater than 60 days past due.
The following table presents the carrying value of the Company’s commercial mortgage loans by LTV and DSCR.
Commercial Mortgage Loans Credit Quality
| | | | | | | | | | | | | | | | |
| | December 31, 2011 | | | December 31, 2010 | |
Loan-to-value | | Carrying Value | | | Avg. Debt-Service Coverage Ratio | | | Carrying Value | | | Avg. Debt-Service Coverage Ratio | |
Greater than 80% | | $ | 422 | | | | 1.67 | x | | $ | 961 | | | | 1.67 | x |
65% - 80% | | | 1,779 | | | | 1.57 | x | | | 1,366 | | | | 2.11 | x |
Less than 65% | | | 1,981 | | | | 2.45 | x | | | 917 | | | | 2.44 | x |
| | | | | | | | | | | | | | | | |
Total commercial mortgage loans | | $ | 4,182 | | | | 1.99 | x | | $ | 3,244 | | | | 2.07 | x |
| | | | | | | | | | | | | | | | |
The following tables present the carrying value of the Company’s mortgage loans by region and property type.
Mortgage Loans by Region
| | | | | | | | | | | | | | | | |
| |
| | December 31, 2011 | | | December 31, 2010 | |
| | Carrying Value | | | Percent of Total | | | Carrying Value | | | Percent of Total | |
East North Central | | $ | 59 | | | | 1.4 | % | | $ | 51 | | | | 1.6 | % |
Middle Atlantic | | | 401 | | | | 9.6 | % | | | 344 | | | | 10.6 | % |
Mountain | | | 61 | | | | 1.5 | % | | | 49 | | | | 1.5 | % |
New England | | | 202 | | | | 4.8 | % | | | 188 | | | | 5.8 | % |
Pacific | | | 1,268 | | | | 30.3 | % | | | 898 | | | | 27.7 | % |
South Atlantic | | | 810 | | | | 19.4 | % | | | 679 | | | | 20.9 | % |
West North Central | | | 16 | | | | 0.4 | % | | | 19 | | | | 0.6 | % |
West South Central | | | 115 | | | | 2.7 | % | | | 117 | | | | 3.6 | % |
Other [1] | | | 1,250 | | | | 29.9 | % | | | 899 | | | | 27.7 | % |
| | | | | | | | | | | | | | | | |
Total mortgage loans | | $ | 4,182 | | | | 100.0 | % | | $ | 3,244 | | | | 100.0 | % |
| | | | | | | | | | | | | | | | |
[1] | Primarily represents loans collateralized by multiple properties in various regions. |
Mortgage Loans by Property Type
| | | | | | | | | | | | | | | | |
| |
| | December 31, 2011 | | | December 31, 2010 | |
| | Carrying Value | | | Percent of Total | | | Carrying Value | | | Percent of Total | |
Commercial | | | | | | | | | | | | | | | | |
Agricultural | | $ | 127 | | | | 3.0 | % | | $ | 177 | | | | 5.5 | % |
Industrial | | | 1,262 | | | | 30.1 | % | | | 833 | | | | 25.7 | % |
Lodging | | | 84 | | | | 2.0 | % | | | 123 | | | | 3.8 | % |
Multifamily | | | 734 | | | | 17.6 | % | | | 479 | | | | 14.8 | % |
Office | | | 836 | | | | 20.0 | % | | | 796 | | | | 24.5 | % |
Retail | | | 918 | | | | 22.0 | % | | | 556 | | | | 17.1 | % |
Other | | | 221 | | | | 5.3 | % | | | 280 | | | | 8.6 | % |
| | | | | | | | | | | | | | | | |
Total mortgage loans | | $ | 4,182 | | | | 100.0 | % | | $ | 3,244 | | | | 100.0 | % |
| | | | | | | | | | | | | | | | |
F-34
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Variable Interest Entities
The Company is involved with various special purpose entities and other entities that are deemed to be VIEs primarily as a collateral manager and as an investor through normal investment activities, as well as a means of accessing capital. A VIE is an entity that either has investors that lack certain essential characteristics of a controlling financial interest or lacks sufficient funds to finance its own activities without financial support provided by other entities.
The Company performs ongoing qualitative assessments of its VIEs to determine whether the Company has a controlling financial interest in the VIE and therefore is the primary beneficiary. The Company is deemed to have a controlling financial interest when it has both the ability to direct the activities that most significantly impact the economic performance of the VIE and the obligation to absorb losses or right to receive benefits from the VIE that could potentially be significant to the VIE. Based on the Company’s assessment, if it determines it is the primary beneficiary, the Company consolidates the VIE in the Company’s Consolidated Financial Statements.
Consolidated VIEs
The following table presents the carrying value of assets and liabilities, and the maximum exposure to loss relating to the VIEs for which the Company is the primary beneficiary. Creditors have no recourse against the Company in the event of default by these VIEs nor does the Company have any implied or unfunded commitments to these VIEs. The Company’s financial or other support provided to these VIEs is limited to its investment management services and original investment.
| | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2011 | | | December 31, 2010 | |
| | Total Assets | | | Total Liabilities [1] | | | Maximum Exposure to Loss [2] | | | Total Assets | | | Total Liabilities [1] | | | Maximum Exposure to Loss [2] | |
CDOs [3] | | $ | 491 | | | $ | 474 | | | $ | 25 | | | $ | 729 | | | $ | 416 | | | $ | 265 | |
Limited partnerships | | | 7 | | | | 3 | | | | 4 | | | | 14 | | | | 6 | | | | 8 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total | | $ | 498 | | | $ | 477 | | | $ | 29 | | | $ | 743 | | | $ | 422 | | | $ | 273 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Included in other liabilities in the Company’s Consolidated Balance Sheets. |
[2] | The maximum exposure to loss represents the maximum loss amount that the Company could recognize as a reduction in net investment income or as a realized capital loss and is the cost basis of the Company’s investment. |
[3] | Total assets included in fixed maturities, AFS, and fixed maturities, FVO, in the Company’s Consolidated Balance Sheets. |
CDOs represent structured investment vehicles for which the Company has a controlling financial interest as it provides collateral management services, earns a fee for those services and also holds investments in the securities issued by these vehicles. Limited partnerships represent one hedge fund for which the Company holds a majority interest in the fund as an investment.
Non-Consolidated VIEs
The Company does not hold any investments issued by VIEs for which the Company is not the primary beneficiary as of December 31, 2011 and 2010.
In addition, the Company, through normal investment activities, makes passive investments in structured securities issued by VIEs for which the Company is not the manager which are included in ABS, CDOs, CMBS and RMBS in the Available-for-Sale Securities table and fixed maturities, FVO, in the Company’s Consolidated Balance Sheets. The Company has not provided financial or other support with respect to these investments other than its original investment. For these investments, the Company determined it is not the primary beneficiary due to the relative size of the Company’s investment in comparison to the principal amount of the structured securities issued by the VIEs, the level of credit subordination which reduces the Company’s obligation to absorb losses or right to receive benefits and the Company’s inability to direct the activities that most significantly impact the economic performance of the VIEs. The Company’s maximum exposure to loss on these investments is limited to the amount of the Company’s investment.
F-35
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Equity Method Investments
The Company has investments in limited partnerships and other alternative investments which include hedge funds, mortgage and real estate funds, mezzanine debt funds, and private equity and other funds (collectively, “limited partnerships”). These investments are accounted for under the equity method and the Company’s maximum exposure to loss as of December 31, 2011 is limited to the total carrying value of $1.4 billion. In addition, the Company has outstanding commitments totaling approximately $376, to fund limited partnership and other alternative investments as of December 31, 2011. The Company’s investments in limited partnerships are generally of a passive nature in that the Company does not take an active role in the management of the limited partnerships. In 2011, aggregate investment income (losses) from limited partnerships and other alternative investments exceeded 10% of the Company’s pre-tax consolidated net income. Accordingly, the Company is disclosing aggregated summarized financial data for the Company’s limited partnership investments. This aggregated summarized financial data does not represent the Company’s proportionate share of limited partnership assets or earnings. Aggregate total assets of the limited partnerships in which the Company invested totaled $75.7 billion and $81.6 billion as of December 31, 2011 and 2010, respectively. Aggregate total liabilities of the limited partnerships in which the Company invested totaled $13.8 billion and $15.6 billion as of December 31, 2011 and 2010, respectively. Aggregate net investment income (loss) of the limited partnerships in which the Company invested totaled $1.2 billion, $927 and ($437) for the periods ended December 31, 2011, 2010 and 2009, respectively. Aggregate net income (loss) of the limited partnerships in which the Company invested totaled $8.1 billion, $9.7 billion, and ($6.9) billion for the periods ended December 31, 2011, 2010 and 2009, respectively. As of, and for the period ended, December 31, 2011, the aggregated summarized financial data reflects the latest available financial information.
Derivative Instruments
The Company utilizes a variety of over-the-counter and exchange traded derivative instruments as a part of its overall risk management strategy, as well as to enter into replication transactions. Derivative instruments are used to manage risk associated with interest rate, equity market, credit spread, issuer default, price, and currency exchange rate risk or volatility. Replication transactions are used as an economical means to synthetically replicate the characteristics and performance of assets that would otherwise be permissible investments under the Company’s investment policies. The Company also purchases and issues financial instruments and products that either are accounted for as free-standing derivatives, such as certain reinsurance contracts, or may contain features that are deemed to be embedded derivative instruments, such as the GMWB rider included with certain variable annuity products.
Cash flow hedges
Interest rate swaps
Interest rate swaps are primarily used to convert interest receipts on floating-rate fixed maturity securities or interest payments on floating-rate guaranteed investment contracts to fixed rates. These derivatives are predominantly used to better match cash receipts from assets with cash disbursements required to fund liabilities.
The Company also enters into forward starting swap agreements to hedge the interest rate exposure related to the purchase of fixed-rate securities. These derivatives are primarily structured to hedge interest rate risk inherent in the assumptions used to price certain liabilities.
Foreign currency swaps
Foreign currency swaps are used to convert foreign currency-denominated cash flows related to certain investment receipts and liability payments to U.S. dollars in order to minimize cash flow fluctuations due to changes in currency rates.
Fair value hedges
Interest rate swaps
Interest rate swaps are used to hedge the changes in fair value of certain fixed rate liabilities and fixed maturity securities due to fluctuations in interest rates.
Foreign currency swaps
Foreign currency swaps are used to hedge the changes in fair value of certain foreign currency-denominated fixed rate liabilities due to changes in foreign currency rates by swapping the fixed foreign payments to floating rate U.S. dollar denominated payments.
F-36
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Non-qualifying strategies
Interest rate swaps, swaptions, caps, floors, and futures
The Company uses interest rate swaps, swaptions, caps, floors, and futures to manage duration between assets and liabilities in certain investment portfolios. In addition, the Company enters into interest rate swaps to terminate existing swaps, thereby offsetting the changes in value of the original swap. As of December 31, 2011 and 2010, the notional amount of interest rate swaps in offsetting relationships was $5.1 billion and $4.7 billion, respectively.
Foreign currency swaps and forwards
The Company enters into foreign currency swaps and forwards to convert the foreign currency exposures of certain foreign currency-denominated fixed maturity investments to U.S. dollars.
Japan 3Win foreign currency swaps
Prior to the second quarter of 2009, The Company offered certain variable annuity products with a GMIB rider through an affiliate, HLIKK, in Japan. The GMIB rider is reinsured to a wholly-owned U.S. subsidiary, which invests in U.S. dollar denominated assets to support the liability. The U.S. subsidiary entered into pay U.S. dollar, receive yen forward contracts to hedge the currency and interest rate exposure between the U.S. dollar denominated assets and the yen denominated fixed liability reinsurance payments.
Japanese fixed annuity hedging instruments
Prior to the second quarter of 2009, The Company offered a yen denominated fixed annuity product through HLIKK and reinsured to a wholly-owned U.S. subsidiary. The U.S. subsidiary invests in U.S. dollar denominated securities to support the yen denominated fixed liability payments and entered into currency rate swaps to hedge the foreign currency exchange rate and yen interest rate exposures that exist as a result of U.S. dollar assets backing the yen denominated liability.
Credit derivatives that purchase credit protection
Credit default swaps are used to purchase credit protection on an individual entity or referenced index to economically hedge against default risk and credit-related changes in value on fixed maturity securities. These contracts require the Company to pay a periodic fee in exchange for compensation from the counterparty should the referenced security issuers experience a credit event, as defined in the contract.
Credit derivatives that assume credit risk
Credit default swaps are used to assume credit risk related to an individual entity, referenced index, or asset pool, as a part of replication transactions. These contracts entitle the Company to receive a periodic fee in exchange for an obligation to compensate the derivative counterparty should the referenced security issuers experience a credit event, as defined in the contract. The Company is also exposed to credit risk due to credit derivatives embedded within certain fixed maturity securities. These securities are primarily comprised of structured securities that contain credit derivatives that reference a standard index of corporate securities.
Credit derivatives in offsetting positions
The Company enters into credit default swaps to terminate existing credit default swaps, thereby offsetting the changes in value of the original swap going forward.
Equity index swaps, options and futures
The Company offers certain equity indexed products, which may contain an embedded derivative that requires bifurcation. The Company enters into S&P index swaps and options to economically hedge the equity volatility risk associated with these embedded derivatives. In addition, during third quarter of 2011 the Company entered into equity index options and futures with the purpose of hedging the impact of an adverse equity market environment on the investment portfolio.
F-37
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
U.S. GMWB product derivatives
The Company offers certain variable annuity products with a GMWB rider in the U.S. The GMWB is a bifurcated embedded derivative that provides the policyholder with a guaranteed remaining balance (“GRB”) if the account value is reduced to zero through a combination of market declines and withdrawals. The GRB is generally equal to premiums less withdrawals. Certain contract provisions can increase the GRB at contractholder election or after the passage of time. The notional value of the embedded derivative is the GRB.
U.S. GMWB reinsurance contracts
The Company has entered into reinsurance arrangements to offset a portion of its risk exposure to the GMWB for the remaining lives of covered variable annuity contracts. Reinsurance contracts covering GMWB are accounted for as free-standing derivatives. The notional amount of the reinsurance contracts is the GRB amount.
U.S. GMWB hedging instruments
The Company enters into derivative contracts to partially hedge exposure associated with a portion of the GMWB liabilities that are not reinsured. These derivative contracts include customized swaps, interest rate swaps and futures, and equity swaps, options, and futures, on certain indices including the S&P 500 index, EAFE index, and NASDAQ index.
The following table represents notional and fair value for U.S. GMWB hedging instruments.
| | | | | | | | | | | | | | | | |
| | Notional Amount | | | Fair Value | |
| | December 31, 2011 | | | December 31, 2010 | | | December 31, 2011 | | | December 31, 2010 | |
Customized swaps | | $ | 8,389 | | | $ | 10,113 | | | $ | 385 | | | $ | 209 | |
Equity swaps, options, and futures | | | 5,320 | | | | 4,943 | | | | 498 | | | | 391 | |
Interest rate swaps and futures | | | 2,697 | | | | 2,800 | | | | 11 | | | | (133 | ) |
| | | | | | | | | | | | | | | | |
Total | | $ | 16,406 | | | $ | 17,856 | | | $ | 894 | | | $ | 467 | |
| | | | | | | | | | | | | | | | |
U.S. macro hedge program
The Company utilizes equity options and futures contracts to partially hedge against a decline in the equity markets and the resulting statutory surplus and capital impact primarily arising from GMDB, GMIB and GMWB obligations.
The following table represents notional and fair value for the U.S. macro hedge program.
| | | | | | | | | | | | | | | | |
| | Notional Amount | | | Fair Value | |
| | December 31, 2011 | | | December 31, 2010 | | | December 31, 2011 | | | December 31, 2010 | |
Equity futures | | | 59 | | | | 166 | | | $ | — | | | $ | — | |
Equity options | | | 6,760 | | | | 12,891 | | | | 357 | | | | 203 | |
| | | | | | | | | | | | | | | | |
Total | | $ | 6,819 | | | $ | 13,057 | | | $ | 357 | | | $ | 203 | |
| | | | | | | | | | | | | | | | |
International program product derivatives
The Company formerly offered certain variable annuity products with GMWB or GMAB riders in the U.K. and Japan. The GMWB and GMAB are bifurcated embedded derivatives. The GMWB provides the policyholder with a GRB if the account value is reduced to zero through a combination of market declines and withdrawals. The GRB is generally equal to premiums less withdrawals. Certain contract provisions can increase the GRB at contractholder election or after the passage of time. The GMAB provides the policyholder with their initial deposit in a lump sum after a specified waiting period. The notional amount of the embedded derivatives are the foreign currency denominated GRBs converted to U.S. dollars at the current foreign spot exchange rate as of the reporting period date.
International program hedging instruments
The Company utilizes equity futures, options and swaps, and currency forwards, and options to partially hedge against a decline in the debt and equity markets or changes in foreign currency exchange rates and the resulting statutory surplus and capital impact primarily arising from GMDB, GMIB and GMWB obligations issued in the U.K. and Japan. The Company also enters into foreign currency denominated interest rate swaps and swaptions to hedge the interest rate exposure related to the potential annuitization of certain benefit obligations.
F-38
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
The following table represents notional and fair value for the international program hedging instruments.
| | | | | | | | | | | | | | | | |
| | Notional Amount | | | Fair Value | |
| | December 31, 2011 | | | December 31, 2010 | | | December 31, 2011 | | | December 31, 2010 | |
Currency forwards | | $ | 8,622 | | | $ | 4,951 | | | $ | 446 | | | $ | 166 | |
Currency options [1] | | | 7,038 | | | | 5,296 | | | | 72 | | | | 62 | |
Equity futures | | | 2,691 | | | | 1,002 | | | | — | | | | — | |
Equity options | | | 1,120 | | | | 1,073 | | | | (3 | ) | | | 4 | |
Equity swaps | | | 392 | | | | 369 | | | | (8 | ) | | | 1 | |
Interest rate futures | | | 739 | | | | — | | | | — | | | | — | |
Interest rate swaps and swaptions | | | 8,117 | | | | — | | | | 35 | | | | — | |
| | | | | | | | | | | | | | | | |
Total | | $ | 28,719 | | | $ | 12,691 | | | $ | 542 | | | $ | 233 | |
| | | | | | | | | | | | | | | | |
[1] | As of December 31, 2011 and 2010, notional amounts include $5.3 billion and $3.1 billion, respectively, related to long positions and $2.1 billion and $2.2 billion, respectively, related to short positions. |
GMAB, GMWB and GMIB reinsurance contracts
The Company reinsured the GMAB, GMWB, and GMIB embedded derivatives for host variable annuity contracts written by HLIKK. The reinsurance contracts are accounted for as free-standing derivative contracts. The notional amount of the reinsurance contracts is the yen denominated GRB balance value converted at the period-end yen to U.S. dollar foreign spot exchange rate. For further information on this transaction, refer to Note 16 of the Notes to Consolidated Financial Statements.
Coinsurance and modified coinsurance reinsurance contracts
During 2010, a subsidiary entered into a coinsurance with funds withheld and modified coinsurance reinsurance agreement with an affiliated captive reinsurer, which creates an embedded derivative. In addition, provisions of this agreement include reinsurance to cede a portion of direct written U.S. GMWB riders, which is accounted for as an embedded derivative. Additional provisions of this agreement cede variable annuity contract GMAB, GMWB and GMIB riders reinsured by the Company that have been assumed from HLIKK and is accounted for as a free-standing derivative. For further information on this transaction, refer to Note 16 of the Notes to Consolidated Financial Statements.
F-39
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Derivative Balance Sheet Classification
The table below summarizes the balance sheet classification of the Company’s derivative related fair value amounts, as well as the gross asset and liability fair value amounts. The fair value amounts presented do not include income accruals or cash collateral held amounts, which are netted with derivative fair value amounts to determine balance sheet presentation. Derivatives in the Company’s separate accounts are not included because the associated gains and losses accrue directly to policyholders. The Company’s derivative instruments are held for risk management purposes, unless otherwise noted in the table below. The notional amount of derivative contracts represents the basis upon which pay or receive amounts are calculated and is presented in the table to quantify the volume of the Company’s derivative activity. Notional amounts are not necessarily reflective of credit risk.
| | | ****** | | | | ****** | | | | ****** | | | | ****** | | | | ****** | | | | ****** | | | | ****** | | | | ****** | |
| | Net Derivatives | | | Asset Derivatives | | | Liability Derivatives | |
| | Notional Amount | | | Fair Value | | | Fair Value | | | Fair Value | |
Hedge Designation/ Derivative Type | | Dec. 31, 2011 | | | Dec. 31, 2010 | | | Dec. 31, 2011 | | | Dec. 31, 2010 | | | Dec. 31, 2011 | | | Dec. 31, 2010 | | | Dec. 31, 2011 | | | Dec. 31, 2010 | |
Cash flow hedges | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest rate swaps | | $ | 6,339 | | | $ | 7,652 | | | $ | 276 | | | $ | 144 | | | $ | 276 | | | $ | 182 | | | $ | — | | | $ | (38 | ) |
Foreign currency swaps | | | 229 | | | | 255 | | | | (5 | ) | | | — | | | | 17 | | | | 18 | | | | (22 | ) | | | (18 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total cash flow hedges | | | 6,568 | | | | 7,907 | | | | 271 | | | | 144 | | | | 293 | | | | 200 | | | | (22 | ) | | | (56 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Fair value hedges | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest rate swaps | | | 1,007 | | | | 1,079 | | | | (78 | ) | | | (47 | ) | | | — | | | | 4 | | | | (78 | ) | | | (51 | ) |
Foreign currency swaps | | | 677 | | | | 677 | | | | (39 | ) | | | (12 | ) | | | 64 | | | | 71 | | | | (103 | ) | | | (83 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total fair value hedges | | | 1,684 | | | | 1,756 | | | | (117 | ) | | | (59 | ) | | | 64 | | | | 75 | | | | (181 | ) | | | (134 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Non-qualifying strategies | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest rate contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest rate swaps, swaptions, caps, floors, and futures | | | 6,252 | | | | 5,490 | | | | (435 | ) | | | (255 | ) | | | 417 | | | | 121 | | | | (852 | ) | | | (376 | ) |
Foreign exchange contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Foreign currency swaps and forwards | | | 208 | | | | 196 | | | | (10 | ) | | | (14 | ) | | | 3 | | | | — | | | | (13 | ) | | | (14 | ) |
Japan 3Win foreign currency swaps | | | 2,054 | | | | 2,285 | | | | 184 | | | | 177 | | | | 184 | | | | 177 | | | | — | | | | — | |
Japanese fixed annuity hedging instruments | | | 1,945 | | | | 2,119 | | | | 514 | | | | 608 | | | | 540 | | | | 608 | | | | (26 | ) | | | — | |
Credit contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Credit derivatives that purchase credit protection | | | 1,134 | | | | 1,730 | | | | 23 | | | | (5 | ) | | | 35 | | | | 18 | | | | (12 | ) | | | (23 | ) |
Credit derivatives that assume credit risk [1] | | | 2,212 | | | | 2,035 | | | | (545 | ) | | | (376 | ) | | | 2 | | | | 7 | | | | (547 | ) | | | (383 | ) |
Credit derivatives in offsetting positions | | | 5,020 | | | | 5,175 | | | | (43 | ) | | | (57 | ) | | | 101 | | | | 60 | | | | (144 | ) | | | (117 | ) |
Equity contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Equity index swaps and options | | | 1,433 | | | | 188 | | | | 23 | | | | (10 | ) | | | 36 | | | | 5 | | | | (13 | ) | | | (15 | ) |
Variable annuity hedge program | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. GMWB product derivatives [2] | | | 34,569 | | | | 40,255 | | | | (2,538 | ) | | | (1,611 | ) | | | — | | | | — | | | | (2,538 | ) | | | (1,611 | ) |
U.S. GMWB reinsurance contracts | | | 7,193 | | | | 8,767 | | | | 443 | | | | 280 | | | | 443 | | | | 280 | | | | — | | | | — | |
U.S. GMWB hedging instruments | | | 16,406 | | | | 17,856 | | | | 894 | | | | 467 | | | | 1,022 | | | | 647 | | | | (128 | ) | | | (180 | ) |
U.S. macro hedge program | | | 6,819 | | | | 13,057 | | | | 357 | | | | 203 | | | | 357 | | | | 203 | | | | — | | | | — | |
International program product derivatives [2] | | | 2,009 | | | | 2,023 | | | | (30 | ) | | | (14 | ) | | | — | | | | — | | | | (30 | ) | | | (14 | ) |
International program hedging instruments | | | 28,719 | | | | 12,691 | | | | 542 | | | | 233 | | | | 672 | | | | 243 | | | | (130 | ) | | | (10 | ) |
Other | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
GMAB, GMWB, and GMIB reinsurance contracts | | | 21,627 | | | | 21,423 | | | | (3,207 | ) | | | (2,633 | ) | | | — | | | | — | | | | (3,207 | ) | | | (2,633 | ) |
Coinsurance and modified coinsurance reinsurance contracts | | | 50,756 | | | | 51,934 | | | | 2,630 | | | | 1,722 | | | | 2,901 | | | | 2,342 | | | | (271 | ) | | | (620 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total non-qualifying strategies | | | 188,356 | | | | 187,224 | | | | (1,198 | ) | | | (1,285 | ) | | | 6,713 | | | | 4,711 | | | | (7,911 | ) | | | (5,996 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total cash flow hedges, fair value hedges, and non-qualifying strategies | | $ | 196,608 | | | $ | 196,887 | | | $ | (1,044 | ) | | $ | (1,200 | ) | | $ | 7,070 | | | $ | 4,986 | | | $ | (8,114 | ) | | $ | (6,186 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance Sheet Location | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Fixed maturities, available-for-sale | | $ | 416 | | | $ | 441 | | | $ | (45 | ) | | $ | (26 | ) | | $ | — | | | $ | — | | | $ | (45 | ) | | $ | (26 | ) |
Other investments | | | 51,231 | | | | 51,633 | | | | 1,971 | | | | 1,453 | | | | 2,745 | | | | 2,021 | | | | (774 | ) | | | (568 | ) |
Other liabilities | | | 28,717 | | | | 20,318 | | | | (254 | ) | | | (357 | ) | | | 981 | | | | 343 | | | | (1,235 | ) | | | (700 | ) |
Consumer notes | | | 35 | | | | 39 | | | | (4 | ) | | | (5 | ) | | | — | | | | — | | | | (4 | ) | | | (5 | ) |
Reinsurance recoverables | | | 55,140 | | | | 58,834 | | | | 3,073 | | | | 2,002 | | | | 3,344 | | | | 2,622 | | | | (271 | ) | | | (620 | ) |
Other policyholder funds and benefits payable | | | 61,069 | | | | 65,622 | | | | (5,785 | ) | | | (4,267 | ) | | | — | | | | — | | | | (5,785 | ) | | | (4,267 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total derivatives | | $ | 196,608 | | | $ | 196,887 | | | $ | (1,044 | ) | | $ | (1,200 | ) | | $ | 7,070 | | | $ | 4,986 | | | $ | (8,114 | ) | | $ | (6,186 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | The derivative instruments related to this strategy are held for other investment purposes. |
[2] | These derivatives are embedded within liabilities and are not held for risk management purposes. |
F-40
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Change in Notional Amount
The net decrease in notional amount of derivatives since December 31, 2010, was primarily due to the following:
• | | The decrease of $8.7 billion in the combined GMWB hedging program, which includes the GMWB product, reinsurance, and hedging derivatives, was primarily a result of policyholder lapses and withdrawals. |
• | | The U.S. macro hedge program notional decreased $6.2 billion primarily due to the expiration of certain out of the money options in January of 2011. |
• | | During 2011, the Company significantly strengthened its hedge protection of variable annuity products offered in Japan. As such, the notional amount related to the international program hedging instruments increased by $16.0 billion as the Company entered into additional foreign currency denominated interest rate swaps and swaptions, currency forwards, currency options and equity futures. |
• | | The coinsurance and modified coinsurance reinsurance contract notional decreased $1.2 billion primarily due to policyholder lapses and withdrawals. |
Change in Fair Value
The improvement in the total fair value of derivative instruments since December 31, 2010, was primarily related to the following:
• | | The fair value related to the international program hedging instruments increased as a result of the additional notional added during the year, as well as strengthening of the Japanese yen, lower global equity markets, and a decrease in interest rates. |
• | | The decrease in the combined GMWB hedging program, which includes the GMWB product, reinsurance, and hedging derivatives, was primarily a result of a general decrease in long-term interest rates and higher interest rate volatility. |
• | | Under an internal reinsurance agreement with an affiliate, the decrease in fair value associated with the GMAB, GMWB, and GMIB reinsurance contracts along with a portion of the GMWB related derivatives are ceded to the affiliated reinsurer and result in an offsetting fair value of the coinsurance and modified coinsurance reinsurance contracts. |
Cash Flow Hedges
For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of OCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing hedge ineffectiveness are recognized in current earnings. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.
The following table presents the components of the gain or loss on derivatives that qualify as cash flow hedges:
Derivatives in Cash Flow Hedging Relationships
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Gain (Loss) Recognized in OCI on Derivative (Effective Portion) | | | Net Realized Capital Gains (Losses) Recognized in Income on Derivative (Ineffective Portion) | |
| | 2011 | | | 2010 | | | 2009 | | | 2011 | | | 2010 | | | 2009 | |
Interest rate swaps | | $ | 245 | | | $ | 232 | | | $ | (357 | ) | | $ | (2 | ) | | $ | 2 | | | $ | 1 | |
Foreign currency swaps | | | (5 | ) | | | 3 | | | | (177 | ) | | | — | | | | (1 | ) | | | 75 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total | | $ | 240 | | | $ | 235 | | | $ | (534 | ) | | $ | (2 | ) | | $ | 1 | | | $ | 76 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Derivatives in Cash Flow Hedging Relationships
| | | | | | | | | | | | | | |
| |
| | | | Gain (Loss) Reclassified from AOCI into Income (Effective Portion) | |
| | | | 2011 | | | 2010 | | | 2009 | |
Interest rate swaps | | Net realized capital gains (losses) | | $ | 6 | | | $ | 5 | | | $ | — | |
Interest rate swaps | | Net investment income (loss) | | | 77 | | | | 56 | | | | 28 | |
Foreign currency swaps | | Net realized capital gains (losses) | | | (1 | ) | | | (7 | ) | | | (115 | ) |
Foreign currency swaps | | Net investment income (loss) | | | — | | | | — | | | | 2 | |
| | | | | | | | | | | | | | |
Total | | | | $ | 82 | | | $ | 54 | | | $ | (85 | ) |
| | | | | | | | | | | | | | |
F-41
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
As of December 31, 2011, the before-tax deferred net gains on derivative instruments recorded in AOCI that are expected to be reclassified to earnings during the next twelve months are $76. This expectation is based on the anticipated interest payments on hedged investments in fixed maturity securities that will occur over the next twelve months, at which time the Company will recognize the deferred net gains (losses) as an adjustment to interest income over the term of the investment cash flows. The maximum term over which the Company is hedging its exposure to the variability of future cash flows (for forecasted transactions, excluding interest payments on existing variable-rate financial instruments) is approximately one year.
During the year ended December 31, 2011, the Company had no net reclassifications from AOCI to earnings resulting from the discontinuance of cash-flow hedges due to forecasted transactions that were no longer probable of occurring. For the years ended December 31, 2010 and 2009, the Company had less than $1 and $1 of net reclassifications, respectively, from AOCI to earnings resulting from the discontinuance of cash-flow hedges due to forecasted transactions that were no longer probable of occurring.
Fair Value Hedges
For derivative instruments that are designated and qualify as a fair value hedge, the gain or loss on the derivative, as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. The Company includes the gain or loss on the derivative in the same line item as the offsetting loss or gain on the hedged item. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.
The Company recognized in income gains (losses) representing the ineffective portion of fair value hedges as follows:
Derivatives in Fair Value Hedging Relationships
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Gain (Loss) Recognized in Income [1] | |
| | 2011 | | | 2010 | | | 2009 | |
| | Derivative | | | Hedged Item | | | Derivative | | | Hedged Item | | | Derivative | | | Hedged Item | |
Interest rate swaps | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized capital gains (losses) | | $ | — | | | $ | — | | | $ | (44 | ) | | $ | 38 | | | $ | 72 | | | $ | (68 | ) |
Benefits, losses and loss adjustment expenses | | | (58 | ) | | | 54 | | | | (1 | ) | | | 3 | | | | (37 | ) | | | 40 | |
Foreign currency swaps | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized capital gains (losses) | | | (1 | ) | | | 1 | | | | 8 | | | | (8 | ) | | | 51 | | | | (51 | ) |
Benefits, losses and loss adjustment expenses | | | (22 | ) | | | 22 | | | | (12 | ) | | | 12 | | | | 2 | | | | (2 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total | | $ | (81 | ) | | $ | 77 | | | $ | (49 | ) | | $ | 45 | | | $ | 88 | | | $ | (81 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | |
[1] | The amounts presented do not include the periodic net coupon settlements of the derivative or the coupon income (expense) related to the hedged item. The net of the amounts presented represents the ineffective portion of the hedge. |
F-42
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Non-qualifying Strategies
For non-qualifying strategies, including embedded derivatives that are required to be bifurcated from their host contracts and accounted for as derivatives, the gain or loss on the derivative is recognized currently in earnings within net realized capital gains (losses). The following table presents the gain or loss recognized in income on non-qualifying strategies:
Non-qualifying Strategies
Gain (Loss) Recognized within Net Realized Capital Gains (Losses)
| | | | | | | | | | | | |
| | December 31, | |
| | 2011 | | | 2010 | | | 2009 | |
Interest rate contracts | | | | | | | | | | | | |
Interest rate swaps, caps, floors, and forwards | | $ | 20 | | | $ | 14 | | | $ | 32 | |
Foreign exchange contracts | | | | | | | | | | | | |
Foreign currency swaps and forwards | | | 1 | | | | (3 | ) | | | (37 | ) |
Japan 3Win foreign currency swaps [1] | | | 31 | | | | 215 | | | | (22 | ) |
Japanese fixed annuity hedging instruments [2] | | | 109 | | | | 385 | | | | (12 | ) |
Credit contracts | | | | | | | | | | | | |
Credit derivatives that purchase credit protection | | | (8 | ) | | | (17 | ) | | | (379 | ) |
Credit derivatives that assume credit risk | | | (141 | ) | | | 157 | | | | 137 | |
Equity contracts | | | | | | | | | | | | |
Equity index swaps and options | | | (67 | ) | | | 5 | | | | (3 | ) |
Variable annuity hedge program | | | | | | | | | | | | |
U.S. GMWB product derivatives | | | (780 | ) | | | 486 | | | | 4,686 | |
U.S. GMWB reinsurance contracts | | | 131 | | | | (102 | ) | | | (988 | ) |
U.S. GMWB hedging instruments | | | 252 | | | | (295 | ) | | | (2,234 | ) |
U.S. macro hedge program | | | (216 | ) | | | (445 | ) | | | (733 | ) |
International program product derivative | | | (12 | ) | | | 24 | | | | 41 | |
International program hedging instruments | | | 735 | | | | (37 | ) | | | (179 | ) |
Other | | | | | | | | | | | | |
GMAB, GMWB, and GMIB reinsurance contracts | | | (326 | ) | | | (769 | ) | | | 1,106 | |
Coinsurance and modified coinsurance reinsurance contracts | | | 373 | | | | 284 | | | | (577 | ) |
| | | | | | | | | | | | |
Total | | $ | 102 | | | $ | (98 | ) | | $ | 838 | |
| | | | | | | | | | | | |
[1] | The associated liability is adjusted for changes in spot rates through realized capital gains and was ($100), ($273) and $64 for the years ended December 31, 2011, 2010 and 2009, respectively. |
[2] | The associated liability is adjusted for changes in spot rates through realized capital gains and losses and was ($129), ($332) and $67 for the years ended December 31, 2011, 2010 and 2009, respectively. |
For the year ended December 31, 2011, the net realized capital gain (loss) related to derivatives used in non-qualifying strategies was primarily comprised of the following:
• | | The net gain associated with the international program hedging instruments was primarily driven by strengthening of the Japanese yen, lower global equity markets, and a decrease in interest rates. |
• | | The loss related to the combined GMWB hedging program, which includes the GMWB product, reinsurance, and hedging derivatives, was primarily a result of a general decrease in long-term interest rates and higher interest rate volatility. |
• | | The net loss associated with GMAB, GMWB, and GMIB reinsurance contracts, which are reinsured to an affiliated captive reinsurer, was primarily due to the strengthening of the Japanese yen and a decrease in equity markets. |
• | | The net gain on the coinsurance and modified coinsurance reinsurance agreement, which is accounted for as a derivative instrument primarily offsets the net loss on GMAB, GMWB, and GMIB reinsurance contracts. For a discussion related to the reinsurance agreement refer to Note 16 of the Notes to Consolidated Financial Statements for more information on this transaction. |
• | | The net loss on U.S. macro hedge program was primarily driven by time decay and a decrease in equity market volatility since the purchase date of certain options during the fourth quarter. |
F-43
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
For the year ended December 31, 2010, the net realized capital gain (loss) related to derivatives used in non-qualifying strategies was primarily comprised of the following:
• | | The net loss on derivatives associated with GMAB, GMWB, and GMIB reinsurance contracts, which are reinsured to an affiliated captive reinsurer, was primarily due to a decrease in Japan interest rates, an increase in Japan currency volatility and a decrease in Japan equity markets. |
• | | The net loss associated with the U.S. macro hedge program was primarily due to a higher equity market valuation, time decay, and lower implied market volatility. |
• | | The net gain on the Japanese fixed annuity hedging instruments was primarily due to the strengthening of the Japanese yen in comparison to the U.S. dollar. |
• | | The net gain related to the Japan 3 Win foreign currency swaps was primarily due to the strengthening of the Japanese yen in comparison to the U.S. dollar, partially offset by the decrease in U.S. long-term interest rates. |
• | | The net gain on the coinsurance and modified coinsurance reinsurance agreement, which is accounted for as a derivative instrument, primarily offsets the net loss on GMAB, GMWB, and GMIB reinsurance contracts. For a discussion related to the reinsurance agreement refer to Note 16 for more information on this transaction. |
• | | The net gain associated with credit derivatives that assume credit risk as a part of replication transactions resulted from credit spread tightening. |
• | | The gain related to the combined GMWB hedging program, which includes the GMWB product, reinsurance, and hedging derivatives, was primarily a result of liability model assumption updates during third quarter, lower implied market volatility, and outperformance of the underlying actively managed funds as compared to their respective indices, partially offset by a general decrease in long-term interest rates and rising equity markets. |
• | | The gain on Japan variable annuity hedges was primarily driven by the appreciation of Japanese yen in comparison to the euro. |
For the year ended December 31, 2009, the net realized capital gain (loss) related to derivatives used in non-qualifying strategies was primarily due to the following:
• | | The gain related to the net GMWB product, reinsurance, and hedging derivatives was primarily due to liability model assumption updates given favorable trends in policyholder experience, the relative outperformance of the underlying actively managed funds as compared to their respective indices, and the impact of the Company’s own credit standing. Additional net gains on GMWB related derivatives include lower implied market volatility and a general increase in long-term interest rates, partially offset by rising equity markets. |
• | | The net gain on derivatives associated with GMAB, GMWB, and GMIB reinsurance contracts, which are reinsured to an affiliated captive reinsurer, was primarily due to an increase in interest rates, an increase in the Japan equity markets, a decline in Japan equity market volatility, and liability model assumption updates for credit standing. |
• | | The net loss on the U.S. macro hedge program was primarily the result of a higher equity market valuation and the impact of trading activity. |
• | | The net loss on the coinsurance and modified coinsurance reinsurance agreement, which is accounted for as a derivative instrument, primarily offsets the net gain on GMAB, GMWB, and GMIB reinsurance contracts. For a discussion related to the reinsurance agreement refer to Note 16 for more information on this transaction. |
In addition, for the year ended December 31, 2009, the Company has incurred losses of $39 on derivative instruments due to counterparty default related to the bankruptcy of Lehman Brothers Inc. These losses were a result of the contractual collateral threshold amounts and open collateral calls in excess of such amounts immediately prior to the bankruptcy filing, as well as interest rate and credit spread movements from the date of the last collateral call to the date of the bankruptcy filing.
Refer to Note 10 for additional disclosures regarding contingent credit related features in derivative agreements.
F-44
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Credit Risk Assumed through Credit Derivatives
The Company enters into credit default swaps that assume credit risk of a single entity, referenced index, or asset pool in order to synthetically replicate investment transactions. The Company will receive periodic payments based on an agreed upon rate and notional amount and will only make a payment if there is a credit event. A credit event payment will typically be equal to the notional value of the swap contract less the value of the referenced security issuer’s debt obligation after the occurrence of the credit event. A credit event is generally defined as a default on contractually obligated interest or principal payments or bankruptcy of the referenced entity. The credit default swaps in which the Company assumes credit risk primarily reference investment grade single corporate issuers and baskets, which include standard and customized diversified portfolios of corporate issuers. The diversified portfolios of corporate issuers are established within sector concentration limits and may be divided into tranches that possess different credit ratings.
The following tables present the notional amount, fair value, weighted average years to maturity, underlying referenced credit obligation type and average credit ratings, and offsetting notional amounts and fair value for credit derivatives in which the Company is assuming credit risk as of December 31, 2011 and 2010.
As of December 31, 2011
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Underlying Referenced Credit Obligation(s) [1] | |
Credit Derivative type by derivative risk exposure | | Notional Amount [2] | | | Fair Value | | | Weighted Average Years to Maturity | | | Type | | Average Credit Rating | | Offsetting Notional Amount [3] | | | Offsetting Fair Value [3] | |
Single name credit default swaps | | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | | $ | 1,067 | | | $ | (18 | ) | | | 3 years | | | Corporate Credit/ Foreign Gov. | | A+ | | $ | 915 | | | $ | (19 | ) |
Below investment grade risk exposure | | | 125 | | | | (7 | ) | | | 2 years | | | Corporate Credit | | B+ | | | 114 | | | | (3 | ) |
Basket credit default swaps [4] | | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | | | 2,375 | | | | (71 | ) | | | 3 years | | | Corporate Credit | | BBB+ | | | 1,128 | | | | 17 | |
Investment grade risk exposure | | | 353 | | | | (63 | ) | | | 5 years | | | CMBS Credit | | BBB+ | | | 353 | | | | 62 | |
Below investment grade risk exposure | | | 477 | | | | (441 | ) | | | 3 years | | | Corporate Credit | | BBB+ | | | — | | | | — | |
Embedded credit derivatives | | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | | | 25 | | | | 24 | | | | 3 years | | | Corporate Credit | | BBB- | | | — | | | | — | |
Below investment grade risk exposure | | | 300 | | | | 245 | | | | 5 years | | | Corporate Credit | | BB+ | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total | | $ | 4,722 | | | $ | (331 | ) | | | | | | | | | | $ | 2,510 | | | $ | 57 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
F-45
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
As of December 31, 2010
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Underlying Referenced Credit Obligation(s) [1] | |
Credit Derivative type by derivative risk exposure | | Notional Amount [2] | | | Fair Value | | | Weighted Average Years to Maturity | | | Type | | Average Credit Rating | | Offsetting Notional Amount [3] | | | Offsetting Fair Value [3] | |
Single name credit default swaps | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
Investment grade risk exposure | | $ | 1,038 | | | $ | (6 | ) | | | 3 years | | | Corporate Credit/ Foreign Gov. | | A+ | | $ | 945 | | | $ | (36 | ) |
Below investment grade risk exposure | | | 151 | | | | (6 | ) | | | 3 years | | | Corporate Credit | | BB- | | | 135 | | | | (11 | ) |
Basket credit default swaps [4] | | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | | | 2,064 | | | | (7 | ) | | | 4 years | | | Corporate Credit | | BBB+ | | | 1,155 | | | | (7 | ) |
Investment grade risk exposure | | | 352 | | | | (32 | ) | | | 6 years | | | CMBS Credit | | A- | | | 352 | | | | 32 | |
Below investment grade risk exposure | | | 667 | | | | (334 | ) | | | 4 years | | | Corporate Credit | | BBB+ | | | — | | | | — | |
Embedded credit derivatives | | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | | | 25 | | | | 25 | | | | 4 years | | | Corporate Credit | | BBB- | | | — | | | | — | |
Below investment grade risk exposure | | | 325 | | | | 286 | | | | 6 years | | | Corporate Credit | | BB | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total | | $ | 4,622 | | | $ | (74 | ) | | | | | | | | | | $ | 2,587 | | | $ | (22 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | |
[1] | The average credit ratings are based on availability and the midpoint of the applicable ratings among Moody’s, S&P, and Fitch. If no rating is available from a rating agency, then an internally developed rating is used. |
[2] | Notional amount is equal to the maximum potential future loss amount. There is no specific collateral related to these contracts or recourse provisions included in the contracts to offset losses. |
[3] | The Company has entered into offsetting credit default swaps to terminate certain existing credit default swaps, thereby offsetting the future changes in value of, or losses paid related to, the original swap. |
[4] | Includes $2.7 billion and $2.6 billion as of December 31, 2011 and 2010, respectively, of standard market indices of diversified portfolios of corporate issuers referenced through credit default swaps. These swaps are subsequently valued based upon the observable standard market index. Also includes $478 and $467 as of December 31, 2011 and 2010, respectively, of customized diversified portfolios of corporate issuers referenced through credit default swaps. |
Collateral Arrangements
The Company enters into various collateral arrangements in connection with its derivative instruments, which require both the pledging and accepting of collateral. As of December 31, 2011 and 2010, collateral pledged having a fair value of $762 and $544, respectively, was included in fixed maturities, AFS, in the Consolidated Balance Sheets.
The following table presents the classification and carrying amount of loaned securities and derivative instruments collateral pledged.
| | | | | | | | |
| | December 31, 2011 | | | December 31, 2010 | |
Fixed maturities, AFS | | $ | 762 | | | $ | 544 | |
Short-term investments | | | 148 | | | | — | |
| | | | | | | | |
Total collateral pledged | | $ | 910 | | | $ | 544 | |
| | | | | | | | |
As of December 31, 2011 and 2010, the Company had accepted collateral with a fair value of $2.4 billion and $1.4 billion, respectively, of which $1.9 billion and $1.1 billion, respectively, was derivative cash collateral which was invested and recorded in the Consolidated Balance Sheets in fixed maturities and short-term investments with corresponding amount recorded in other assets and other liabilities. The Company is only permitted by contract to sell or repledge the noncash collateral in the event of a default by the counterparty. As of December 31, 2011 and 2010, noncash collateral accepted was held in separate custodial accounts and were not included in the Company’s Consolidated Balance Sheets.
Securities on Deposit with States
The Company is required by law to deposit securities with government agencies in states where it conducts business. As of December 31, 2011 and 2010, the fair value of securities on deposit was approximately $14.
F-46
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
5. Reinsurance
Accounting Policy
The Company cedes insurance to affiliated and unaffiliated insurers in order to limit its maximum losses and to diversify its exposures and provide statutory surplus relief. Such arrangements do not relieve the Company of its primary liability to policyholders. Failure of reinsurers to honor their obligations could result in losses to the Company. The Company also assumes reinsurance from other insurers and is a member of and participates in reinsurance pools and associations. Reinsurance accounting is followed for ceded and assumed transactions that provide indemnification against loss or liability relating to insurance risk (i.e. risk transfer). If the ceded transactions do not provide risk transfer, the Company accounts for these transactions as financing transactions.
Reinsurance accounting is followed for ceded and assumed transactions that provide indemnification against loss or liability relating to insurance risk (i.e. risk transfer). To meet risk transfer requirements, a reinsurance agreement must include insurance risk, consisting of underwriting, investment, and timing risk, and a reasonable possibility of a significant loss to the reinsurer. If the ceded and assumed transactions do not meet risk transfer requirements, the Company accounts for these transactions as financing transactions.
Premiums, benefits, losses and loss adjustment expenses reflect the net effects of ceded and assumed reinsurance transactions. Included in other assets are prepaid reinsurance premiums, which represent the portion of premiums ceded to reinsurers applicable to the unexpired terms of the reinsurance agreements. Included in reinsurance recoverables are balances due from reinsurance companies for paid and unpaid losses and loss adjustment expenses and are presented net of an allowance for uncollectible reinsurance.
The Company reinsures certain of its risks to other reinsurers under yearly renewable term, coinsurance, and modified coinsurance arrangements, and variations thereof. The cost of reinsurance related to long-duration contracts is accounted for over the life of the underlying reinsured policies using assumptions consistent with those used to account for the underlying policies.
The Company evaluates the financial condition of its reinsurers and concentrations of credit risk. Reinsurance is placed with reinsurers that meet strict financial criteria established by the Company. As of December 31, 2011, 2010 and 2009, there were no reinsurance-related concentrations of credit risk greater than 10% of the Company’s stockholders’ equity. As of December 31, 2011, 2010, and 2009, the Company’s policy for the largest amount retained on any one life by the Life Insurance segment was $10.
Results
Insurance recoveries on ceded reinsurance agreements, which reduce death and other benefits, were $252, $324, and $450 for the years ended December 31, 2011, 2010, and 2009, respectively. The Company reinsures 31% of GMDB, as well as a portion of GMWB, on contracts issued prior to July 2007, offered in connection with its variable annuity contracts. The Company maintains reinsurance agreements with HLA, whereby the Company cedes both group life and group accident and health risk. Under these treaties, the Company ceded group life premium of $106, $129, and $178 in 2011, 2010, and 2009, respectively, and accident and health premium of $191 , $205, and $232, respectively, to HLA. Effective October 1, 2009, HLAI entered into a modified coinsurance and coinsurance with funds withheld reinsurance agreement with an affiliated captive reinsurer, White River Life Reinsurance (“WRR”). The agreement provides that HLAI will cede, and WRR will reinsure, a portion of the risk associated with direct written and assumed variable annuities and the associated GMDB and GMWB riders, HLAI assumed HLIKK’s variable annuity contract and rider benefits, and HLAI assumed HLL’s GMDB and GMWB annuity contract and rider benefits. Under this transaction, the Company ceded $71, $56, and $62 in 2011, 2010 and 2009, respectively. Refer to Note 16 of the Notes to Consolidated Financial Statements for further information.
Net fee income, earned premiums and other were comprised of the following:
| | | | | | | | | | | | |
| | For the Years Ended December 31, | |
| | 2011 | | | 2010 | | | 2009 | |
Gross fee income, earned premiums and other | | $ | 4,756 | | | $ | 4,756 | | | $ | 4,890 | |
Reinsurance assumed | | | 13 | | | | 69 | | | | 70 | |
Reinsurance ceded | | | (733 | ) | | | (759 | ) | | | (860 | ) |
| | | | | | | | | | | | |
Net fee income, earned premiums and other | | $ | 4,036 | | | $ | 4,066 | | | $ | 4,100 | |
| | | | | | | | | | | | |
F-47
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
6. Deferred Policy Acquisition Costs and Present Value of Future Profits
Accounting Policy
The Company capitalizes acquisition costs that vary with and are primarily related to the acquisition of new and renewal insurance contracts. The Company’s deferred policy acquisition cost (“DAC”) asset, which includes the present value of future profits, related to most universal life-type contracts (including variable annuities) is amortized over the estimated life of the contracts acquired in proportion to the present value of estimated gross profits (“EGPs”). EGPs are also used to amortize other assets and liabilities in the Company’s Consolidated Balance Sheets such as, sales inducement assets (“SIA”) and unearned revenue reserves (“URR”). Components of EGPs are used to determine reserves for universal life type contracts (including variable annuities) with death or other insurance benefits such as guaranteed minimum death, guaranteed minimum income and universal life secondary guarantee benefits. These benefits are accounted for and collectively referred to as death and other insurance benefit reserves and are held in addition to the account value liability representing policyholder funds.
For most contracts, the Company estimates gross profits over 20 years as EGPs emerging subsequent to that timeframe are immaterial. Products sold in a particular year are aggregated into cohorts. Future gross profits for each cohort are projected over the estimated lives of the underlying contracts, based on future account value projections for variable annuity and variable universal life products. The projection of future account values requires the use of certain assumptions including: separate account returns; separate account fund mix; fees assessed against the contract holder’s account balance; surrender and lapse rates; interest margin; mortality; and the extent and duration of hedging activities and hedging costs.
The Company determines EGPs from a single deterministic reversion to mean (“RTM”) separate account return projection which is an estimation technique commonly used by insurance entities to project future separate account returns. Through this estimation technique, the Company’s DAC model is adjusted to reflect actual account values at the end of each quarter. Through a consideration of recent market returns, the Company will unlock, or adjust, projected returns over a future period so that the account value returns to the long-term expected rate of return, providing that those projected returns do not exceed certain caps or floors. This Unlock for future separate account returns is determined each quarter.
In the third quarter of each year, the Company completes a comprehensive non-market related policyholder behavior assumption study and incorporates the results of those studies into its projection of future gross profits. Additionally, throughout the year, the Company evaluates various aspects of policyholder behavior and periodically revises its policyholder assumptions as credible emerging data indicates that changes are warranted. Upon completion of an assumption study or evaluation of credible new information, the Company will revise its assumptions to reflect its current best estimate. These assumption revisions will change the projected account values and the related EGPs in the DAC, SIA and URR amortization models, as well as, the death and other insurance benefit reserving models.
All assumption changes that affect the estimate of future EGPs including the update of current account values, the use of the RTM estimation technique, and policyholder behavior assumptions are considered an Unlock in the period of revision. An Unlock adjusts the DAC, SIA, URR and death and other insurance benefit reserve balances in the Consolidated Balance Sheets with an offsetting benefit or charge in the Consolidated Statements of Operations in the period of the revision. An Unlock that results in an after-tax benefit generally occurs as a result of actual experience or future expectations of product profitability being favorable compared to previous estimates. An Unlock that results in an after-tax charge generally occurs as a result of actual experience or future expectations of product profitability being unfavorable compared to previous estimates.
An Unlock revises EGPs to reflect the Company’s current best estimate assumptions. The Company also tests the aggregate recoverability of DAC by comparing the existing DAC balance to the present value of future EGPs.
Effective October 1, 2009, HLAI entered into a modified coinsurance and coinsurance with funds withheld reinsurance agreement with an affiliated captive reinsurer, White River Life Reinsurance (“WRR”). The agreement provides that HLAI will cede, and WRR will reinsure 100% of the in-force and prospective variable annuities and associated GMDB and GMWB riders written or reinsured by HLAI. This transaction resulted in a DAC Unlock of $2.0 billion, pre-tax and $1.3 billion, after-tax. See Note 16 of the Notes to Consolidated Financial Statements for further information on the transaction.
F-48
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
6. Deferred Policy Acquisition Costs and Present Value of Future Profits (continued)
Results
Changes in the DAC balance are as follows:
| | | | | | | | | | | | |
| | 2011 | | | 2010 | | | 2009 | |
Balance, January 1 | | $ | 4,949 | | | $ | 5,779 | | | $ | 9,944 | |
Deferred costs | | | 533 | | | | 521 | | | | 674 | |
Amortization — DAC | | | (429 | ) | | | (381 | ) | | | (813 | ) |
Amortization — Unlock benefit (charge), pre-tax [1] | | | (187 | ) | | | 166 | | | | (2,905 | ) |
Amortization — DAC from discontinued operations | | | — | | | | (17 | ) | | | (11 | ) |
Adjustments to unrealized gains and losses on securities available-for-sale and other[2] | | | (269 | ) | | | (1,120 | ) | | | (1,080 | ) |
Effect of currency translation | | | 1 | | | | (10 | ) | | | 24 | |
Cumulative effect of accounting change, pre-tax [3] | | | — | | | | 11 | | | | (54 | ) |
| | | | | | | | | | | | |
Balance, December 31 | | $ | 4,598 | | | $ | 4,949 | | | $ | 5,779 | |
| | | | | | | | | | | | |
[1] | The most significant contributors to the Unlock charge recorded during the year ended December 31, 2011 were assumption changes which reduced expected future gross profits including additional costs associated with implementing the U.S. variable annuity macro hedge program, as well as actual separate account returns below our aggregated estimated return. |
The most significant contributor to the Unlock benefit recorded during the twelve months ended December 31, 2010 was actual separate account returns above our aggregated estimated return and the impacts of assumption updates.
The most significant contributors to the Unlock amount recorded during the twelve months ended December 31, 2009 were a charge of $2.0 billion related to reinsurance of a block of in-force and prospective U.S. variable annuities and the associated GMDB and GMWB riders with an affiliated captive reinsurer, as well as actual separate account returns significantly below our aggregated estimated return for the first quarter of 2009, partially offset by actual returns greater than our aggregated estimated return for the period from April 1, 2009 to December 31, 2009. Also included in the unlock was a $49 charge related to DAC recoverability impairment associated with the decision to suspend sales in the U.K. variable annuity business
[2] | The most significant contributor to the adjustments was the effect of declining interest rates, resulting in unrealized gains on securities classified in AOCI. Other includes a $34 decrease as a result of the disposition of DAC from the sale of the Hartford Investments Canada Corporation in 2010. |
[3] | For the year ended December 31, 2010 the effect of adopting new accounting guidance for embedded credit derivatives resulted in a decrease to retained earnings and, as a result, a DAC benefit. In addition, an offsetting amount was recorded in unrealized losses as unrealized losses decreased upon adoption of the new accounting guidance. |
For the year ended December 31, 2009 the effect of adopting new accounting guidance for investments other- than- temporarily impaired resulted in an increase to retained earnings and, as a result, a DAC charge. In addition, an offsetting amount was recorded in unrealized losses as unrealized losses increased upon adoption of the new accounting guidance.
As of December 31, 2011, estimated future net amortization expense of present value of future profits for the succeeding five years is $17, $16, $16, $15 and $15 in 2012, 2013, 2014, 2015 and 2016, respectively.
F-49
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
7. Goodwill
Accounting Policy
Goodwill represents the excess of costs over the fair value of net assets acquired. Goodwill is not amortized but is reviewed for impairment at least annually or more frequently if events occur or circumstances change that would indicate that a triggering event for a potential impairment has occurred. During the fourth quarter of 2011, the Company changed the date of its annual impairment test for all reporting units to October 31st from January 1st. As a result, all reporting units performed an impairment test on October 31, 2011 in addition to the annual impairment test performed on January 1, 2011. The change was made to be consistent across all of the parent company’s reporting units and to more closely align the impairment testing date with the long-range planning and forecasting process. The Company has determined that this change in accounting principle is preferable under the circumstances and does not result in any delay, acceleration or avoidance of impairment. As it was impracticable to objectively determine projected cash flows and related valuation estimates as of each October 31 for periods prior to October 31, 2011without applying information that has been learned since those periods, the Company has prospectively applied the change in the annual goodwill impairment testing date from October 31, 2011.
The goodwill impairment test follows a two-step process. In the first step, the fair value of a reporting unit is compared to its carrying value. If the carrying value of a reporting unit exceeds its fair value, the second step of the impairment test is performed for purposes of measuring the impairment. In the second step, the fair value of the reporting unit is allocated to all of the assets and liabilities of the reporting unit to determine an implied goodwill value. If the carrying amount of the reporting unit’s goodwill exceeds the implied goodwill value, an impairment loss is recognized in an amount equal to that excess.
Management’s determination of the fair value of each reporting unit incorporates multiple inputs into discounted cash flow calculations, including assumptions that market participants would make in valuing the reporting unit. Assumptions include levels of economic capital, future business growth, earnings projections, assets under management for certain reporting units, and the weighted average cost of capital used for purposes of discounting. Decreases in the amount of economic capital allocated to a reporting unit, decreases in business growth, decreases in earnings projections and increases in the weighted average cost of capital will all cause a reporting unit’s fair value to decrease.
Results
The carrying amount of goodwill allocated to reporting segments is shown below.
| | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2011 | | | December 31, 2010 | |
| Gross | | | Accumulated Impairments | | | Carrying Value | | | Gross | | | Accumulated Impairments | | | Carrying Value | |
Individual Life | | $ | 224 | | | $ | — | | | $ | 224 | | | $ | 224 | | | | — | | | $ | 224 | |
Retirement Plans | | | 87 | | | | — | | | | 87 | | | | 87 | | | | — | | | | 87 | |
Mutual Funds | | | 159 | | | | — | | | | 159 | | | | 159 | | | | — | | | | 159 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total Goodwill | | $ | 470 | | | $ | — | | | $ | 470 | | | $ | 470 | | | $ | — | | | $ | 470 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
The Company completed its annual goodwill assessment for the individual reporting units on January 1, 2011 and October 31, 2011, which resulted in no impairment of goodwill. All reporting units passed the first step of both impairment tests with a significant margin.
The Company completed its annual goodwill assessment for the individual reporting units on January 1, 2010, which resulted in no write-downs of goodwill in 2010. The reporting units passed the first step of their annual impairment tests with a significant margin with the exception of the Individual Life reporting unit. Individual Life completed the second step of the annual goodwill impairment test resulting in an implied goodwill value that was in excess of its carrying value. Even though the fair value of the reporting unit was lower than its carrying value, the implied level of goodwill in Individual Life exceeded the carrying amount of goodwill. In the hypothetical purchase accounting required by step two of the goodwill impairment test, the implied present value of future profits was substantially lower than that of the DAC asset removed in purchase accounting. A higher discount rate was used for calculating the present value of future profits as compared to that used for calculating the present value of estimated gross profits for DAC. As a result, in the hypothetical purchase accounting, implied goodwill exceeded the carrying amount of goodwill.
The Company completed its annual goodwill assessment for the individual reporting units of the Company on January 1,2009 and concluded that the fair value of each reporting unit for which goodwill had been allocated was in excess of the respective reporting unit’s carrying value.
F-50
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
8. Separate Accounts, Death Benefits and Other Insurance Benefit Features
Accounting Policy
The Company records the variable portion of individual variable annuities, 401(k), institutional, 403(b)/457, private placement life and variable life insurance products within separate accounts. Separate account assets are reported at fair value and separate account liabilities are reported at amounts consistent with separate account assets. Investment income and gains and losses from those separate account assets accrue directly to the policyholder, who assumes the related investment risk, and are offset by the related liability changes reported in the same line item in the Consolidated Statements of Operations. The Company earns fees for investment management, certain administrative expenses, and mortality and expense risks assumed which are reported in fee income.
Certain contracts classified as universal life-type include death and other insurance benefit features including GMDB offered with variable annuity contracts, or secondary guarantee benefits offered with universal life (“UL”) insurance contracts. GMDBs have been written in various forms as described in this note. UL secondary guarantee benefits ensure that the policy will not terminate, and will continue to provide a death benefit, even if there is insufficient policy value to cover the monthly deductions and charges. These death and other insurance benefit features require an additional liability be held above the account value liability representing the policyholders’ funds. This liability is reported in reserve for future policy benefits in the Company’s Consolidated Balance Sheets. Changes in the death and other insurance benefit reserves are recorded in benefits, losses and loss adjustment expenses in the Company’s Consolidated Statements of Operations.
Consistent with the Company’s policy on DAC Unlock, the Company regularly evaluates estimates used and adjusts the additional liability balance, with a related charge or credit to benefits, losses and loss adjustment expense. For further information on the DAC Unlock, see Note 6 Deferred Policy Acquisition Costs and Present Value of Future Benefits.
The Company reinsures the GMDBs associated with its in-force block of business. The Company also assumes, through reinsurance, minimum death, income, withdrawal and accumulation benefits offered by an affiliate. The death and other insurance benefit liability is determined by estimating the expected present value of the benefits in excess of the policyholder’s expected account value in proportion to the present value of total expected assessments. The additional death and other insurance benefits and net reinsurance costs are recognized ratably over the accumulation period based on total expected assessments.
Results
Changes in the gross GMDB and UL secondary guarantee benefits are as follows:
| | | | | | | | |
| | GMDB | | | UL Secondary Guarantees | |
Liability balance as of January 1, 2011 | | $ | 1,115 | | | $ | 113 | |
Incurred | | | 271 | | | | 53 | |
Paid | | | (276 | ) | | | — | |
Unlock | | | 48 | | | | 62 | |
| | | | | | | | |
Liability – gross, as of December 31, 2011 | | $ | 1,158 | | | $ | 228 | |
| | | | | | | | |
Reinsurance Recoverable – as of January 1, 2011 | | $ | 686 | | | $ | 30 | |
Incurred | | | 128 | | | | (8 | ) |
Paid | | | (143 | ) | | | — | |
Unlock | | | 53 | | | | — | |
| | | | | | | | |
Reinsurance Recoverable – as of December 31, 2011 | | $ | 724 | | | $ | 22 | |
| | | | | | | | |
| | | | | | | | |
| | GMDB | | | UL Secondary Guarantees | |
Liability balance as of January 1, 2010 | | $ | 1,304 | | | $ | 76 | |
Incurred | | | 286 | | | | 39 | |
Paid | | | (350 | ) | | | — | |
Unlock | | | (125 | ) | | | (2 | ) |
| | | | | | | | |
Liability – gross, as of December 31, 2010 | | $ | 1,115 | | | $ | 113 | |
| | | | | | | | |
Reinsurance Recoverable – as of January 1, 2010 | | $ | 802 | | | $ | 22 | |
Incurred | | | 125 | | | | 8 | |
Paid | | | (177 | ) | | | — | |
Unlock | | | (64 | ) | | | — | |
| | | | | | | | |
Reinsurance Recoverable – as of December 31, 2010 | | $ | 686 | | | $ | 30 | |
| | | | | | | | |
F-51
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
8. Separate Accounts, Death Benefits and Other Insurance Benefit Features (continued)
The following table provides details concerning GMDB and GMIB exposure as of December 31, 2011:
Breakdown of Variable Annuity Account Value by GMDB/GMIB Type
| | | | | | | | | | | | | | | | |
| |
Maximum anniversary value (“MAV”) [1] | | Account Value (“AV”) [8] | | | Net amount at Risk (“NAR”) [9] | | | Retained Net Amount at Risk (“RNAR”) [9] | | | Weighted Average Attained Age of Annuitant | |
MAV only | | $ | 20,718 | | | | 5,998 | | | $ | 483 | | | | 68 | |
With 5% rollup [2] | | | 1,469 | | | | 521 | | | | 37 | | | | 68 | |
With Earnings Protection Benefit Rider (“EPB”) [3] | | | | | | | | | | | | | | | | |
Benefit Rider (“EPB”) [3] | | | 5,378 | | | | 940 | | | | 21 | | | | 65 | |
With 5% rollup & EPB | | | 585 | | | | 169 | | | | 7 | | | | 68 | |
| | | | | | | | | | | | | | | | |
Total MAV | | | 28,150 | | | | 7,628 | | | | 548 | | | | | |
Asset Protection Benefit (APB) [4] | | | 22,343 | | | | 3,139 | | | | 610 | | | | 66 | |
Lifetime Income Benefit (LIB) – Death Benefit [5] | | | 1,095 | | | | 120 | | | | 37 | | | | 64 | |
Reset [6] (5-7 years) | | | 3,139 | | | | 307 | | | | 165 | | | | 68 | |
Return of Premium [7] /Other | | | 21,512 | | | | 876 | | | | 243 | | | | 65 | |
| | | | | | | | | | | | | | | | |
Subtotal U.S. GMDB | | $ | 76,239 | | | $ | 12,070 | | | $ | 1,603 | | | | 67 | |
Less: General Account Value with U.S. GMBD | | | 7,251 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Subtotal Separate Account Liabilities with GMDB | | | 68,988 | | | | | | | | | | | | | |
Separate Account Liabilities without U.S. GMDB | | | 74,871 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Total Separate Account Liabilities | | $ | 143,859 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Japan GMDB [10], [11] | | $ | 16,983 | | | $ | 5,167 | | | $ | — | | | | 68 | |
Japan GMIB [10], [11] | | $ | 16,262 | | | $ | 4,805 | | | $ | — | | | | 67 | |
| | | | | | | | | | | | | | | | |
[1] | MAV: the GMDB is the greatest of current AV, net premiums paid and the highest AV on any anniversary before age 80 (adjusted for withdrawals). |
[2] | Rollup: the GMDB is the greatest of the MAV, current AV, net premium paid and premiums (adjusted for withdrawals) accumulated at generally 5% simple interest up to the earlier of age 80 or 100% of adjusted premiums. |
[3] | EPB GMDB is the greatest of the MAV, current AV, or contract value plus a percentage of the contract’s growth. The contract’s growth is AV less premiums net of withdrawals, subject to a cap of 200% of premiums net of withdrawals. |
[4] | APB GMDB is the greater of current AV or MAV, not to exceed current AV plus 25% times the greater of net premiums and MAV (each adjusted for premiums in the past 12 months). |
[5] | LIB GMDB is the greatest of current AV, net premiums paid, or for certain contracts a benefit amount that ratchets over time, generally based on market performance. |
[6] | Reset GMDB is the greatest of current AV, net premiums paid and the most recent five to seven year anniversary AV before age 80 (adjusted for withdrawals). |
[7] | ROP: the GMDB is the greater of current AV and net premiums paid. |
[8] | AV includes the contract holder’s investment in the separate account and the general account. |
[9] | NAR is defined as the guaranteed benefit in excess of the current AV. RNAR is NAR reduced for reinsurances. NAR and RNAR are highly sensitive to equity market movements and increase when equity markets decline. |
[10] | Assumed GMDB includes a ROP and MAV (before age 80) paid in a single lump sum. GMIB is a guarantee to return initial investment, adjusted for earnings liquidity, paid through a fixed annuity, after a minimum deferral period of 10, 15 or 20 years. The guaranteed remaining balance (“GRB”) related to the Japan GMIB was $21.1 billion and $20.9 billion as of December 31, 2011 and December 31, 2010, respectively. The GRB related to the Japan GMAB and GMWB was $567 and $570 as of December 31, 2011 and December 31, 2010, respectively. These liabilities are not included in the Separate Account as they are not legally insulated from the general account liabilities of the insurance enterprise. As of December 31, 2011, 100% of RNAR is reinsured to an affiliate. See Note 10 of the Notes to Condensed Consolidated Financial statements. |
[11] | Policies with a guaranteed living benefit (a GMWB in the US or a GMIB in Japan) also have a guaranteed death benefit. The NAR for each benefit is shown, however these benefits are not additive. When a policy terminates due to death, any NAR related to GMWB or GMIB is released. Similarly, when a policy goes into benefit status on a GMWB or GMIB, its GMDB NAR is released. |
See Note 3 of the Notes to Consolidated Financial Statements for a description of the Company’s guaranteed living benefits that are accounted for at fair value.
Account balances of contracts with guarantees were invested in variable separate accounts as follows:
| | | | | | | | |
Asset type | | December 31, 2011 | | | December 31, 2010 | |
Equity securities (including mutual funds) | | $ | 61,472 | | | $ | 75,601 | |
Cash and cash equivalents | | $ | 7,516 | | | | 8,365 | |
| | | | | | | | |
Total | | $ | 68,988 | | | $ | 83,966 | |
| | | | | | | | |
As of December 31, 2011 and December 31, 2010, approximately 17% and 15%, respectively, of the equity securities above were invested in fixed income securities through these funds and approximately 83% and 85%, respectively, were invested in equity securities.
F-52
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
9. Sales Inducements
Accounting Policy
The Company currently offers enhanced crediting rates or bonus payments to contract holders on certain of its individual and group annuity products. The expense associated with offering a bonus is deferred and amortized over the life of the related contract in a pattern consistent with the amortization of deferred policy acquisition costs. Amortization expense associated with expenses previously deferred is recorded over the remaining life of the contract. Consistent with the Unlock, the Company unlocked the amortization of the sales inducement asset. See Note 6 for more information concerning the Unlock.
Results
Changes in deferred sales inducement activity were as follows for the years ended December 31:
| | | | | | | | | | | | |
| | 2011 | | | 2010 | | | 2009 | |
Balance, beginning of year | | $ | 197 | | | $ | 194 | | | $ | 533 | |
Sales inducements deferred | | | 6 | | | | 10 | | | | 43 | |
Amortization—Unlock | | | (4 | ) | | | (9 | ) | | | (286 | ) |
Amortization charged to income | | | (13 | ) | | | 2 | | | | (96 | ) |
| | | | | | | | | | | | |
Balance, end of year | | $ | 186 | | | $ | 197 | | | $ | 194 | |
| | | | | | | | | | | | |
10. Commitments and Contingencies
Accounting Policy
Management evaluates each contingent matter separately. A loss is recorded if probable and reasonably estimable. Management establishes reserves for these contingencies at its “best estimate,” or, if no one number within the range of possible losses is more probable than any other, the Company records an estimated reserve at the low end of the range of losses.
Litigation
The Company is involved in claims litigation arising in the ordinary course of business, both as a liability insurer defending or providing indemnity for third-party claims brought against insureds and as an insurer defending coverage claims brought against it. The Company accounts for such activity through the establishment of unpaid loss and loss adjustment expense reserves. Management expects that the ultimate liability, if any, with respect to such ordinary-course claims litigation, after consideration of provisions made for potential losses and costs of defense, will not be material to the consolidated financial condition, results of operations or cash flows of the Company.
The Company is also involved in other kinds of legal actions, some of which assert claims for substantial amounts. These actions include, among others and in addition to the matter described below, putative state and federal class actions seeking certification of a state or national class. Such putative class actions have alleged, for example, improper sales practices in connection with the sale of life insurance and other investment products; and improper fee arrangements in connection with investment products and structured settlements. The Company also is involved in individual actions in which punitive damages are sought, such as claims alleging bad faith in the handling of insurance claims. Management expects that the ultimate liability, if any, with respect to such lawsuits, after consideration of provisions made for estimated losses, will not be material to the consolidated financial condition of the Company. Nonetheless, given the large or indeterminate amounts sought in certain of these actions, and the inherent unpredictability of litigation, the outcome in certain matters could, from time to time, have a material adverse effect on the Company’s results of operations or cash flows in particular quarterly or annual periods.
Apart from the inherent difficulty of predicting litigation outcomes, particularly the matter specifically identified below purports to seek substantial damages for unsubstantiated conduct spanning a multi-year period based on novel and complex legal theories. The alleged damages are not quantified or factually supported in the complaint, and, in any event, the Company’s experience shows that demands for damages often bear little relation to a reasonable estimate of potential loss. The matter is in the earliest stages of litigation, with no substantive legal decisions by the court defining the scope of the claims or the potentially available damages. The Company has not yet answered the complaint or asserted its defenses, and fact discovery has not yet begun. Accordingly, management cannot reasonably estimate the possible loss or range of loss, if any, or predict the timing of the eventual resolution of this matter.
F-53
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
10. Commitments and Contingencies (continued)
Mutual Fund Fees Litigation — In October 2010, a derivative action was brought on behalf of six Hartford retail mutual funds in the United States District Court for the District of Delaware, alleging that Hartford Investment Financial Services, LLC (“HIFSCO”) received excessive advisory and distribution fees in violation of its statutory fiduciary duty under Section 36(b) of the Investment Company Act of 1940. In February 2011, a nearly identical derivative action was brought against HIFSCO in the United States District Court for the District of New Jersey, on behalf of six additional Hartford retail mutual funds. Both actions were assigned to the Honorable Renee Marie Bumb, a judge in the District of New Jersey who was sitting by designation with respect to the Delaware action. Plaintiffs in each action seek to rescind the investment management agreements and distribution plans between HIFSCO and the funds and to recover the total fees charged thereunder or, in the alternative, to recover any improper compensation HIFSCO received. In addition, plaintiffs in the New Jersey action seek recovery of lost earnings. HIFSCO moved to dismiss both actions and, in September 2011, the motions to dismiss were granted in part and denied in part, with leave to amend the complaints. In November 2011, a stipulation of voluntary dismissal was filed in the Delaware action and plaintiffs in the New Jersey action filed an amended complaint on behalf of six mutual funds, seeking the same relief as in their original complaint. HIFSCO disputes the allegations and has filed a partial motion to dismiss.
Derivative Commitments
Certain of the Company’s derivative agreements contain provisions that are tied to the financial strength ratings of the individual legal entity that entered into the derivative agreement as set by nationally recognized statistical rating agencies. If the legal entity’s financial strength were to fall below certain ratings, the counterparties to the derivative agreements could demand immediate and ongoing full collateralization and in certain instances demand immediate settlement of all outstanding derivative positions traded under each impacted bilateral agreement. The settlement amount is determined by netting the derivative positions transacted under each agreement. If the termination rights were to be exercised by the counterparties, it could impact the legal entity’s ability to conduct hedging activities by increasing the associated costs and decreasing the willingness of counterparties to transact with the legal entity. The aggregate fair value of all derivative instruments with credit-risk-related contingent features that are in a net liability position as of December 31, 2011, is $403. Of this $403, the legal entities have posted collateral of $425 in the normal course of business. Based on derivative market values as of December 31, 2011, a downgrade of one level below the current financial strength ratings by either Moody’s or S&P could require an additional $15 to be posted as collateral. Based on derivative market values as of December 31, 2011, a downgrade by either Moody’s or S&P of two levels below the legal entities’ current financial strength ratings would not require additional collateral to be posted. These collateral amounts could change as derivative market values change, as a result of changes in our hedging activities or to the extent changes in contractual terms are negotiated. The nature of the collateral that we would post, if required, would be primarily in the form of U.S. Treasury bills and U.S. Treasury notes.
Lease Commitments
The rent paid to Hartford Fire for operating leases was $19, $15 and $25 for the years ended December 31, 2011, 2010 and 2000, respectively. Future minimum lease commitments are as follows:
| | | | |
2012 | | $ | 16 | |
2013 | | | 12 | |
2014 | | | 8 | |
2015 | | | 6 | |
2016 | | | 4 | |
Thereafter | | | 7 | |
| | | | |
Total | | $ | 53 | |
| | | | |
F-54
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
10. Commitments and Contingencies (continued)
Unfunded Commitments
As of December 31, 2011, the Company has outstanding commitments totaling $852, of which $399 is largely related to commercial whole loans expected to fund in the first half of 2012. Additionally, $376 is committed to fund limited partnerships and other alternative investments. These capital commitments may be called by the partnership during the commitment period (on average two to four years) to fund the purchase of new investments and partnership expenses. Once the commitment period expires, the Company is under no obligation to fund the remaining unfunded commitment but may elect to do so. The remaining outstanding commitments are related to various funding obligations associated with private placement securities. These have a commitment period of one month to one year.
Guaranty Fund and Other Insurance-related Assessments
In all states, insurers licensed to transact certain classes of insurance are required to become members of a guaranty fund. In most states, in the event of the insolvency of an insurer writing any such class of insurance in the state, members of the funds are assessed to pay certain claims of the insolvent insurer. A particular state’s fund assesses its members based on their respective written premiums in the state for the classes of insurance in which the insolvent insurer was engaged. Assessments are generally limited for any year to one or two percent of premiums written per year depending on the state.
The Company accounts for guaranty fund and other insurance assessments in accordance with Accounting Standards Codification 405-30, “Accounting by Insurance and Other Enterprises for Insurance-Related Assessments”. Liabilities for guaranty funds and other insurance-related assessments are accrued when an assessment is probable, when it can be reasonably estimated, and when the event obligating the Company to pay an imposed or probable assessment has occurred. Liabilities for guaranty funds and other insurance-related assessments are not discounted and are included as part of other liabilities in the Consolidated Balance Sheets. As of December 31, 2011 and 2010, the liability balance was $43 and $7, respectively. As of December 31, 2011 and 2010, $26 and $9, respectively, related to premium tax offsets were included in other assets. In 2011, the Company recognized $22 for expected assessments related to the Executive Life Insurance Company of New York (ELNY) insolvency.
11. Income Tax
Accounting Policy
The Company recognizes taxes payable or refundable for the current year and deferred taxes for the tax consequences of differences between the financial reporting and tax basis of assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse.
The Company is included in The Hartford’s consolidated Federal income tax return. The Company and The Hartford have entered into a tax sharing agreement under which each member in the consolidated U.S. Federal income tax return will make payments between them such that, with respect to any period, the amount of taxes to be paid by the Company, subject to certain tax adjustments, is consistent with the “parent down” approach. Under this approach, the Company’s deferred tax assets and tax attributes are considered realized by it so long as the group is able to recognize (or currently use) the related deferred tax asset or attribute. Thus the need for a valuation allowance is determined at the consolidated return level rather than at the level of the individual entities comprising the consolidated group.
The Company recorded a deferred tax asset valuation allowance that is adequate to reduce the total deferred tax asset to an amount that will more likely than not be realized. The deferred tax asset valuation allowance was $89 as of December 31, 2011 and $139 as of December 31, 2010. In assessing the need for a valuation allowance, management considered future taxable temporary difference reversals, future taxable income exclusive of reversing temporary differences and carryforwards, taxable income in open carryback years, as well as other tax planning strategies. These tax planning strategies include holding a portion of debt securities with market value losses until recovery, selling appreciated securities to offset capital losses, business considerations such as asset-liability matching, and the sales of certain corporate assets. Management views such tax planning strategies as prudent and feasible and will implement them, if necessary, to realize the deferred tax asset. Based on the availability of additional tax planning strategies identified in the second quarter of 2011, the Company released $56, or 100% of the valuation allowance associated with investment realized capital losses. Future economic conditions and debt market volatility, including increases in interest rates, can adversely impact the Company’s tax planning strategies and in particular the Company’s ability to utilize tax benefits on previously recognized realized capital losses.
F-55
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
11. Income Tax (continued)
Results
Income tax expense (benefit) is as follows:
| | | | | | | | | | | | |
| | For the years ended December 31, | |
| | 2011 | | | 2010 | | | 2009 | |
Income Tax Expense (Benefit) | | | | | | | | | | | | |
Current - U.S. Federal | | $ | (176 | ) | | $ | 49 | | | $ | 300 | |
- International | | | — | | | | 5 | | | | — | |
| | | | | | | | | | | | |
Total Current | | $ | (176 | ) | | | 54 | | | | 300 | |
| | | | | | | | | | | | |
Deferred - U.S. Federal Excluding NOL Carryforward | | | 76 | | | | 175 | | | | (2,387 | ) |
- Net Operating Loss Carryforward | | | (163 | ) | | | (1 | ) | | | 688 | �� |
| | | | | | | | | | | | |
Total Deferred | | | (87 | ) | | | 174 | | | | (1,699 | ) |
| | | | | | | | | | | | |
Total Income tax expense (benefit) | | $ | (263 | ) | | $ | 228 | | | $ | (1,399 | ) |
| | | | | | | | | | | | |
Deferred tax assets (liabilities) include the following as of December 31:
| | | | | | | | |
Deferred Tax Assets | | 2011 | | | 2010 | |
Tax basis deferred policy acquisition costs | | $ | 479 | | | $ | 531 | |
Investment-related items | | | 92 | | | | 348 | |
Insurance product derivatives | | | 2,011 | | | | 1,792 | |
NOL Carryover | | | 252 | | | | 83 | |
Minimum tax credit | | | 387 | | | | 542 | |
Foreign tax credit carryovers | | | 17 | | | | — | |
Depreciable & Amortizable assets | | | 37 | | | | 48 | |
Other | | | 23 | | | | 1 | |
| | | | | | | | |
Total Deferred Tax Assets | | | 3,298 | | | | 3,345 | |
Valuation Allowance | | | (89 | ) | | | (139 | ) |
| | | | | | | | |
Net Deferred Tax Assets | | | 3,209 | | | | 3,206 | |
| | | | | | | | |
Deferred Tax Liabilities | | | | | | | | |
Financial statement deferred policy acquisition costs and reserves | | | (827 | ) | | | (1,000 | ) |
Net unrealized gain on investments | | | (735 | ) | | | (5 | ) |
Employee benefits | | | (41 | ) | | | (33 | ) |
Other | | | | | | | (30 | ) |
| | | | | | | | |
Total Deferred Tax Liabilities | | | (1,603 | ) | | | (1,068 | ) |
| | | | | | | | |
Total Deferred Tax Asset (Liability) | | | 1,606 | | | | 2,138 | |
| | | | | | | | |
As of December 31, 2011 and 2010, the deferred tax asset included the expected tax benefit attributable to foreign net operating losses of $ 359 and $310, which have no expiration. The Company had a current income tax recoverable of $330 as of December 31, 2011 and a current income tax recoverable of $258 as of December 31, 2010.
If the Company were to follow a “separate entity” approach, the current tax benefit related to any of the Company’s tax attributes realized by virtue of its inclusion in The Hartford’s consolidated tax return would have been recorded directly to surplus rather than income. These benefits were $0, $0 and $65 for 2011, 2010 and 2009, respectively.
Included in the Company’s December 31, 2011 $1.6 billion net deferred tax asset is $1.8 billion relating to items treated as ordinary for federal income tax purposes, and a $238 net deferred tax liability for items classified as capital in nature. The $238 capital items are comprised of $497 of gross deferred tax assets related to realized capital losses and $735 of gross deferred tax liabilities related to net unrealized capital gains.
F-56
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
11. Income Tax (continued)
The Company or one or more of its subsidiaries files income tax returns in the U.S. federal jurisdiction, and various states and foreign jurisdictions. The Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations for years prior to 2007. The audit of the years 2007-2009 commenced during 2010 and is expected to conclude by the end of 2012, with no material impact on the consolidated financial condition or results of operations. In addition, in the second quarter of 2011, the Company recorded a tax benefit of $52 as a result of a resolution of a tax matter with the IRS for the computation of the dividends-received deduction (DRD) for years 1998, 2000 and 2001. Management believes that adequate provision has been made in the financial statements for any potential assessments that may result from tax examinations and other tax-related matters for all open tax years.
The Company’s unrecognized tax benefits are settled with the parent consistent with the terms of the tax sharing agreement described above.
A reconciliation of the tax provision at the U.S. Federal statutory rate to the provision (benefit) for income taxes is as follows:
| | | | | | | | | | | | |
| | For the years ended December 31, | |
| | 2011 | | | 2010 | | | 2009 | |
Tax provision at the U.S. federal statutory rate | | | (7 | ) | | | 332 | | | $ | (1,239 | ) |
Dividends received deduction | | | (201 | ) | | | (145 | ) | | | (181 | ) |
Foreign related investments | | | (1 | ) | | | 3 | | | | 28 | |
Valuation Allowance | | | (50 | ) | | | 58 | | | | 31 | |
Other | | | (4 | ) | | | (20 | ) | | | (38 | ) |
| | | | | | | | | | | | |
Total | | $ | (263 | ) | | $ | 228 | | | $ | (1,399 | ) |
| | | | | | | | | | | | |
12. Debt
Short-Term Debt
The Company became a member of the Federal Home Loan Bank of Boston (“FHLBB”) in May 2011. Membership allows the Company access to collateralized advances, which may be used to support various spread-based business and enhance liquidity management. The Connecticut Department of Insurance (“CTDOI”) will permit the Company to pledge up to $1.48 billion in qualifying assets to secure FHLBB advances for 2012. The amount of advances that can be taken are dependent on the asset types pledged to secure the advances. The pledge limit is recalculated annually based on statutory admitted assets and capital and surplus. The Company would need to seek the prior approval of the CTDOI if there were a desire to exceed these limits. As of December 31, 2011, the Company had no advances outstanding under the FHLBB facility.
Consumer Notes
The Company issued consumer notes through its Retail Investor Notes Program prior to 2009. A consumer note is an investment product distributed through broker-dealers directly to retail investors as medium-term, publicly traded fixed or floating rate, or a combination of fixed and floating rate, notes. Consumer notes are part of the Company’s spread-based business and proceeds are used to purchase investment products, primarily fixed rate bonds. Proceeds are not used for general operating purposes. Consumer notes maturities may extend up to 30 years and have contractual coupons based upon varying interest rates or indexes (e.g. consumer price index) and may include a call provision that allows the Company to extinguish the notes prior to its scheduled maturity date. Certain Consumer notes may be redeemed by the holder in the event of death. Redemptions are subject to certain limitations, including calendar year aggregate and individual limits. The aggregate limit is equal to the greater of $1 or 1% of the aggregate principal amount of the notes as of the end of the prior year. The individual limit is $250 thousand per individual. Derivative instruments are utilized to hedge the Company’s exposure to market risks in accordance with Company policy.
As of December 31, 2011, these consumer notes have interest rates ranging from 4% to 5% for fixed notes and, for variable notes, based on December 31, 2011 rates, either consumer price index plus 100 to 260 basis points, or indexed to the S&P 500, Dow Jones Industrials, foreign currency, or the Nikkei 225. The aggregate maturities of Consumer Notes are as follows: $155 in 2012, $78 in 2013, $13 in 2014, $30 in 2015, $18 in 2016 and $20 thereafter. For 2011, 2010 and 2009, interest credited to holders of consumer notes was $15, $25 and $51, respectively.
F-57
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
13. Statutory Results
The domestic insurance subsidiaries of the Company prepare their statutory financial statements in conformity with statutory accounting practices prescribed or permitted by the applicable state insurance department which vary materially from U.S. GAAP. Prescribed statutory accounting practices include publications of the National Association of Insurance Commissioners (“NAIC”), as well as state laws, regulations and general administrative rules. The differences between statutory financial statements and financial statements prepared in accordance with GAAP vary between domestic and foreign jurisdictions. The principal differences are that statutory financial statements do not reflect deferred policy acquisition costs and limit deferred income taxes, life benefit reserves predominately use interest rate and mortality assumptions prescribed by the NAIC, bonds are generally carried at amortized cost and reinsurance assets and liabilities are presented net of reinsurance.
The statutory net income amounts for the years ended December 31, 2011, 2010 and 2009, and the statutory capital and surplus amounts as of December 31, 2011, 2010 and 2009 in the table below are based on actual statutory filings with the applicable regulatory authorities.
| | | | | | | | | | | | |
| | For the years ended December 31, | |
| | 2011 | | | 2010 | | | 2009 | |
Combined statutory net (loss) income | | $ | (669 | ) | | $ | 208 | | | $ | 1,866 | |
| | | | | | | | | | | | |
Statutory capital and surplus | | $ | 5,920 | | | $ | 5,832 | | | $ | 5,365 | |
| | | | | | | | | | | | |
Statutory accounting practices do not consolidate the net (loss) income of subsidiaries as performed under U.S. GAAP. Therefore, the combined statutory net (loss) income above presents the total statutory net income of the Company and its other insurance subsidiaries to present a comparable statutory net (loss) income.
In December 2009, the NAIC issued Statement of Statutory Accounting Principles (“SSAP”) No. 10R, Income Taxes – Revised, A Temporary Replacement of SSAP No. 10. SSAP No. 10R was updated in September 2010 and is effective for annual periods December 31, 2009 and interim and annual periods of 2010 and 2011. SSAP No. 10R increases the realization period for deferred tax assets from one year to three years and increases the asset recognition limit from 10% to 15% of adjusted statutory capital and surplus.
Dividends
Dividends to the Company from its insurance subsidiaries are restricted, as is the ability of the Company to pay dividends to its parent company. Future dividend decisions will be based on, and affected by, a number of factors, including the operating results and financial requirements of the Company on a stand-alone basis and the impact of regulatory restrictions.
The payment of dividends by Connecticut-domiciled insurers is limited under the insurance holding company laws of Connecticut. These laws require notice to and approval by the state insurance commissioner for the declaration or payment of any dividend, which, together with other dividends or distributions made within the preceding twelve months, exceeds the greater of (i) 10% of the insurer’s policyholder surplus as of December 31 of the preceding year or (ii) net income (or net gain from operations, if such company is a life insurance company) for the twelve-month period ending on the thirty-first day of December last preceding, in each case determined under statutory insurance accounting principles. In addition, if any dividend of a Connecticut-domiciled insurer exceeds the insurer’s earned surplus, it requires the prior approval of the Connecticut Insurance Commissioner. The insurance holding company laws of the other jurisdictions in which the Company’s insurance subsidiaries are incorporated (or deemed commercially domiciled) generally contain similar (although in certain instances somewhat more restrictive) limitations on the payment of dividends.
The Company’s subsidiaries are permitted to pay up to a maximum of approximately $399 in dividends in 2012 without prior approval from the applicable insurance commissioner. In 2011, the Company received dividends of $7 from its subsidiaries. With respect to dividends to its parent, the Company’s dividend limitation under the holding company laws of Connecticut is $592 in 2012. However, because the Company’s earned surplus is negative as of December 31, 2011, the Company will not be permitted to pay any dividends to its parent in 2012 without prior approval from the Connecticut Insurance Commissioner until such time as earned surplus becomes positive. In 2011, the Company did not pay dividends to its parent company.
F-58
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
14. Pension Plans, Postretirement, Health Care and Life Insurance Benefit and Savings Plans
Pension Plans
Hartford Life’s employees are included in The Hartford’s non-contributory defined benefit pension, The Hartford Retirement Plan for U.S. Employees, and postretirement health care and life insurance benefit plans. Defined benefit pension expense, postretirement health care and life insurance benefits expense allocated by The Hartford to the Company, was $45, $43 and $32 for the years ended December 31, 2011, 2010 and 2009, respectively.
Investment and Savings Plan
Substantially all U.S. employees are eligible to participate in The Hartford’s Investment and Savings Plan under which designated contributions may be invested in common stock of The Hartford or certain other investments. These contributions are matched, up to 3% of compensation, by The Hartford. In 2004, The Hartford began allocating a percentage of base salary to the Plan for eligible employees. In 2011, employees whose prior year earnings were less than $110,000 received a contribution of 1.5% of base salary and employees whose prior year earnings were more than $110,000 received a contribution of 0.5% of base salary. The cost to Hartford Life for this plan was approximately $9, $13 and $13 for the years ended December 31, 2011, 2010 and 2009, respectively.
15. Stock Compensation Plans
The Hartford has three primary stock-based compensation plans. The Company is included in these plans and has been allocated compensation expense of $14, $32 and $25 for the years ended December 31, 2011, 2010 and 2009, respectively. The Company’s income tax benefit recognized for stock-based compensation plans was $5, $11 and $7 for the years ended December 31, 2011, 2010 and 2009, respectively. The Company did not capitalize any cost of stock-based compensation.
16. Transactions with Affiliates
Parent Company Transactions
Transactions of the Company with Hartford Fire Insurance Company, Hartford Holdings and its affiliates relate principally to tax settlements, reinsurance, insurance coverage, rental and service fees, payment of dividends and capital contributions. In addition, an affiliated entity purchased group annuity contracts from the Company to fund structured settlement periodic payment obligations assumed by the affiliated entity as part of claims settlements with property casualty insurance companies and self-insured entities. As of December 31, 2011 and 2010, the Company had $54 and $53 of reserves for claim annuities purchased by affiliated entities. For the years ended December 31, 2011, 2010, and 2009, the Company recorded earned premiums of $12, $18, and $285 for these intercompany claim annuities. In the fourth quarter of 2008, the Company issued a payout annuity to an affiliate for $2.2 billion of consideration. The Company will pay the benefits associated with this payout annuity over 12 years.
Substantially all general insurance expenses related to the Company, including rent and employee benefit plan expenses are initially paid by The Hartford. Direct expenses are allocated to the Company using specific identification, and indirect expenses are allocated using other applicable methods. Indirect expenses include those for corporate areas which, depending on type, are allocated based on either a percentage of direct expenses or on utilization.
The Company has issued a guarantee to retirees and vested terminated employees (“Retirees”) of The Hartford Retirement Plan for U.S. Employees (“the Plan”) who retired or terminated prior to January 1, 2004. The Plan is sponsored by The Hartford. The guarantee is an irrevocable commitment to pay all accrued benefits which the Retiree or the Retiree’s designated beneficiary is entitled to receive under the Plan in the event the Plan assets are insufficient to fund those benefits and The Hartford is unable to provide sufficient assets to fund those benefits. The Company believes that the likelihood that payments will be required under this guarantee is remote.
In 1990, Hartford Fire guaranteed the obligations of the Company with respect to life, accident and health insurance and annuity contracts issued after January 1, 1990. The guarantee was issued to provide an increased level of security to potential purchasers of HLIC’s products. Although the guarantee was terminated in 1997, it still covers policies that were issued from 1990 to 1997. As of December 31, 2011 and 2010, no recoverables have been recorded for this guarantee, as the Company was able to meet these policyholder obligations.
Reinsurance Assumed from Affiliates
Prior to June 1, 2009, yen and U.S. dollar based fixed market value adjusted (“MVA”) annuity products, written by HLIKK, were sold to customers in Japan. HLIKK, a wholly owned Japanese subsidiary of Hartford Life, Inc., subsequently reinsured in-force and prospective MVA annuities to the Company effective September 1, 2004. As of December 31, 2011 and 2010, $2.6 billion and $2.7 billion, respectively, of the account value had been assumed by the Company.
F-59
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
16. Transactions with Affiliates (continued)
A subsidiary of the Company, Hartford Life and Annuity Insurance Company (“HLAI”), entered into a reinsurance agreement with HLIKK effective August 31, 2005. HLAI assumed in-force and prospective GMIB riders. Via amendment, effective July 31, 2006, HLAI also assumed GMDB on covered contracts that have an associated GMIB rider in force on or after July 31, 2006. GMIB riders issued prior to April 1, 2005 were recaptured, while GMIB riders issued by HLIKK subsequent to April 1, 2005, continue to be reinsured by HLAI. Additionally, a tiered reinsurance premium structure was implemented.
HLAI has three additional reinsurance agreements with HLIKK covering certain variable annuity contracts. Effective September 30, 2007, HLAI assumed 100% of the in-force and prospective GMAB, GMIB and GMDB risks issued by HLIKK. Effective February 29, 2008, HLAI assumed 100% of the in-force and prospective GMIB and GMDB riders issued by HLIKK. Effective October 1, 2008, HLAI assumed 100% of the in-force and prospective GMDB riders issued on or after April 1, 2005 by HLIKK. The GMDB reinsurance is accounted for as a Death Benefit and Other Insurance Benefit Reserves which is not reported at fair value. The liability for the assumed GMDB reinsurance was $50 and $54 and the net amount at risk for the assumed GMDB reinsurance was $5.0 billion and $4.1 billion at December 31, 2011 and 2010, respectively.
While the form of the agreement between HLAI and HLIKK for the GMIB business is reinsurance, in substance and for accounting purposes the agreement is a free standing derivative. As such, the reinsurance agreement for the GMIB business is recorded at fair value on the Company’s balance sheet, with prospective changes in fair value recorded in net realized capital gains (losses) in net income (loss). The fair value of the GMIB liability was $3.2 billion and $2.6 billion at December 31, 2011 and 2010, respectively.
Effective November 1, 2010, HLAI entered into a reinsurance agreement with Hartford Life Limited Ireland, (“HLL”), a wholly owned UK subsidiary of HLAI. Through this agreement, HLL agreed to cede, and HLAI agreed to reinsure, GMDB and GMWB risks issued by HLL on its variable annuity business. The GMDB reinsurance is accounted for as a Death Benefit and Other Insurance Benefit Reserves which is not reported at fair value. The liability for the assumed GMDB reinsurance was $5 and $8 and the net amount at risk for the assumed GMDB reinsurance was $80 and $23 at December 31, 2011 and 2010, respectively.
While the form of the agreements between HLAI and HLIKK, and HLAI and HLL for the GMAB/GMWB business is reinsurance, in substance and for accounting purposes these agreements are free standing derivatives. As such, the reinsurance agreements for the GMAB/GMWB business are recorded at fair value on the Company’s Consolidated Balance Sheets, with prospective changes in fair value recorded in net realized capital gains (losses) in net income (loss). The fair value of the GMAB/GMWB liability was $37 and $43 at December 31, 2011 and 2010, respectively.
Reinsurance Ceded to Affiliates
Effective October 1, 2009, and amended on November 1, 2010, HLAI, a subsidiary of HLIC, entered into a modified coinsurance (“modco”) and coinsurance with funds withheld reinsurance agreement with White River Life Reinsurance (“WRR”), an affiliated captive insurance company. The agreement provides that HLAI will cede, and WRR will reinsure a portion of the risk associated with direct written and assumed variable annuities and the associated GMDB and GMWB riders, HLAI assumed HLIKK’s variable annuity contract and rider benefits, and HLAI assumed HLL’s GMDB and GMWB annuity contract and rider benefits.
Under modco, the assets and the liabilities, and under coinsurance with funds withheld, the assets, associated with the reinsured business will remain on the consolidated balance sheet of HLIC in segregated portfolios, and WRR will receive the economic risks and rewards related to the reinsured business through modco and funds withheld adjustments. These adjustments are recorded as an adjustment to operating expenses.
For the year ended December 31, 2011 the impact of this transaction was a decrease to earnings of $323 after-tax. Included in this amount are net realized capital gains of $503, which represents the change in valuation of the derivative associated with this transaction. In addition, the balance sheet of the Company reflects a modco reinsurance (payable)/recoverable, a deposit liability as well as a net reinsurance recoverable that is comprised of an embedded derivative. The balance of the modco reinsurance (payable)/recoverable, deposit liability and net reinsurance recoverable were ($2.9) billion, $0, $2.6 billion and $(864), $78, and $1.7 billion at December 31, 2011 and December 31, 2010, respectively.
F-60
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
16. Transactions with Affiliates (continued)
At inception of the contract, HLIC recognized in net income the unlock of the unearned revenue reserve, sales inducement asset and deferred policy acquisition costs related to the direct U.S. variable annuity business of HLAI as well as the impact of remitting the premiums and reserves to WRR. The following table illustrates the transaction’s impact on the Company’s Statement of Operations as of December 31, 2010 and 2009, respectively.
| | | | | | | | | | | | |
| | 2011 | | | 2010 | | | 2009 | |
Fee Income and other | | $ | — | | | $ | — | | | $ | 84 | |
Earned premiums | | | (71 | ) | | | (56 | ) | | | (62 | ) |
Net realized gains (losses) | | | 503 | | | | 546 | | | | (629 | ) |
| | | | | | | | | | | | |
Total revenues | | | 432 | | | | 490 | | | | (607 | ) |
Benefits, losses and loss adjustment expenses | | | (51 | ) | | | (40 | ) | | | (51 | ) |
Amortization of deferred policy acquisition costs and present value of future profits | | | — | | | | — | | | | 1,883 | |
Insurance operating costs and other expenses | | | 972 | | | | (348 | ) | | | (9 | ) |
| | | | | | | | | | | | |
Total expenses | | | 921 | | | | (388 | ) | | | 1,823 | |
Income (loss) before income taxes | | | (489 | ) | | | 878 | | | | (2,430 | ) |
Income tax expense (benefit) | | | (166 | ) | | | 308 | | | | (851 | ) |
| | | | | | | | | | | | |
Net income (loss) | | $ | (323 | ) | | $ | 570 | | | $ | (1,579 | ) |
| | | | | | | | | | | | |
[1] | At inception of contract, HLIC recognized in net income the unlock of the unearned revenue reserve, sales inducement asset and deferred policy acquisition costs related to the direct U.S. variable annuity business of HLAI as well as the impact of remitting the premium and reserves to WRR. 2009 figures illustrate the transaction’s impact at inception on the Company’s Statement of Operations and the fourth quarter of 2009 activity. |
Effective November 1, 2007, HLAI entered into a modco and coinsurance with funds withheld agreement with Champlain Life Reinsurance Company, an affiliate captive insurance company, to provide statutory surplus relief for certain life insurance policies. The Agreement is accounted for as a financing transaction for U.S. GAAP. A standby unaffiliated third party Letter of Credit supports a portion of the statutory reserves that have been ceded to the Champlain Life Reinsurance Company.
17. Restructuring, Severance and Other Costs
During the year ended December 31, 2009, the Company completed a review of several strategic alternatives with a goal of preserving capital, reducing risk and stabilizing its ratings. These alternatives included the potential restructuring, discontinuation or disposition of various business lines. Following that review, the Company announced that it would suspend all new sales in its European operations and suspend sales of certain IIP business. The Company has also executed on plans to change the management structure of the organization and reorganized the nature and focus of certain of the Company’s operations. These plans resulted in termination benefits to current employees, costs to terminate leases and other contracts and asset impairment charges. The Company completed these restructuring activities and executed final payment during the year ended December 31, 2010.
The following pre-tax charges were incurred during the year ended December 31, 2009 in connection with these restructuring activities:
| | | | |
Severance benefits | | $ | 19 | |
Asset impairment charges | | | 26 | |
Other contract termination charges | | | 5 | |
| | | | |
Total restructuring, severance and other costs | | $ | 50 | |
| | | | |
The amounts incurred during the year ended December 31, 2009 were recorded in Insurance operating costs and other expenses within the Company’s Other category. There were no restructuring or severance costs incurred in 2011 and 2010.
F-61
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
18. Sale of Assets and Joint Venture
Servicing Agreement of Hartford Life Private Placement LLC
On November 22, 2011, the Company entered into an agreement with Philadelphia Financial Group, Inc. (“Philadelphia Financial”) whereby Philadelphia Financial will acquire certain assets that are used to administer the Company’s private placement life insurance (“PPLI”) businesses currently administered by Hartford Life Private Placement, LLC (“HLPP”), an affiliate of the Company. The PPLI business administered by HLPP includes the life insurance owned by banks, corporations and high net worth individuals, and group annuity policies. The transaction is expected to close in the second quarter of 2012, subject to regulatory approvals and closing conditions. Upon closing, Philadelphia Financial and the Company will enter into a servicing agreement whereby Philadelphia Financial will service the PPLI businesses administered by HLPP. The Company will retain certain corporate functions associated with this business as well as the mortality risk on the insurance policies. Under the terms of the transaction, Philadelphia Financial will receive certain future income from the policies and pay the Company $118 at closing, resulting in an estimated deferred gain between $65 and $75 after-tax, which will be amortized over the estimated life of the underlying insurance policies. The actual amount may be different. The deferred gain is not expected to have a material impact on the Company’s results of operations in future periods. The assets and liabilities of the PPLI business are included in the Runoff Operations segment.
Sale of Joint Venture Interest in ICATU Hartford Seguros, S.A.
On November 23, 2009, the Company entered into a Share Purchase Agreement to sell its joint venture interest in ICATU Hartford Seguros, S.A. (“IHS”), its Brazilian insurance operation, to its partner, ICATU Holding S.A., for $135. The transaction closed in 2010, and the Company received cash proceeds of $130, which was net of capital gains tax withheld of $5. The investment in IHS was reported as an equity method investment in Other assets. As a result of the Share Purchase Agreement, the Company recorded in 2009, an asset impairment charge, net of unrealized capital gains and foreign currency translation adjustments, in net realized capital losses of $44, after-tax.
See Note 19 for sale of subsidiaries that met the criteria for discontinued operations.
19. Discontinued Operations
During the fourth quarter of 2010, the Company completed the sales of its indirect wholly-owned subsidiaries Hartford Investments Canada Corporation (“HICC”) and Hartford Advantage Investment, Ltd. (“HAIL”). The Company recognized a net realized capital gain of $41, after-tax, on the sale of HICC and a net realized capital loss of $4, after-tax, on the sale of HAIL. HICC was previously included in the Mutual Funds reporting segment and HAIL was included in the Runoff reporting segment. The Company does not expect these sales to have a material impact on the Company’s future earnings.
The following table presents the combined amounts related to the operations of HICC and HAIL, which have been reflected as discontinued operations in the Consolidated Statements of Operations.
| | | | | | | | |
| | For the years ended December 31, | |
| | 2010 | | | 2009 | |
Revenues | | | | | | | | |
Fee income and other | | $ | 36 | | | $ | 29 | |
Net realized capital losses | | | — | | | | (1 | ) |
| | | | | | | | |
Total revenues | | | 36 | | | | 28 | |
| | |
Benefits, losses and expenses | | | | | | | | |
Insurance operating and other expenses | | | 28 | | | | 24 | |
Amortization of deferred policy acquisition costs and present value of future profits | | | 17 | | | | 11 | |
| | | | | | | | |
Total benefits, losses and expenses | | | 45 | | | | 35 | |
Loss before income taxes | | | (9 | ) | | | (7 | ) |
Income tax benefit | | | (3 | ) | | | (2 | ) |
| | | | | | | | |
Loss from operations of discontinued operations, net of tax | | | (6 | ) | | | (5 | ) |
Net realized capital gain on disposal, net of tax | | | 37 | | | | — | |
| | | | | | | | |
Income (loss) from discontinued operations, net of tax | | $ | 31 | | | $ | (5 | ) |
| | | | | | | | |
F-62
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
20. Quarterly Results For 2011 and 2010 (Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | |
| | March 31, | | | June 30, | | | September 30, | | | December 31, | |
| | 2011 | | | 2010 | | | 2011 | | | 2010 | | | 2011 | | | 2010 | | | 2011 | | | 2010 | |
Total revenues | | $ | 1,181 | | | $ | 1,247 | | | $ | 1,772 | | | $ | 2,203 | | | $ | 2,537 | | | $ | 1,229 | | | $ | 1,113 | | | $ | 1,302 | |
Total benefits, losses and expenses | | | 877 | | | | 1,238 | | | | 1,505 | | | | 2,392 | | | | 3,385 | | | | 690 | | | | 855 | | | | 712 | |
Income (loss) from continuing operations, net of tax | | | 239 | | | | (7 | ) | | | 324 | | | | (84 | ) | | | (525 | ) | | | 379 | | | | 206 | | | | 433 | |
Income (loss) from discontinued operations, net of tax | | | — | | | | (1 | ) | | | — | | | | (1 | ) | | | — | | | | (3 | ) | | | — | | | | 36 | |
Net income (loss) | | | 239 | | | | (8 | ) | | | 324 | | | | (85 | ) | | | (525 | ) | | | 376 | | | | 206 | | | | 469 | |
Less: Net income (loss) attributable to the noncontrolling interest | | | 1 | | | | 2 | | | | 1 | | | | 3 | | | | (4 | ) | | | 2 | | | | 2 | | | | 1 | |
Net income (loss) attributable to Hartford Life Insurance Company | | $ | 238 | | | $ | (10 | ) | | $ | 323 | | | $ | (88 | ) | | $ | (521 | ) | | $ | 374 | | | $ | 204 | | | $ | 468 | |
21. Subsequent Event
On March 21, 2012, The Hartford announced that it has decided to focus on its Property and Casualty, Group Benefits and Mutual Funds businesses. As a result, the Company will cease selling its individual annuity products in the second quarter of 2012. In addition, the Company is pursuing sales or other strategic alternatives for its Individual Life, Woodbury Financial Services and Retirement Plans businesses.
F-63
SCHEDULE SUMMARY OF INVESTMENTS OTHER THAN INVESTMENTS IN AFFILIATESHARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
SCHEDULE I
SUMMARY OF INVESTMENTS—OTHER THAN INVESTMENTS IN AFFILIATES
($ in millions)
| | | | | | | | | | | | |
| | As of December 31, 2011 | |
Type of Investment | | Cost | | | Fair Value | | | Amount at which shown on Balance Sheet | |
Fixed maturities | | | | | | | | | | | | |
Bonds and notes | | | | | | | | | | | | |
U.S. government and government agencies and authorities (guaranteed and sponsored) | | $ | 5,687 | | | $ | 6,018 | | | $ | 6,018 | |
States, municipalities and political subdivisions | | | 1,504 | | | | 1,557 | | | | 1,557 | |
Foreign governments | | | 1,121 | | | | 1,224 | | | | 1,224 | |
Public utilities | | | 5,507 | | | | 6,101 | | | | 6,101 | |
All other corporate bonds | | | 22,577 | | | | 24,128 | | | | 24,128 | |
All other mortgage-backed and asset-backed securities | | | 9,840 | | | | 8,750 | | | | 8,750 | |
| | | | | | | | | | | | |
Total fixed maturities, available-for-sale | | | 46,236 | | | | 47,778 | | | | 47,778 | |
Fixed maturities, at fair value using fair value option | | | 1,476 | | | | 1,317 | | | | 1,317 | |
| | | | | | | | | | | | |
Total fixed maturities | | | 47,712 | | | | 49,095 | | | | 49,095 | |
| | | | | | | | | | | | |
Equity securities | | | | | | | | | | | | |
Common stocks | | | | | | | | | | | | |
Industrial, miscellaneous and all other | | | 285 | | | | 294 | | | | 294 | |
Non-redeemable preferred stocks | | | 158 | | | | 104 | | | | 104 | |
| | | | | | | | | | | | |
Total equity securities, available-for-sale | | | 443 | | | | 398 | | | | 398 | |
Equity securities, trading | | | 1,860 | | | | 1,967 | | | | 1,967 | |
| | | | | | | | | | | | |
Total equity securities | | | 2,303 | | | | 2,365 | | | | 2,365 | |
| | | | | | | | | | | | |
Mortgage loans | | | 4,182 | | | | 4,382 | | | | 4,182 | |
Policy loans | | | 1,952 | | | | 2,099 | | | | 1,952 | |
Investments in partnerships and trusts | | | 1,376 | | | | 1,376 | | | | 1,376 | |
Futures, options and miscellaneous | | | 1,110 | | | | 1,974 | | | | 1,974 | |
Short-term investments | | | 3,882 | | | | 3,882 | | | | 3,882 | |
| | | | | | | | | | | | |
Total investments | | $ | 62,517 | | | $ | 65,173 | | | $ | 64,826 | |
| | | | | | | | | | | | |
S-1
SUPPLEMENTARY INSURANCE INFORMATIONHARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
SCHEDULE III
SUPPLEMENTARY INSURANCE INFORMATION
(In millions)
| | | | | | | | | | | | | | | | |
Segment | | Deferred Policy Acquisition Costs and Present Value of Future Profits | | | Future Policy Benefits, Unpaid Losses and Loss Adjustment Expenses | | | Unearned Premiums | | | Other Policyholder Funds and Benefits Payable | |
As of December 31, 2011 | | | | | | | | | | | | | | | | |
Individual Annuity | | $ | 1,186 | | | $ | 2,326 | | | $ | 29 | | | $ | 16,985 | |
Individual Life | | | 2,558 | | | | 1,011 | | | | 1 | | | | 7,014 | |
Retirement Plans | | | 714 | | | | 436 | | | | 2 | | | | 7,959 | |
Mutual Funds | | | 27 | | | | — | | | | — | | | | 4 | |
Runoff Operations | | | 113 | | | | 7,511 | | | | 74 | | | | 14,983 | |
Other | | | — | | | | 547 | | | | 15 | | | | — | |
| | | | | | | | | | | | | | | | |
Consolidated | | $ | 4,598 | | | $ | 11,831 | | | $ | 121 | | | $ | 46,945 | |
| | | | | | | | | | | | | | | | |
As of December 31, 2010 | | | | | | | | | | | | | | | | |
Individual Annuity | | $ | 1,303 | | | $ | 2,089 | | | $ | 22 | | | $ | 16,835 | |
Individual Life | | | 2,620 | | | | 850 | | | | 1 | | | | 6,352 | |
Retirement Plans | | | 842 | | | | 458 | | | | 3 | | | | 6,841 | |
Mutual Funds | | | 43 | | | | — | | | | — | | | | 4 | |
Runoff Operations | | | 141 | | | | 7,441 | | | | 72 | | | | 15,615 | |
Other | | | — | | | | 547 | | | | 15 | | | | — | |
| | | | | | | | | | | | | | | | |
Consolidated | | $ | 4,949 | | | $ | 11,385 | | | $ | 113 | | | $ | 45,647 | |
| | | | | | | | | | | | | | | | |
S-2
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
SCHEDULE III
SUPPLEMENTARY INSURANCE INFORMATION (continued)
| | | | | | | | | | | | | | | | | | | | | | | | |
Segment | | Earned Premiums, Fee Income and Other | | | Net Investment Income | | | Benefits, Losses and Loss Adjustment Expenses | | | Amortization of Deferred Policy Acquisition Costs and Present Value of Future Profits | | | Insurance Operating Costs and Other Expenses [1] | | | Net Written Premiums | |
For the year ended December 31, 2011 | | | | | | | | | | | | | | | | | | | | | | | | |
Individual Annuity | | $ | 1,651 | | | $ | 769 | | | $ | 1,080 | | | $ | 186 | | | $ | 742 | | | | N/A | |
Individual Life | | | 858 | | | | 420 | | | | 761 | | | | 219 | | | | 194 | | | | N/A | |
Retirement Plans | | | 380 | | | | 396 | | | | 308 | | | | 134 | | | | 354 | | | | N/A | |
Mutual Funds | | | 569 | | | | 1 | | | | — | | | | 47 | | | | 374 | | | | N/A | |
Runoff Operations | | | 221 | | | | 941 | | | | 852 | | | | 30 | | | | 982 | | | | N/A | |
Other | | | 357 | | | | 39 | | | | 92 | | | | — | | | | 267 | | | | N/A | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Consolidated | | $ | 4,036 | | | $ | 2,566 | | | $ | 3,093 | | | $ | 616 | | | $ | 2,913 | | | | N/A | |
| | | | | | | | | | | | | | | | | | | | | | | | |
For the year ended December 31, 2010 | | | | | | | | | | | | | | | | | | | | | | | | |
Individual Annuity | | $ | 1,721 | | | $ | 813 | | | $ | 1,057 | | | $ | (39 | ) | | $ | 287 | | | | N/A | |
Individual Life | | | 819 | | | | 362 | | | | 591 | | | | 120 | | | | 199 | | | | N/A | |
Retirement Plans | | | 359 | | | | 364 | | | | 278 | | | | 27 | | | | 340 | | | | N/A | |
Mutual Funds | | | 580 | | | | (1 | ) | | | — | | | | 51 | | | | 385 | | | | N/A | |
Runoff Operations | | | 254 | | | | 1,221 | | | | 1,168 | | | | 56 | | | | 128 | | | | N/A | |
Other | | | 333 | | | | 100 | | | | 92 | | | | — | | | | 292 | | | | N/A | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Consolidated | | $ | 4,066 | | | $ | 2,859 | | | $ | 3,186 | | | $ | 215 | | | $ | 1,631 | | | | N/A | |
| | | | | | | | | | | | | | | | | | | | | | | | |
For the year ended December 31, 2009 | | | | | | | | | | | | | | | | | | | | | | | | |
Individual Annuity | | $ | 1,549 | | | $ | 770 | | | $ | 1,374 | | | $ | 3,189 | | | $ | 526 | | | | N/A | |
Individual Life | | | 902 | | | | 304 | | | | 584 | | | | 312 | | | | 185 | | | | N/A | |
Retirement Plans | | | 324 | | | | 315 | | | | 269 | | | | 56 | | | | 346 | | | | N/A | |
Mutual Funds | | | 437 | | | | (16 | ) | | | — | | | | 50 | | | | 315 | | | | N/A | |
Runoff Operations | | | 549 | | | | 1,279 | | | | 1,593 | | | | 111 | | | | 205 | | | | N/A | |
Other | | | 339 | | | | 196 | | | | 239 | | | | (2 | ) | | | 261 | | | | N/A | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Consolidated | | $ | 4,100 | | | $ | 2,848 | | | $ | 4,059 | | | $ | 3,716 | | | $ | 1,838 | | | | N/A | |
| | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Includes dividends and goodwill impairment. |
N/A – Not applicable to life insurance pursuant to Regulation S-X.
S-3
REINSURANCEHARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
SCHEDULE IV
REINSURANCE
(In millions)
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | Percentage of | |
| | Gross | | | Ceded to Other | | | Assumed From Other | | | Net | | | Amount Assumed | |
| | Amount | | | Companies | | | Companies | | | Amount | | | to Net | |
For the year ended December 31, 2011 | | | | | | | | | | | | | | | | | | | | |
Life insurance in force | | $ | 316,817 | | | $ | 130,029 | | | $ | 1,941 | | | $ | 188,729 | | | | 1 | % |
| | | | | | | | | | | | | | | | | | | | |
Insurance Revenues | | | | | | | | | | | | | | | | | | | | |
Life insurance and annuities | | $ | 4,451 | | | $ | 531 | | | $ | 13 | | | $ | 3,933 | | | | — | |
Accident and health insurance | | | 305 | | | | 202 | | | | — | | | | 103 | | | | — | |
| | | | | | | | | | | | | | | | | | | | |
Total insurance Revenues | | $ | 4,756 | | | $ | 733 | | | $ | 13 | | | $ | 4,036 | | | | — | |
| | | | | | | | | | | | | | | | | | | | |
For the year ended December 31, 2010 | | | | | | | | | | | | | | | | | | | | |
Life insurance in force | | $ | 359,644 | | | $ | 150,446 | | | $ | 2,027 | | | $ | 211,225 | | | | 1 | % |
| | | | | | | | | | | | | | | | | | | | |
Insurance Revenues | | | | | | | | | | | | | | | | | | | | |
Life insurance and annuities | | $ | 4,440 | | | $ | 546 | | | $ | 69 | | | $ | 3,963 | | | | 2 | % |
Accident and health insurance | | | 316 | | | | 213 | | | | — | | | | 103 | | | | — | |
| | | | | | | | | | | | | | | | | | | | |
Total insurance Revenues | | $ | 4,756 | | | $ | 759 | | | $ | 69 | | | $ | 4,066 | | | | 2 | % |
| | | | | | | | | | | | | | | | | | | | |
For the year ended December 31, 2009 | | | | | | | | | | | | | | | | | | | | |
Life insurance in force | | $ | 356,432 | | | $ | 145,639 | | | $ | 2,157 | | | $ | 212,950 | | | | 1 | % |
| | | | | | | | | | | | | | | | | | | | |
Insurance Revenues | | | | | | | | | | | | | | | | | | | | |
Life insurance and annuities | | $ | 4,552 | | | $ | 628 | | | $ | 70 | | | $ | 3,994 | | | | 2 | % |
Accident and health insurance | | | 338 | | | | 232 | | | | — | | | | 106 | | | | — | |
| | | | | | | | | | | | | | | | | | | | |
Total insurance Revenues | | $ | 4,890 | | | $ | 860 | | | $ | 70 | | | $ | 4,100 | | | | 2 | % |
| | | | | | | | | | | | | | | | | | | | |
S-4
VALUATION AND QUALIFYING ACCOUNTSHARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
SCHEDULE V
VALUATION AND QUALIFYING ACCOUNTS
(In millions)
| | | | | | | | | | | | | | | | | | | | |
| | Balance January 1, | | | Charged to Costs and Expenses | | | Translation Adjustment | | | Write-offs/ Payments/ Other | | | Balance December 31, | |
2011 | | | | | | | | | | | | | | | | | | | | |
Valuation allowance on deferred tax asset | | $ | 139 | | | $ | (50 | ) | | $ | — | | | $ | — | | | $ | 89 | |
Valuation allowance on mortgage loans | | | 62 | | | | (25 | ) | | | — | | | | (14 | ) | | | 23 | |
2010 | | | | | | | | | | | | | | | | | | | | |
Valuation allowance on deferred tax asset | | | 80 | | | | 59 | | | | — | | | | — | | | | 139 | |
Valuation allowance on mortgage loans | | | 260 | | | | 108 | | | | — | | | | (306 | ) | | | 62 | |
2009 | | | | | | | | | | | | | | | | | | | | |
Valuation allowance on deferred tax asset | | | 49 | | | | 31 | | | | — | | | | — | | | | 80 | |
Valuation allowance on mortgage loans | | | 13 | | | | 292 | | | | — | | | | (45 | ) | | | 260 | |
S-5